WO2015111597A1 - Method for preparing citrulline - Google Patents

Method for preparing citrulline Download PDF

Info

Publication number
WO2015111597A1
WO2015111597A1 PCT/JP2015/051462 JP2015051462W WO2015111597A1 WO 2015111597 A1 WO2015111597 A1 WO 2015111597A1 JP 2015051462 W JP2015051462 W JP 2015051462W WO 2015111597 A1 WO2015111597 A1 WO 2015111597A1
Authority
WO
WIPO (PCT)
Prior art keywords
citrulline
arginine
culture
microorganism
medium
Prior art date
Application number
PCT/JP2015/051462
Other languages
French (fr)
Japanese (ja)
Inventor
圭介 古市
玲子 渡部
伊藤 裕之
恵理 山本
Original Assignee
株式会社明治
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社明治 filed Critical 株式会社明治
Priority to JP2015559080A priority Critical patent/JP6535285B2/en
Priority to SG11201605881YA priority patent/SG11201605881YA/en
Priority to CN201580015339.1A priority patent/CN107172883A/en
Publication of WO2015111597A1 publication Critical patent/WO2015111597A1/en
Priority to HK18102979.1A priority patent/HK1243461A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/10Citrulline; Arginine; Ornithine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Definitions

  • the present invention relates to a method for preparing citrulline, and more particularly to a method for preparing citrulline using microorganisms such as lactic acid bacteria.
  • the present invention also relates to a method for producing a composition (eg, dairy product) containing citrulline at a high concentration.
  • the present invention includes a method for preparing a culture solution containing a microorganism capable of producing citrulline with enhanced conversion efficiency from arginine to citrulline, and a microorganism capable of producing citrulline with an increased cell concentration.
  • the present invention relates to a method for preparing a culture solution.
  • Citrulline is a functional amino acid, and in Japan, its use as a food was approved in 2007 after its use as a medicine. In addition, citrulline has been ingested overseas as a food product since before 2007, and has been sold as a supplement, for example, for functions of improving blood flow, preventing arteriosclerosis, and enhancing energy. Furthermore, it has been reported that citrulline has other functions such as coldness improvement, skin function improvement, fatigue reduction / recovery, muscle growth, and motor function improvement.
  • citrulline is extremely expensive as a food material, and the amount of intake necessary for exerting its function is relatively large (for example, several hundred mg). Therefore, when citrulline is to be added to foods or the like in an effective amount, the problem is that it is expensive.
  • Citrulline is currently produced mainly by fermentation.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 63-068091
  • Patent Document 2 describes the production of L-citrulline by culturing microorganisms belonging to the genus Corynebacterium and Brevibacterium and generating and accumulating L-citrulline in the culture solution. The law is disclosed.
  • Patent Laid-Open No. 05-168486 Patent Document 2 discloses that a lactic acid bacterium belonging to the genus Pediococcus is infected with a bacteriophage to act on L-arginine to produce L-citrulline. A method for producing L-citrulline is disclosed.
  • Patent Document 3 discloses that L-ornithine-producing deficient cells dried with a water-soluble organic solvent are brought into contact with L-arginine to produce L-citrulline. -A method for producing citrulline is disclosed. This publication exemplifies bacteria belonging to the genera Bacillus, Pseudomonas, and Streptococcus.
  • Patent Document 4 discloses a method for producing L-citrulline by a fermentation method of Vibrio bacteria.
  • Non-patent Documents 1, 2, and 3 describe that all of arginine was converted to ornithine by L. lactis .
  • Non-Patent Document 3 describes as a known fact that all of arginine is converted to ornithine when arginine is metabolized by L. lactis .
  • Japanese Patent Application Laid-Open No. 2009-112205 Patent Document 5 describes that an ornithine-containing composition is produced by producing L-ornithine in a fermentation process for producing cheese or the like.
  • arginine deiminase an enzyme that converts arginine to citrulline
  • OTC ornithine carbamyltransferase
  • citrulline is converted to citrulline by ADI in microorganisms having the ability to metabolize arginine, but citrulline is immediately converted to ornithine by OTC, so that citrulline accumulates in the culture medium. It is suggested not to.
  • Inventors of the present invention by using a microorganism having citrulline-producing ability, cultivating citrulline efficiently by culturing a medium at a temperature higher than normal (optimum temperature for culturing microorganisms). The knowledge that it can be obtained.
  • the present inventors ferment a raw material (for example, raw milk) by using a microorganism having citrulline-producing ability at a temperature higher than normal (optimum temperature for fermentation of the microorganism), thereby producing citrulline.
  • the knowledge that it can manufacture the composition (For example, food-drinks, such as fermented milk products) contained in high concentration, was acquired.
  • the present inventors have obtained the knowledge that the ability of microorganisms to produce citrulline can be enhanced by adding arginine to a medium or raw material and culturing and fermenting it.
  • the present inventors have obtained knowledge that the concentration (number) of microorganisms can be increased by culturing while controlling the pH of the medium (culture solution).
  • the present invention is based on these findings.
  • an object of the present invention is to provide a method for culturing and fermenting microorganisms with improved conversion efficiency from arginine to citrulline.
  • the object of the present invention is to provide a culture method in which the concentration of microorganisms capable of producing citrulline is increased.
  • the present invention relates to the following aspects (1) to (18).
  • the lactic acid bacterium is one or more selected from the group consisting of Lactococcus lactis spp. Lactis OLS3789, OLS3797, and OLS3818, according to (2) A method for preparing citrulline
  • a method for producing a citrulline-containing composition wherein a microorganism having citrulline-producing ability is added (blended) to a raw material and fermented at a temperature of 40 ° C or higher and 70 ° C or lower.
  • the lactic acid bacterium is one or more selected from the group consisting of Lactococcus lactis spp. Lactis OLS3789, OLS3797, and OLS3818, according to (6)
  • a method for producing a citrulline-containing composition (9) The method for producing a citrulline-containing composition according to any one of (5) to (8), wherein the raw material is raw material milk. (10) The method for producing a citrulline-containing composition according to any one of (5) to (9), wherein the citrulline-containing composition is a food or drink.
  • a method for preparing a culture solution comprising a microorganism having a citrulline-producing ability and having enhanced conversion efficiency from arginine to citrulline at a culture temperature of 40 ° C. or higher and 70 ° C. or lower, the microorganism having citrulline-producing ability Is cultured in a medium supplemented with arginine.
  • (12) Add arginine to the medium before culturing and / or The method for preparing a culture solution according to (11), wherein arginine is intermittently added during the culture, or arginine is continuously added during the culture.
  • Culture having a citrulline producing ability including a microorganism having an increased conversion efficiency from arginine to citrulline at a culture temperature of 35 ° C. or higher and 70 ° C. or lower, and having an increased concentration of the microorganism (cell concentration)
  • a method for preparing a liquid characterized in that a microorganism having citrulline-producing ability is added to arginine and cultured in a medium having a pH in the range of 5 to 7, to increase the concentration of the microorganism.
  • citrulline can be produced efficiently. Moreover, according to the method for producing a citrulline-containing composition of the present invention, a nutritional composition such as a dairy product containing citrulline at a high concentration can be obtained. Moreover, according to the microorganism culture method and fermentation method of the present invention, the conversion efficiency from arginine to citrulline can be increased. And according to the microorganism cultivation method of the present invention, the concentration of microorganisms can be increased.
  • citrulline-containing composition of the present invention a microorganism having the ability to produce citrulline with improved conversion efficiency from arginine to citrulline and / or increased microorganism concentration and / or Alternatively, citrulline can be efficiently produced using the culture solution, and a nutritional composition such as a dairy product containing citrulline at a high concentration can be obtained.
  • the method for preparing citrulline of the present invention is characterized in that a microorganism having citrulline-producing ability is inoculated into a medium and cultured at a temperature higher than usual (the optimum temperature for culturing microorganisms).
  • the culture temperature is specifically 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower.
  • the culture temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
  • the culture temperature in the present invention is higher than the normal culture temperature (for example, optimum temperature) of microorganisms having citrulline production ability.
  • Citrulline can be efficiently produced by culturing microorganisms in such a temperature range.
  • L. lactis having the ability to metabolize arginine is arginine deiminase (ADI), an enzyme that converts arginine to citrulline, and ornithine carbamyltransferase (ADI), an enzyme that converts citrulline to ornithine.
  • ADI arginine deiminase
  • ADI arginine deiminase
  • ADI ornithine carbamyltransferase
  • OTC OTC gene, both of which are thought to be controlled by the same promoter.
  • ADI enhances the conversion of arginine to citrulline
  • OTC suppresses the conversion of citrulline to ornithine, or It is considered that citrulline accumulates in the medium (culture medium) with both of these actions and phenomena. That is, as in the present invention, when the culture temperature is high, arginine is efficiently converted to citrulline, and therefore, it is considered that an efficient method for preparing citrulline can be realized.
  • the culture time of the present invention is not particularly limited as long as it is appropriately selected from the conditions under which a microorganism capable of producing citrulline can be cultured, but is preferably 2 to 48 hours, more preferably 3 to 36 hours, and still more preferably 4 to 4 hours. 24 hours.
  • the microorganism having citrulline producing ability of the present invention is not particularly limited as long as it produces citrulline, but is preferably 40 ° C. or higher and 48 ° C. or lower, more preferably 42 ° C. or higher and 47 ° C. or lower, and further preferably 44 ° C. or higher. It is preferable to culture at a temperature of 46 ° C. or less to efficiently produce citrulline. According to another aspect of the present invention, the temperature is 40 ° C. or more and 70 ° C. or less, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43 ° C. It is.
  • the microorganism having citrulline producing ability in the present invention is preferably a lactic acid bacterium, bifidobacteria or propionic acid bacterium having citrulline producing ability, more preferably a lactic acid bacterium or bifidobacteria having citrulline producing ability, and more preferably. Is a lactic acid bacterium having citrulline-producing ability.
  • the lactic acid bacteria having citrulline-producing ability of the present invention are preferably Lactococcus lactis, Lactobacillus fermentum, Lactobacillus buchnerii, Enterococcus faecalis, Oenococcus oeni, Pediococcus pentosaceus, Lactobacillus amylovorus, lacto One or more selected from the group consisting of Bacillus brevis and Lactobacillus reuteri, more preferably selected from the group consisting of Lactococcus lactis, Lactobacillus fermentum, and Lactobacillus buchneri Or more, more preferably Lactococcus lactis.
  • the Lactococcus lactis having the ability to produce citrulline of the present invention is preferably one or more selected from the group consisting of Lactococcus lactis subspecies lactis and Lactococcus lactis subspecies cremolith, more preferably Is Lactococcus lactis subsp .
  • Lactis more preferably one or two selected from the group consisting of Lactococcus lactis spp. Lactis OLS3789, OLS3797, and OLS3818 More than a seed. These strains are deposited with the depository as described later.
  • Lactococcus lactis spp. Lactis OLS3789 having the ability to produce citrulline according to the present invention is Lactococcus lactis spp. Lactis OLS3789 as described above, and received from the National Institute of Microbiology, Japan Patent Evaluation Organization: NITE BP-1387 (Indication of identification: Lactococcus lactis spp. Lactis OLS3789, deposit date: July 18, 2012), Lactococcus lactis spp. Lactis OLS3797, independent administrative agency Product Evaluation Technology Organization, Patent Microorganism Depositary Center No. NITE BP-1388 (indication of identification: Lactococcus lactis spp.
  • Lactis OLS3797 date of deposit: July 18, 2012
  • Lactococcus lactis spp. Lactis OLS3818 an independent administrative agency receiving the product evaluation technology mechanism, Patent microorganisms Depositary number: NITE BP-1389 (of identification:. Lactococcus lactis spp lactis OLS3818, date of deposit: July 18, 2012) that it has been deposited in A.
  • Lactococcus lactis spp. Lactis OLS3789 has the following scientific properties (morphological, characteristics on the medium, physiological properties, etc.).
  • Lactococcus lactis spp. Lactis OLS3797 has the following scientific properties (morphological, characteristics on the medium, physiological properties, etc.).
  • Lactococcus lactis spp. Lactis OLS3818 has the following scientific properties (morphological, characteristics on the medium, physiological properties, etc.).
  • the medium of the present invention may be appropriately selected from those capable of culturing microorganisms capable of producing citrulline, and is not particularly limited.
  • examples thereof include skim milk, skim concentrated milk, reduced skim milk, and their protein degradation products, whey. , Whey concentrate, reduced whey, and their protein degradation products, raw milk, whole fat milk (sterilized milk), whole fat concentrated milk, reduced whole fat milk, etc., preferably skim milk, reduced skim milk , And these protein degradation products, whey, reduced whey, and these protein degradation products.
  • citrulline is produced in the medium.
  • the medium containing citrulline may be used as it is as a raw material or material for food or drink, preferably as a raw material or material for dairy products, or citrulline is separated (isolated or the like) from this medium.
  • citrulline having a desired purity may be prepared and used after processing by treatment such as or concentration.
  • functional foods, nutritional foods, etc. are mentioned as food and drink, and dairy products include, for example, milk drinks, fermented milk (more preferably yogurt), lactic acid bacteria drinks, cheese, ice cream and the like. .
  • a microorganism having citrulline-producing ability is added (mixed) to a raw material and fermented at a temperature higher than usual (the optimum temperature for fermentation of microorganisms). It is characterized by doing.
  • the fermentation temperature is specifically 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower.
  • the fermentation temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
  • the fermentation temperature in the present invention is higher than the normal fermentation temperature (for example, optimum temperature) of microorganisms having citrulline production ability.
  • Citrulline can be efficiently produced by culturing microorganisms in such a temperature range. About this reason, it is thought similarly to the reason already demonstrated in the preparation method of the citrulline of this invention.
  • the citrulline may be used as it is as a citrulline-containing composition without isolating citrulline from the citrulline-containing medium, or a desired operation (for example, centrifugation, You may utilize the culture medium processed by membrane separation etc. as a citrulline containing composition.
  • the fermentation time of the present invention may be appropriately selected from the conditions under which a microorganism having citrulline producing ability can be fermented, and is not particularly limited, but is preferably 2 to 24 hours, more preferably 3 to 16 hours, still more preferably 4 to 4 hours. 12 hours.
  • the raw material of the present invention may be appropriately selected from those that can be fermented by microorganisms capable of producing citrulline, and is not particularly limited.
  • skim milk, skim concentrated milk, reduced skim milk, and their protein degradation products whey , Whey concentrate, reduced whey, and their protein degradation products, raw milk, whole fat milk (sterilized milk), whole fat concentrated milk, reduced whole fat milk, etc., preferably skim milk, reduced skim milk , And these protein degradation products, whey, reduced whey, and these protein degradation products.
  • a milk raw material or a dairy product when raw milk is used as a raw material, a milk raw material or a dairy product can be obtained as a citrulline-containing composition.
  • a function derived from citrulline is added to the obtained milk raw material or dairy product (citrulline-containing composition), and its nutritional value is enhanced.
  • citrulline is not added (mixed) from the outside, but the citrulline content can be increased in the production process. The manufacturing cost of the final product can be kept low.
  • fermented milk (more preferably yogurt) is obtained as a citrulline-containing composition by using fermented milk mix (more preferably yogurt mix) as a raw material.
  • a function derived from citrulline is added to the obtained fermented milk (more preferably yogurt), and its nutritional value is enhanced.
  • citrulline content can be increased in the production process instead of adding (blending) citrulline from the outside. Can reduce the manufacturing cost of the final product based on yogurt).
  • citrulline is produced in the raw material.
  • the raw material containing citrulline may be used as it is as a raw material or raw material for food or drink, preferably as a raw material or raw material for dairy products, or citrulline is separated (isolated, etc.) from this raw material.
  • citrulline having a desired purity may be prepared and used after processing by treatment such as or concentration.
  • functional foods, nutritional foods, etc. are mentioned as food and drink
  • dairy products include, for example, milk drinks, fermented milk (more preferably yogurt), lactic acid bacteria drinks, cheese, ice cream and the like. .
  • Citrulline-containing food and drink as described above, a medium containing citrulline obtained by the method for preparing citrulline of the present invention, or a raw material containing citrulline obtained by the method for producing a citrulline-containing composition according to the present invention, or a processed product thereof,
  • a medium containing citrulline obtained by the method for preparing citrulline of the present invention or a raw material containing citrulline obtained by the method for producing a citrulline-containing composition according to the present invention, or a processed product thereof
  • each can be used as the food and drink itself or the raw material or material of the food or drink. Therefore, according to the present invention, there is provided a citrulline-containing food or drink using the citrulline-containing medium of the present invention, or a raw material containing citrulline, or a processed product thereof as the food or drink itself or the raw material or material of the food or drink. be able to.
  • the citrulline or citrulline-containing composition, or a processed product thereof can be efficiently kept at low preparation costs (processing costs), production costs, etc. Can be provided. Therefore, by using the citrulline or citrulline-containing composition of the present invention, it is possible to increase the citrulline content in the production process of citrulline-containing foods and drinks while increasing the commercial value by adding functions derived from citrulline. For the reason of being able to do so, the manufacturing cost etc. can be suppressed low and it can provide efficiently.
  • the citrulline-containing food or drink of the present invention is not particularly limited as long as it allows the inclusion of citrulline, and examples thereof include milk drinks, fermented milk (more preferably yogurt), lactic acid bacteria drinks, cheese, ice cream and the like. Dairy products.
  • Preparation method of culture solution containing microorganisms capable of producing citrulline with increased conversion efficiency from arginine to citrulline Preparation of culture solution containing microorganisms capable of producing citrulline with improved conversion efficiency from arginine to citrulline of the present invention
  • the method is characterized in that the microorganism is cultured in a medium to which arginine is added at a culture temperature higher than usual (the optimum temperature for fermentation of the microorganism).
  • the culture temperature is specifically 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower.
  • the culture temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
  • the microorganism having the ability to produce citrulline of the present invention is cultured at a temperature of 40 ° C. to 48 ° C., preferably 42 ° C. to 47 ° C., more preferably 44 ° C. to 46 ° C.
  • a method for improving citrulline production ability of the microorganism is provided.
  • the culturing is performed at 40 ° C. or higher and 70 ° C. or lower, a preferable upper limit temperature of the culture is 68 ° C., a more preferable upper limit is 65 ° C., and a preferable lower limit temperature is 42 ° C., more preferable.
  • the lower limit is 43 ° C.
  • the microorganism having the citrulline producing ability of the present invention was obtained by appropriately treating the culture or composition obtained by the method for preparing citrulline of the present invention or the method for producing a citrulline-containing composition, A microorganism having enhanced conversion efficiency from arginine to citrulline can be used.
  • the medium of a preferred embodiment of the present invention is a medium to which arginine is added.
  • Citrulline can be efficiently produced by culturing microorganisms with such a medium composition (formulation).
  • the reason for this can be considered as follows.
  • the following explanation (theory) is merely an assumption, and the present invention is not limited by this theory. That is, as described in the prior art, for example, in Non-Patent Documents 1 and 2 above, regarding the metabolic activity of arginine in L. lactis, when arginine is added to the medium, the amount of transcription of genes encoding ADI and OCT is increased. It is reported to increase.
  • the addition of arginine to the medium is expected to increase the transcription amount of the gene encoding ADI.
  • the culture temperature is 40 ° C. or higher and 70 ° C., and in some cases 48 ° C. or lower, the culture temperature is high. In addition, it is considered that this phenomenon is maintained.
  • the transcription amount of the gene encoding ADI increases, or even when the culture temperature is high, such as 40 ° C. or higher and 70 ° C. or lower, and in some cases 48 ° C. or lower, It is difficult to predict immediately that this phenomenon is maintained or that the transcription amount of the gene encoding OCT is suppressed. Therefore, it is not appropriate to judge that the present invention is obvious from Non-Patent Documents 1 and 2.
  • arginine when culturing a microorganism having citrulline-producing ability, arginine is added to the medium before culturing and / or arginine is intermittently added to the medium during the culture. Alternatively, arginine is continuously added to the medium during the culture. Thereby, the citrulline producing ability of the microorganisms having citrulline producing ability can be enhanced. In this case, it is preferable that the microorganism having citrulline-producing ability has a long time for contacting with a sufficient concentration of arginine.
  • arginine when culturing a microorganism capable of producing citrulline, it is preferable to add (formulate) arginine to the medium before culturing, and add arginine to the medium before culturing, and intermittently or More preferably, arginine is continuously added (added) to the medium, and more preferably, arginine is continuously added to the medium during the culture.
  • the addition amount of arginine of the present invention is not particularly limited as long as it is appropriately selected from citrulline or a composition containing citrulline, or conditions under which these processed products can be prepared and manufactured. To 5% by mass, more preferably 0.7 to 4% by mass, and still more preferably 1 to 3% by mass.
  • the method for adding arginine of the present invention is not particularly limited as long as arginine can be added (mixed) aseptically to the medium, and after adding arginine to the medium, the medium is subjected to heat sterilization or filter sterilization.
  • an arginine aqueous solution may be separately prepared, and the arginine aqueous solution may be added to the medium after heat sterilization or filter sterilization.
  • a medium having a pH in the range of 5 or more and 7 or less is used, and preferably in a range of pH of 5 or more and 6.5 or less.
  • a certain medium is used, more preferably a medium having a pH in the range of 5 or more and 6 or less, and further preferably a medium having a pH in the range of 5.5 or more and 6 or less.
  • “cultured in a medium having a pH in the range of 5 to 7” preferably means that the pH of the medium is in the range of 5 to 7 from the beginning to the end of the culture. However, this does not necessarily mean that the pH of the medium is always in the range of 5 or more and 7 or less from the beginning to the end of the culture. That is, in the state where the pH of the medium is in the range of 5 or more and 7 or less, the culture may be performed for a sufficient time to increase the conversion efficiency from arginine to citrulline, specifically 1 to 60 hours, preferably 2 to The culture may be performed for 48 hours, more preferably 3 to 36 hours, and still more preferably 4 to 24 hours.
  • the method for adding an alkali of the present invention is not particularly limited as long as it is appropriately selected from conditions under which the pH of the medium can be controlled or managed within a predetermined range.
  • the microorganism before culturing a microorganism having citrulline-producing ability, the microorganism may be activated and cultured.
  • the culture conditions for the activation culture may be appropriately selected according to the type of microorganism having citrulline production ability, and are not particularly limited.
  • the microorganism cells are subjected to a treatment such as centrifugation or membrane separation from a culture solution containing microorganisms capable of producing citrulline with increased conversion efficiency from arginine to citrulline. Then, the cells may be used in the method for preparing citrulline or the method for producing a citrulline-containing composition of the present invention.
  • a treatment such as centrifugation or membrane separation from a culture solution containing microorganisms capable of producing citrulline with increased conversion efficiency from arginine to citrulline.
  • Method for producing a composition containing a microorganism capable of producing citrulline with enhanced conversion efficiency from arginine to citrulline Production of a composition comprising a microorganism capable of producing citrulline with enhanced efficiency of conversion of arginine into citrulline according to the present invention
  • the method is characterized in that the microorganism is fermented with a raw material to which arginine is added at a culture temperature higher than usual (the optimum temperature for fermentation of the microorganism).
  • the culture temperature is specifically 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower.
  • the culture temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
  • the microorganism having citrulline producing ability of the present invention is fermented at a temperature of 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower.
  • a method for improving citrulline production ability of the microorganism is provided.
  • the fermentation temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
  • the microorganism having the citrulline production ability of the present invention is provided with arginine obtained by appropriately treating the culture or composition obtained by the method for preparing citrulline of the present invention or the method for producing a citrulline-containing composition. It is possible to use microorganisms that have improved the conversion efficiency from citrus to citrulline.
  • the raw material according to a preferred embodiment of the present invention is a raw material to which arginine is added.
  • Citrulline can be efficiently produced by fermenting microorganisms with the composition (formulation) of such raw materials. The reason for this is considered to be the same as the reason explained in the method for preparing a culture solution containing a microorganism having the ability to produce citrulline with improved conversion efficiency from arginine to citrulline of the present invention.
  • the medium is directly used as a citrulline-containing composition without isolating citrulline from the citrulline-containing medium.
  • the medium treated by a desired operation for example, centrifugation, membrane separation, etc. may be used as the citrulline-containing composition.
  • the addition amount of arginine of the present invention is not particularly limited as long as it is appropriately selected from citrulline or a composition containing citrulline, or conditions under which these processed products can be prepared and manufactured, but is preferably 0.5 to the raw material. To 5% by mass, more preferably 0.7 to 4% by mass, and still more preferably 1 to 3% by mass.
  • the method for adding arginine of the present invention is not particularly limited as long as arginine can be aseptically added (blended) to the medium, and after adding arginine to the raw material, the raw material is subjected to heat sterilization or filter sterilization.
  • an arginine aqueous solution may be separately prepared, and the arginine aqueous solution may be added to the raw material after heat sterilization or filter sterilization.
  • arginine when culturing a microorganism having citrulline-producing ability, arginine is added to the medium before culturing and / or arginine is intermittently added to the medium during the culture. Alternatively, arginine is continuously added to the medium during the culture. Thereby, the citrulline producing ability of the microorganisms having citrulline producing ability can be enhanced. At this time, it is preferable for the microorganism having citrulline producing ability to have a long time for contacting with a sufficient concentration of arginine.
  • arginine it is preferable to add (formulate) arginine to the medium or raw material before culturing, and add arginine to the medium before culturing and intermittently (for example, a predetermined amount in a lump) during the culturing or It is more preferable to add (add) arginine to the medium continuously (for example, gradually little by little), and it is more preferable to add arginine to the medium continuously during the culture.
  • the microorganism may be activated and cultured before fermentation using a microorganism having citrulline-producing ability.
  • the culture conditions for the activation culture may be appropriately selected according to the type of microorganism having citrulline production ability, and are not particularly limited.
  • the composition of a microorganism containing citrulline-producing ability with enhanced conversion efficiency from arginine to citrulline is centrifuged, membrane-separated, etc.
  • the preparation method is characterized in that the microorganism is cultured in a medium having a pH in the range of 5 or more and 7 or less at a normal culture temperature (optimum temperature for fermentation of the microorganism).
  • a culture temperature 48 ° C. or lower, preferably 38 ° C. or higher and 48 ° C. or lower, more preferably 40 ° C. or higher and 48 ° C. or lower, more preferably 42 ° C. or higher and 47 ° C.
  • the microorganism may be cultured at a temperature suitable for culturing a microorganism capable of producing citrulline (for example, an optimum temperature).
  • the microorganism is cultured at a culture temperature of 35 ° C. or higher and 70 ° C.
  • the lower limit is preferably 38 ° C., more preferably 40 ° C., still more preferably 42 ° C., particularly preferably 44 ° C.
  • the upper limit is preferably 68 ° C., more preferably 65 ° C.
  • the pH is in the range of 5 to 7, preferably the pH is in the range of 5 to 6.5, more preferably the pH is 5 or more. It is characterized by culturing in a medium to which arginine is added, which is in the range of 6 or less, more preferably in the range of pH 5.5 or more and 6 or less.
  • the microorganism having citrulline producing ability of the present invention is 35 ° C. or higher and 48 ° C. or lower, preferably 38 ° C. or higher and 48 ° C. or lower, more preferably 40 ° C. or higher and 48 ° C. or lower, and still more preferably.
  • concentration of the microorganism bacterial cell concentration
  • the microorganism is cultured at a culture temperature of 35 ° C. or higher and 70 ° C.
  • the microorganism having the citrulline production ability of the present invention is provided with arginine obtained by appropriately treating the culture or composition obtained by the method for preparing citrulline of the present invention or the method for producing a citrulline-containing composition. It is possible to use microorganisms that have improved the conversion efficiency from citrus to citrulline.
  • a medium having a pH in the range of 5 or more and 7 or less is used, and preferably in a range of pH of 5 or more and 6.5 or less.
  • a concentration of the microorganism (bacteria) using a certain medium, more preferably using a medium having a pH in the range of 5 to 6, more preferably using a medium having a pH in the range of 5.5 to 6 A method for improving body concentration is provided.
  • concentration) of the microorganisms which have a citrulline production ability can be raised, and a citrulline production ability can be raised.
  • the addition amount of arginine of the present invention is not particularly limited as long as it is appropriately selected from citrulline or a composition containing citrulline, or conditions under which these processed products can be prepared and manufactured. To 5% by mass, more preferably 0.7 to 4% by mass, and still more preferably 1 to 3% by mass.
  • “cultured in a medium having a pH in the range of 5 to 7” preferably means that the pH of the medium is in the range of 5 to 7 from the beginning to the end of the culture. However, this does not necessarily mean that the pH of the medium is always in the range of 5 or more and 7 or less from the beginning to the end of the culture. That is, in the state where the pH of the medium is in the range of 5 or more and 7 or less, it may be cultured for a sufficient time to increase the bacterial cell concentration, specifically 1 to 60 hours, preferably 2 to 48 hours. The culture is preferably performed for 3 to 36 hours, more preferably 4 to 24 hours.
  • the method for adding alkali is not particularly limited as long as it is appropriately selected from the conditions under which the pH of the medium can be controlled or managed within a predetermined range.
  • the microorganism before culturing a microorganism having citrulline-producing ability, the microorganism may be activated and cultured.
  • the culture conditions for the activation culture may be appropriately selected according to the type of microorganism having citrulline production ability, and are not particularly limited.
  • the microorganism body is subjected to a treatment such as centrifugation or membrane separation from a culture solution containing a microorganism having a citrulline-producing ability and having an increased cell concentration, and then the present invention.
  • a treatment such as centrifugation or membrane separation from a culture solution containing a microorganism having a citrulline-producing ability and having an increased cell concentration.
  • You may use the microbial cell for the preparation method of the citrulline of invention, or the manufacturing method of a citrulline containing composition.
  • the arginine when arginine is used as an alkali, the arginine is added to the medium by the method for preparing citrulline of the present invention, the method for preparing a culture solution containing a microorganism having the ability to produce citrulline of the present invention, or the like. And in common. Therefore, when arginine is excessively added to the medium by the above preparation method or the like, the pH of the medium may change to the alkali side, and the pH of the medium may greatly deviate from the range of 5 to 7. . When arginine is added excessively to the medium in this way, citrulline production ability can be increased somewhat, so it is acceptable only for the purpose of enhancing citrulline production ability, but the cell concentration is sufficiently increased.
  • citrulline production amount relative amount of citrulline
  • the production of citrulline per culture solution (medium) containing the microorganisms Note that the amount (absolute amount of citrulline) may not be sufficiently increased.
  • Method for preparing a culture solution containing microorganisms having citrulline-producing ability with increased conversion efficiency from arginine to citrulline and increased microorganism concentration (bacterial cell concentration) Increased conversion efficiency from arginine to citrulline of the present invention
  • a method for preparing a culture solution containing a microorganism having a citrulline-producing ability and having an increased microorganism concentration (cell concentration) has a pH of 5 at a culture temperature higher than normal (optimum temperature for fermentation of microorganisms).
  • the microorganism is cultured in a medium in the range of 7 or less, and the microorganism is cultured at a culture temperature of 40 to 48 ° C., preferably 42 to 47 ° C., more preferably 44 to 46 ° C.
  • the pH is in the range of 5 to 7, preferably the pH is in the range of 5 to 6.5, more preferably the pH is in the range of 5 to 6, more preferably the pH is In the range of .5 to 6, characterized by culturing in a medium supplemented with arginine.
  • the preparation method according to the present invention is a method in which the microorganism is in a temperature range of 40 ° C. or higher and 70 ° C.
  • the pH is in the range of 5 to 7, preferably the pH is in the range of 5 to 6.5, more preferably the pH is in the range of 5 to 6. More preferably, the culture is performed in a medium supplemented with arginine having a pH in the range of 5.5 to 6.
  • the preparation conditions of the culture solution containing the microorganisms having citrulline-producing ability with improved conversion efficiency from arginine to citrulline of the present invention, and the citrulline-producing ability with increased microorganism concentration of the present invention cell concentration
  • the method for adding arginine to a medium (culture solution) and the method for adjusting (controlling) the pH of the medium (culture solution) increase the conversion efficiency from arginine to citrulline and increase the concentration of microorganisms. As long as the (bacterial cell concentration) can be increased, the above method can be applied.
  • arginine when culturing a microorganism having citrulline-producing ability, arginine is added to the medium before culturing and / or arginine is intermittently added to the medium during the culture. Alternatively, arginine is continuously added to the medium during the culture. Thereby, the citrulline producing ability of the microorganisms having citrulline producing ability can be enhanced. At this time, it is preferable for the microorganism having citrulline producing ability that the pH of the medium is neutral at the start of the culture.
  • arginine it is preferable not to add (formulate) arginine to the medium before culturing, and intermittently (for example, a predetermined amount in a lump) or during the culturing without adding arginine to the medium before culturing. It is more preferable to add (add) arginine to the medium (for example, gradually in small amounts), and it is more preferable to add arginine to the medium continuously during the culture.
  • the conversion efficiency from arginine to citrulline can be increased, and the concentration of the microorganism (cell density) can be increased.
  • the addition amount of arginine of the present invention is not particularly limited as long as it is appropriately selected from citrulline or a composition containing citrulline, or conditions under which these processed products can be prepared and manufactured. To 5% by mass, more preferably 0.7 to 4% by mass, and still more preferably 1 to 3% by mass.
  • the bacterial cell concentration was measured by the method for measuring the number of lactic acid bacteria described in "Ministerial Ordinance on Milk and Dairy Product Component Standards (Ministerial Ordinance on Milk) (Japan)".
  • the culture temperature of the BCP medium was 30 ° C.
  • Arginine concentration, citrulline concentration and ornithine concentration were measured by HPLC method.
  • Example 1 Arginine metabolic capacity of lactic acid bacteria and bifidobacteria Arginine metabolic capacity was examined for lactic acid bacteria and bifidobacteria described in Table 1 below.
  • the MRS medium or GAM medium was sterilized at 121 ° C. for 15 minutes. Thereafter, the aqueous arginine solution was sterilized by filtration and then added to these media to adjust the arginine concentration to 27 mM.
  • These prepared media were inoculated with 1% by weight of an activating culture solution of lactic acid bacteria and bifidobacteria MRS medium shown in Table 1 below.
  • the culture temperature is 30 ° C. and the culture time is 16 hours, and the aerobic culture is performed in a stationary state. In other cells, the culture temperature is 37 ° C. and the culture time is 16 hours, and the culture is preferably performed in a stationary state. Air-cultured.
  • Example 2 Lactococcus lactis ssp.lactis and Lactococcus lactis ssp.diacetylactis result of metabolic capacity
  • Lactococcus lactis ssp.lactis the Lactococcus lactis ssp. 1 strain of Lactococcus lactis ssp.diacetylactis a related species of the lactis, citrulline to ornithine conversion We searched for strains that did not.
  • NO.1 to NO.29 are Lactococcus lactis ssp.lactis
  • NO.30 is Lactococcus lactis ssp.diacetylactis .
  • the MRS medium was sterilized at 121 ° C. for 15 minutes. Thereafter, the aqueous arginine solution was sterilized by filtration and then added to these media to adjust the arginine concentration to 27 mM.
  • These prepared media were inoculated with 1% by weight of an activated culture solution of MRS medium of the strains shown in Table 2 below. These strains were aerobically cultured in a stationary state at a culture temperature of 30 ° C. and a culture time of 16 hours.
  • Example 3 Effect of culture temperature (37 ° C, 40 ° C) on the metabolism of arginine in Lactococcus lactis ssp. Lactis
  • the cells were cultured in the same manner as in Example 2 except that the culture temperature was 37 ° C or 40 ° C. Then, the metabolic capacity of arginine was examined. The results were as shown in Table 3 below. Here, strains having relatively high Cit / Orn were searched and 6 strains were selected.
  • Example 4 Verification of arginine metabolic capacity of Lactococcus lactis ssp. Lactis in reduced skim milk (1) From the results of Example 3, strains having relatively high Cit / Orn were searched, and 5 strains were selected and used. That is, the metabolic ability of arginine was examined for 5 strains described in Table 4 below. At this time, reduced skim milk (concentration of skim milk powder: 10% by weight) to which arginine was added at 1% by weight (hereinafter referred to as “1% Arg + 10% reduced skim milk”) was used as a medium.
  • 1% Arg + 10% reduced skim milk concentration of skim milk powder
  • Example 5 Verification of the ability of Lactococcus lactis ssp. Lactis to metabolize arginine in reduced skim milk (2) Bacterial cells were cultured in the same manner as in Example 4 except that the culture temperature was 44.5 ° C., 46 ° C., and further from 50 ° C. to 70 ° C. in increments of 5 degrees, and the metabolic capacity of arginine was examined. The results were as shown in Table 5 below. In addition, from the result of Example 4, a strain having a relatively high Cit / Orn was searched, and three strains were selected and used.
  • Example 6 Use the Lactococcus lactis ssp.lactis OLS3797 strain or manufacture of yogurt containing citrulline using OLS3818 strain Lactococcus lactis ssp.lactis OLS3797 strain or OLS3818 strain to produce a fermented milk containing citrulline (yogurt). That is, raw material milk (yogurt base) described in Table 6 below was prepared and sterilized at 95 ° C. for 3 minutes. Then, as a yogurt starter, 2% by weight of a mixed starter of Lactobacillus bulgaricus and Streptococcus thermophilus is added to this raw milk, and Lactococcus lactis ssp.
  • a yogurt starter 2% by weight of a mixed starter of Lactobacillus bulgaricus and Streptococcus thermophilus is added to this raw milk, and Lactococcus lactis ssp.
  • Lactis OLS3797 strain or OLS3818 strain is added, fermented at 45 ° C, and yogurt Manufactured.
  • the culture solution of the MRS medium was centrifuged (8000 rpm, 10 minutes), and only the cells were collected and used. At this time, the amount of MRS medium used was the same weight as the amount of raw milk described in Table 6 below.
  • the concentrations of arginine, citrulline and ornithine in these fermented milk (yogurt) were measured. The results were as shown in Table 7 below. It was confirmed that most of arginine was metabolized and most of it was converted to citrulline. That is, it was revealed that fermented milk (yogurt) containing citrulline at a high concentration can be produced using Lactococcus lactis ssp. Lactis OLS3797 strain or OLS3818 strain.
  • Example 7 Examination of preparation method of culture solution of strain having high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis OLS3797) (1) A method for preparing a culture solution having high conversion efficiency (activity) from arginine to citrulline was examined.
  • L. lactis was statically cultured in MRS medium to prepare a culture solution.
  • MRS medium MRS medium
  • the growth of L. lactis stopped and the bacterial cell concentration did not increase as the pH of the culture solution decreased. Therefore, by adding alkali to the culture solution, suppressing the decrease in the pH of the culture solution, and controlling the pH, L.
  • lactis is stirred and cultured in the MRS medium (pH-controlled culture) to achieve the cell concentration.
  • the effect of was examined. That is, the possibility of increasing the conversion efficiency from arginine to citrulline per unit volume in the culture solution of L. lactis by controlling the pH of L. lactis in MRS medium was examined.
  • the MRS medium was sterilized at 121 ° C. for 15 minutes.
  • Aqueous sodium hydroxide NaOH: 10% by weight was added to the culture solution, and the L. lactis OLS3797 strain was stirred and cultured (pH controlled culture) while controlling the pH of the culture solution to 5.5. Measured over time. Specifically, the MRS medium activation culture solution (culture temperature: 30 ° C., culture time: 16 hours) of L. lactis OLS3797 strain was inoculated at 1% by weight into the MRS medium and stirred culture (culture temperature: 30 ° C.). , Stirring speed: 200 rpm). The change with time of the bacterial cell concentration was as shown in FIG.
  • the conversion efficiency from arginine to citrulline per unit volume in the culture solution of L. lactis is higher in the case of pH controlled culture in MRS medium than in the case of stationary culture in MRS medium. It was done.
  • the difference in conversion efficiency from arginine to citrulline per unit time / unit cell in the culture solution of L. lactis in the case of pH controlled culture in MRS medium compared to the case of static culture in MRS medium, the difference in conversion efficiency from arginine to citrulline per unit time / unit cell in the culture solution of L. lactis in the case of pH controlled culture in MRS medium.
  • the conversion efficiency from arginine to citrulline per unit time / unit cell is the concentration of citrulline 4 hours and 8 hours after the start of culture, the number of viable bacteria and the culture time (4 hours and 8 hours). Calculated as the value divided by.
  • Example 8 Examination of preparation method of culture solution of strain having high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis 3797 strain) (2) In Example 7, when L. lactis was cultured under pH control, the cell concentration (number of cells) increased, but the conversion efficiency from arginine to citrulline per unit time / unit cell did not change. Therefore, before starting the culture of L. lactis, by stationary culture was added to arginine to MRS medium, possibly the conversion efficiency is increased from arginine per unit volume in the culture of L. lactis to citrulline Was examined. That is, the L.
  • lactis OLS3797 strain was statically cultured in a normal MRS medium and an MRS medium containing 0.5% by weight of arginine, and “1% Arg + 10% reduced skim milk” was used. The conversion efficiency from arginine to citrulline was measured.
  • the MRS medium was sterilized at 121 ° C. for 15 minutes.
  • an activated culture solution of L. lactis 3797 strain (culture temperature 30 ° C., culture time 16 hours) is inoculated into 1% by weight of MRS medium and left to stand (culture temperature: 30 ° C., culture time: 16 hours). Then, 20 mL of this culture solution is centrifuged (8000 rpm, 10 minutes), and only the cells are collected, then inoculated into 40 mL of “1% Arg + 10% reduced skim milk” and stirred culture (culture temperature) : 44.5 ° C., culture time: 4 hours), and the conversion efficiency from arginine to citrulline was examined. The results were as shown in Table 9 below.
  • the activated culture solution was inoculated at 1% by weight into MRS medium containing 0.5% by weight of arginine and allowed to stand (culture temperature: 30 ° C., culture time: 16 hours). Then, 20 mL of this culture solution is centrifuged (8000 rpm, 10 minutes), and only the cells are collected, then inoculated into 40 mL of “1% Arg + 10% reduced skim milk” and stirred culture (culture temperature) : 44.5 ° C., culture time: 4 hours), and the conversion efficiency from arginine to citrulline was examined. The results were as shown in Table 9 below.
  • Example 9 Examination of preparation method of culture solution of strain having high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis OLS3797) (3)
  • arginine when arginine was added to the medium, the conversion efficiency of L. lactis from arginine to citrulline increased. Therefore, by adding arginine to the MRS medium before starting the cultivation of L. lactis and then carrying out pH-controlled cultivation, the conversion efficiency of arginine to citrulline per unit volume in the culture solution of L. lactis can be increased. The sex was examined. That is, L.
  • lactis OLS3797 strain was subjected to pH control culture in MRS medium containing 0.5% by weight of arginine, and the culture solution was used to convert arginine to citrulline in “1% Arg + 10% reduced skim milk”. The conversion efficiency of was measured.
  • the MRS medium was sterilized at 121 ° C. for 15 minutes. Thereafter, the aqueous arginine solution was sterilized by filtration and then added to this medium to adjust the arginine concentration to 0.5% by weight.
  • the culture broths after 8, 9, 10, 11, 12, and 13 hours from the start of the culture were collected, and these culture broths were cooled and stored in ice water. Then, this culture broth is inoculated at 5% by weight into “1% Arg + 10% reduced skim milk” and statically cultured (culture temperature: 44.5 ° C., culture time: 8 hours), from arginine to citrulline. The conversion efficiency was examined. The results were as shown in Table 10 below.
  • Example 10 Examination of a method for preparing a culture solution of a strain having a high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis OLS3797 strain) (4)
  • arginine was added to the medium before starting the culture of lactic acid bacteria (bacteria)
  • the conversion efficiency from arginine to citrulline was greatly increased, but reached the highest level compared to the case where arginine was not added.
  • the bacterial cell concentration decreased.
  • lactis collectively arginine to the culture medium (culture solution) (intermittently) was added, by pH control culture, per unit volume in the culture fluid of L. lactis The possibility of increasing the conversion efficiency of arginine to citrulline was investigated.
  • the MRS medium was sterilized at 121 ° C. for 15 minutes.
  • aqueous sodium hydroxide solution NaOH: 10% by weight
  • L. lactis OLS3797 strain was stirred and cultured (pH controlled culture) while controlling the pH of the culture solution to 5.5. Etc. were measured over time.
  • an arginine aqueous solution arginine: 10% by weight
  • the MRS medium activation culture solution of L L.
  • lactis OLS3797 strain (culture temperature: 30 ° C., culture time: 16 hours) was inoculated into the MRS medium at 1% by weight, NaOH was added, and the culture was performed.
  • Stirring culture (culture temperature: 30 ° C., stirring speed: 200 rpm) while controlling the pH of the solution to 5.5, and 10 hours after the start of the culture, the aqueous arginine solution is sterilized by filtration, and then added to this medium.
  • the arginine concentration was adjusted to 0.5% by weight. Changes in the bacterial cell concentration, pH, arginine concentration, citrulline concentration and ornithine concentration over time were as shown in FIG.
  • Example 7 As described above, the highest cell concentration reached 7.1 ⁇ 10 9 cfu / mL, and compared with Example 7, the cell concentration was comparable. On the other hand, compared with Example 9, the conversion efficiency from arginine to citrulline decreased.
  • Example 11 Examination of a method for preparing a culture solution of a strain having a high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis OLS3797 strain) (5)
  • arginine was added to the medium (culture solution) all at once (intermittently), and when pH-controlled culture was performed, normal (conventional) pH control was performed.
  • the highest cell concentration reached the same level, but before starting the cultivation of lactic acid bacteria (bacteria)
  • arginine is added to citrulline compared to the case where arginine is added to the medium. The conversion efficiency decreased. Therefore, while culturing L.
  • lactis arginine was added to the medium (culture medium) in small amounts (continuously), and pH-controlled culture was performed, so that per unit volume in the culture medium of L. lactis.
  • the possibility of increasing the conversion efficiency of arginine to citrulline was investigated.
  • the MRS medium was sterilized at 121 ° C. for 15 minutes.
  • aqueous arginine solution (arginine: 10% by weight) was added to the culture solution, and the L. lactis OLS3797 strain was stirred and cultured (pH controlled culture) while controlling the pH of the culture solution to 5.5. Measured over time. At this time, 4 hours after the start of the culture, an aqueous arginine solution (arginine: 10% by weight) was sterilized by filtration and then added to this medium (culture solution) to adjust the pH of the medium to 5.5. Specifically, the MRS medium activation culture solution of L.
  • lactis OLS3797 strain (culture temperature: 30 ° C., culture time: 16 hours) was inoculated into the MRS medium at 1% by weight, arginine was added, and the culture was performed.
  • Stirring culture (culture temperature: 30 ° C., stirring speed: 200 rpm) while controlling the pH of the solution to 5.5, and 4 hours after the start of the culture, the arginine aqueous solution was sterilized by filtration and then added to this medium. The pH of the medium was adjusted to 5.5. Changes in the bacterial cell concentration, pH, arginine concentration, citrulline concentration and ornithine concentration over time were as shown in FIG.
  • “Supernatant” is obtained by inoculating a supernatant obtained by centrifuging a culture solution into “1% ⁇ Arg + 10% reduced skim milk” at 5% by weight.
  • Cell was prepared by centrifuging the culture broth, removing the supernatant, freezing the collected cells at ⁇ 80 ° C., and then thawing them into “1% Arg + 10% reduced skim milk” Inoculated at 5% by weight.
  • arginine neutralizing agent, substrate
  • the medium culture solution
  • arginine was immediately converted to ornithine for a while after starting the addition of arginine to the medium, but in the latter half of the culture, some of the arginine was not converted to ornithine and was accumulated as it was. .
  • Example 9 the highest cell concentration reached 6.5 ⁇ 10 9 cfu / mL, and compared with Example 7 and Example 10, the cell concentration was comparable. And compared with Example 9, the conversion efficiency from arginine to citrulline became comparable. That is, here, the bacterial cell concentration increased and the conversion efficiency from arginine to citrulline increased.
  • the conversion efficiency from arginine to citrulline was also comparable when only the bacterial cells were collected and stored frozen. Then, 4 to 8 hours after the start of the culture, all of the arginine was metabolized and most of the arginine was converted to citrulline.
  • the concentration (inoculation amount) added to the medium (culture solution) is from 1/20 Decrease to about 1/50.
  • the concentration added to the medium is 5% by weight, when only the cells are collected and used, the concentration added to the medium can be estimated to be 0.25 to 0.1% by weight. That is, when arginine is added (as a neutralizing agent) continuously during culture (for example, until the end of the culture) and a culture solution is prepared by pH-controlled culture, only the cells are collected and used. Then, a dairy product containing citrulline at a high concentration can be efficiently produced.

Abstract

 Disclosed are a method for preparing citrulline that makes it possible to produce citrulline efficiently, and a method for producing a citrulline-containing composition containing citrulline at high concentration. Also disclosed are a method for culturing and a method for fermenting microorganisms having increased conversion efficiency from arginine to citrulline, and a culture method that increases the concentration of microorganisms having the ability to produce citrulline. Citrulline can be produced efficiently by inoculating medium with microorganisms having the ability to produce citrulline and culturing at a higher temperature than usual, and by adding microorganisms having the ability to produce citrulline to a raw material and fermenting at a higher temperature than usual. The conversion efficiency from arginine to citrulline can also be increased, or the concentration of microorganisms can be increased, by adding arginine to medium or raw material and culturing or fermenting microorganisms having the ability to produce citrulline, and by culturing by controlling the pH of the medium.

Description

シトルリンの調製方法Method for preparing citrulline
 本発明は、シトルリンの調製方法に関し、さらに詳しくは、乳酸菌などの微生物を用いたシトルリンの調製方法に関する。また、本発明は、シトルリンを高濃度で含む組成物(例えば、乳製品)の製造方法に関する。さらに、本発明は、アルギニンからシトルリンへの変換効率が高められた、シトルリン産生能を有する微生物を含む培養液の調製方法、および、菌体濃度が高められた、シトルリン産生能を有する微生物を含む培養液の調製方法に関する。 The present invention relates to a method for preparing citrulline, and more particularly to a method for preparing citrulline using microorganisms such as lactic acid bacteria. The present invention also relates to a method for producing a composition (eg, dairy product) containing citrulline at a high concentration. Furthermore, the present invention includes a method for preparing a culture solution containing a microorganism capable of producing citrulline with enhanced conversion efficiency from arginine to citrulline, and a microorganism capable of producing citrulline with an increased cell concentration. The present invention relates to a method for preparing a culture solution.
 シトルリンは機能性のアミノ酸であり、日本では、医薬品として使用が認められた後に、2007年に食品として使用が認められている。また、シトルリンは海外では、2007年以前から食品として摂取され、例えば、血流改善、動脈硬化予防、精力増強の機能から、サプリメントとして販売されてきた実績がある。さらに、シトルリンは他にも、冷性改善、皮膚機能改善、疲労軽減・回復、筋肉成長、運動機能向上などの機能を有することが報告されている。 Citrulline is a functional amino acid, and in Japan, its use as a food was approved in 2007 after its use as a medicine. In addition, citrulline has been ingested overseas as a food product since before 2007, and has been sold as a supplement, for example, for functions of improving blood flow, preventing arteriosclerosis, and enhancing energy. Furthermore, it has been reported that citrulline has other functions such as coldness improvement, skin function improvement, fatigue reduction / recovery, muscle growth, and motor function improvement.
 一方、シトルリンは食品素材として極めて高価であり、さらに、その機能を発揮させるために必要な摂取量は比較的に多量(例えば、数百mg)である。従って、シトルリンを食品等に有効量で配合しようとすると、その高価であることが問題となる。 On the other hand, citrulline is extremely expensive as a food material, and the amount of intake necessary for exerting its function is relatively large (for example, several hundred mg). Therefore, when citrulline is to be added to foods or the like in an effective amount, the problem is that it is expensive.
 シトルリンは現状では、主に発酵法で生産される。例えば、特開昭63-068091号公報(特許文献1)には、コリネバクテリウム属やブレビバクテリウム属に属する微生物を培養し、培養液中にL-シトルリンを生成蓄積させるL-シトルリンの製造法が開示されている。また、特開平05-168486号公報(特許文献2)には、ペディオコッカス属に属する乳酸菌にバクテリオファージを感染させて溶菌したものを、L-アルギニンに作用させて、L-シトルリンを生成させるL-シトルリンの製造方法が開示されている。また、特開平08-089269号公報(特許文献3)には、水溶性有機溶剤で乾燥したL-オルニチン生産能欠如菌体を、L-アルギニンに接触作用させて、L-シトルリンを生成させるL-シトルリンの製造方法が開示されている。この公報には、バチルス属、シュードモナス属、ストレプトコッカス属に属する細菌が例示されている。また、特開2010-088301号公報(特許文献4)には、ビブリオ属細菌の発酵法によるL-シトルリンの製造方法が開示されている。 Citrulline is currently produced mainly by fermentation. For example, Japanese Patent Application Laid-Open No. 63-068091 (Patent Document 1) describes the production of L-citrulline by culturing microorganisms belonging to the genus Corynebacterium and Brevibacterium and generating and accumulating L-citrulline in the culture solution. The law is disclosed. Japanese Patent Laid-Open No. 05-168486 (Patent Document 2) discloses that a lactic acid bacterium belonging to the genus Pediococcus is infected with a bacteriophage to act on L-arginine to produce L-citrulline. A method for producing L-citrulline is disclosed. Japanese Patent Application Laid-Open No. 08-089269 (Patent Document 3) discloses that L-ornithine-producing deficient cells dried with a water-soluble organic solvent are brought into contact with L-arginine to produce L-citrulline. -A method for producing citrulline is disclosed. This publication exemplifies bacteria belonging to the genera Bacillus, Pseudomonas, and Streptococcus. Japanese Patent Laid-Open No. 2010-088301 (Patent Document 4) discloses a method for producing L-citrulline by a fermentation method of Vibrio bacteria.
 しかしながら、これら従来技術には、シトルリンの生産効率および生産費の観点から、まだ改善の余地があり、依然として、生産効率や費用対効果の高いシトルリンの調製方法への希求が存在しているといえる。 However, these conventional techniques still have room for improvement from the viewpoint of citrulline production efficiency and production cost, and it can be said that there is still a need for a production method of citrulline that is highly efficient and cost-effective. .
 ここで、本発明者らの知る限りでは、乳酸菌の一種であるラクトコッカス・ラクティス(Llactis)を用いて、アルギニンからシトルリンやオルニチンを生産することは報告されていないが、Llactisにより、アルギニンが代謝されることは幾つか報告されている(非特許文献1、2、および3)。例えば、非特許文献1および2には、Llactisによって、アルギニンの全部がオルニチンに変換されたことが記載されている。また、非特許文献3には、Llactisによって、アルギニンを代謝した場合に、アルギニンの全部がオルニチンに変換されることが既知の事実として記載されている。そして、特開2009-112205号公報(特許文献5)には、チーズ等の製造の発酵過程において、L-オルニチンを産生させ、オルニチン含有組成物を製造することが記載されている。 Here, as far as the present inventors know, it has not been reported to produce citrulline or ornithine from arginine using Lactobacillus lactis ( L. lactis ), but L. lactis Several reports have been made that arginine is metabolized (Non-patent Documents 1, 2, and 3). For example, Non-Patent Documents 1 and 2 describe that all of arginine was converted to ornithine by L. lactis . Further, Non-Patent Document 3 describes as a known fact that all of arginine is converted to ornithine when arginine is metabolized by L. lactis . Japanese Patent Application Laid-Open No. 2009-112205 (Patent Document 5) describes that an ornithine-containing composition is produced by producing L-ornithine in a fermentation process for producing cheese or the like.
 さらに、アルギニンの代謝に関する遺伝子の発現の研究では、Llactisにおいて、アルギニンからシトルリンに変換する酵素のアルギニンデイミナーゼ(ADI)と、シトルリンからオルニチンに変換する酵素のオルニチンカーボミルトランスフェラーゼ(OTC)の遺伝子が隣接してコードされていることや、これら2つの遺伝子が同一のプロモーターによって、その発現を制御されていることが報告されている(非特許文献4)。 Furthermore, in the study of gene expression related to the metabolism of arginine, in L. lactis , arginine deiminase (ADI), an enzyme that converts arginine to citrulline, and ornithine carbamyltransferase (OTC), an enzyme that converts citrulline to ornithine. It has been reported that the genes are encoded adjacently and that the expression of these two genes is controlled by the same promoter (Non-patent Document 4).
 また、アルギニンの代謝に関する遺伝子の発現の研究では、Llactis以外の乳酸菌として、エンテロコッカス・フェカーリス(Enterococcus faecalis)およびラクトバチルス・プランタルム(Lactobacillus planturum)においても、ADIとOTCの遺伝子が隣接してコードされていることや、これら2つの遺伝子が同一のプロモーターによって、その発現を制御されていることが報告されている(非特許文献5および6)。 Furthermore, studies of the expression of genes related to the metabolism of arginine, L. As lactic acid bacteria other than lactis, even in Enterococcus faecalis (Enterococcus faecalis) and Lactobacillus plantarum (Lactobacillus planturum), ADI and OTC gene adjacent code It has been reported that the expression of these two genes is controlled by the same promoter (Non-patent Documents 5 and 6).
 これらの研究では、リアルタイムPCRを用いて、ADIとOTCの遺伝子の発現が同時に制御されていることを確認している。そして、Llactisでは、様々な培養条件において、ADIとOTCの活性が測定されており(非特許文献1)、その何れの培養条件においても、ADIよりもOTCの活性が高くなることが報告されている。 In these studies, real-time PCR is used to confirm that the expression of ADI and OTC genes is controlled simultaneously. In L. lactis , the activities of ADI and OTC were measured under various culture conditions (Non-patent Document 1), and it was reported that the activity of OTC was higher than that of ADI under any of the culture conditions. Has been.
 つまり、これらの研究から、アルギニン代謝能を有する微生物にあっては、ADIにより、アルギニンはシトルリンへ変換されるが、OTCにより、シトルリンは直ちにオルニチンへ変換されるため、シトルリンは培養液中に蓄積しないことが示唆されている。 That is, from these studies, arginine is converted to citrulline by ADI in microorganisms having the ability to metabolize arginine, but citrulline is immediately converted to ornithine by OTC, so that citrulline accumulates in the culture medium. It is suggested not to.
特開昭63-068091号公報JP 63-068091 A 特開平05-168486号公報JP 05-168486 A 特開平08-089269号公報Japanese Patent Laid-Open No. 08-089269 特開2010-088301号公報JP 2010-088301 A 特開2009-112205号公報JP 2009-112205 A
 乳酸菌などの微生物を用いて、アルギニンの大部分をシトルリンへ効率的に変換するためには、シトルリンがオルニチンへ変換されることを抑制することが有効であると考えられた。ところが、本発明者らの知る限りでは、これまでに、アルギニンの大部分をシトルリンへ効率的に変換する方法に関しては報告されていない。 In order to efficiently convert most of arginine to citrulline using microorganisms such as lactic acid bacteria, it was considered effective to suppress the conversion of citrulline to ornithine. However, as far as the present inventors know, no method has been reported so far for efficiently converting most of arginine to citrulline.
 本発明者らは、今般、シトルリン産生能を有する微生物を用いて、通常(微生物の培養の至適温度)よりも高い温度で、培地を培養することにより、シトルリンを効率的に微生物に生産させることができるとの知見を得た。また、本発明者らは、シトルリン産生能を有する微生物を用いて、通常(微生物の発酵の至適温度)よりも高い温度で、原料(例えば、原料乳など)を発酵させることにより、シトルリンを高濃度で含む組成物(例えば、発酵乳製品などの飲食品)を製造することができるとの知見を得た。 Inventors of the present invention, by using a microorganism having citrulline-producing ability, cultivating citrulline efficiently by culturing a medium at a temperature higher than normal (optimum temperature for culturing microorganisms). The knowledge that it can be obtained. In addition, the present inventors ferment a raw material (for example, raw milk) by using a microorganism having citrulline-producing ability at a temperature higher than normal (optimum temperature for fermentation of the microorganism), thereby producing citrulline. The knowledge that it can manufacture the composition (For example, food-drinks, such as fermented milk products) contained in high concentration, was acquired.
 さらに、本発明者らは、アルギニンを培地や原料へ添加して培養や発酵することにより、微生物のシトルリン産生能を高めることができるとの知見を得た。そして、本発明者らは、培地(培養液)のpHを制御して培養することにより、微生物の濃度(個数)を高めることができるとの知見を得た。本発明は、これらの知見に基づくものである。 Furthermore, the present inventors have obtained the knowledge that the ability of microorganisms to produce citrulline can be enhanced by adding arginine to a medium or raw material and culturing and fermenting it. The present inventors have obtained knowledge that the concentration (number) of microorganisms can be increased by culturing while controlling the pH of the medium (culture solution). The present invention is based on these findings.
 従って、本発明は、シトルリンを効率的に生産できるシトルリンの調製方法の提供をその目的としている。また、本発明は、シトルリンを高濃度で含むシトルリン含有組成物の製造方法の提供をその目的としている。 Therefore, an object of the present invention is to provide a method for preparing citrulline that can efficiently produce citrulline. Another object of the present invention is to provide a method for producing a citrulline-containing composition containing citrulline at a high concentration.
 さらに、本発明は、アルギニンからシトルリンへの変換効率を高めた微生物の培養方法や発酵方法の提供をその目的としている。そして、本発明は、シトルリン産生能を有する微生物の濃度を高めた培養方法の提供をその目的としている。 Furthermore, an object of the present invention is to provide a method for culturing and fermenting microorganisms with improved conversion efficiency from arginine to citrulline. The object of the present invention is to provide a culture method in which the concentration of microorganisms capable of producing citrulline is increased.
 すなわち、本発明は以下の態様(1)~(18)に関する。
(1)シトルリン産生能を有する微生物を培地に接種し、40℃以上70℃以下の温度で培養することを特徴とする、シトルリンの調製方法。
(2)シトルリン産生能を有する微生物が乳酸菌、ビフィズス菌またはプロピオン酸菌である、(1)に記載のシトルリンの調製方法。
(3)乳酸菌がラクトコッカス・ラクティス、ラクトバチルス・ファーメンタム、およびラクトバチルス・ブフネリからなる群から選択される1種または2種以上である、(2)に記載のシトルリンの調製方法。
(4)乳酸菌がラクトコッカス・ラクティス亜種ラクティス(Lactococcus lactis spp. lactis) OLS3789株、OLS3797株、およびOLS3818株からなる群から選択される1種または2種以上である、(2)に記載のシトルリンの調製方法。
That is, the present invention relates to the following aspects (1) to (18).
(1) A method for preparing citrulline, comprising inoculating a culture medium with a citrulline-producing ability into a medium and culturing at a temperature of 40 ° C. or higher and 70 ° C. or lower.
(2) The method for preparing citrulline according to (1), wherein the microorganism having citrulline producing ability is a lactic acid bacterium, a bifidobacteria or a propionic acid bacterium.
(3) The method for preparing citrulline according to (2), wherein the lactic acid bacteria is one or more selected from the group consisting of Lactococcus lactis, Lactobacillus fermentum, and Lactobacillus buchneri.
(4) The lactic acid bacterium is one or more selected from the group consisting of Lactococcus lactis spp. Lactis OLS3789, OLS3797, and OLS3818, according to (2) A method for preparing citrulline.
(5)シトルリン産生能を有する微生物を原料に添加(配合)し、40℃以上70℃以下の温度で発酵することを特徴とする、シトルリン含有組成物の製造方法。
(6)シトルリン産生能を有する微生物が乳酸菌、ビフィズス菌またはプロピオン酸菌である、(5)に記載のシトルリン含有組成物の製造方法。
(7)乳酸菌がラクトコッカス・ラクティス、ラクトバチルス・ファーメンタム、およびラクトバチルス・ブフネリからなる群から選択される1種または2種以上である、(6)に記載のシトルリン含有組成物の製造方法。
(8)乳酸菌がラクトコッカス・ラクティス亜種ラクティス(Lactococcus lactis spp. lactis) OLS3789株、OLS3797株、およびOLS3818株からなる群から選択される1種または2種以上である、(6)に記載のシトルリン含有組成物の製造方法。
(9)原料が原料乳である、(5)~(8)のいずれかに記載のシトルリン含有組成物の製造方法。
(10)シトルリン含有組成物が飲食品である、(5)~(9)のいずれかに記載のシトルリン含有組成物の製造方法。
(5) A method for producing a citrulline-containing composition, wherein a microorganism having citrulline-producing ability is added (blended) to a raw material and fermented at a temperature of 40 ° C or higher and 70 ° C or lower.
(6) The method for producing a citrulline-containing composition according to (5), wherein the microorganism having citrulline-producing ability is a lactic acid bacterium, a bifidobacteria, or a propionic acid bacterium.
(7) The method for producing a citrulline-containing composition according to (6), wherein the lactic acid bacteria is one or more selected from the group consisting of Lactococcus lactis, Lactobacillus fermentum, and Lactobacillus buchnerii .
(8) The lactic acid bacterium is one or more selected from the group consisting of Lactococcus lactis spp. Lactis OLS3789, OLS3797, and OLS3818, according to (6) A method for producing a citrulline-containing composition.
(9) The method for producing a citrulline-containing composition according to any one of (5) to (8), wherein the raw material is raw material milk.
(10) The method for producing a citrulline-containing composition according to any one of (5) to (9), wherein the citrulline-containing composition is a food or drink.
(11)シトルリン産生能を有し、かつ40℃以上70℃以下の培養温度におけるアルギニンからシトルリンへの変換効率が高められた微生物を含む培養液の調製方法であって、シトルリン産生能を有する微生物を、アルギニンを添加した培地で培養することを特徴とする、調製方法。
(12)培養の前にアルギニンを培地に添加する、および/または、
 培養の途中で断続的にアルギニンを添加する、もしくは、培養の途中で継続的にアルギニンを添加する、(11)に記載の培養液の調製方法。
(13)シトルリン産生能を有する微生物を含み、かつ当該微生物の濃度が高められた培養液の調製方法であって、シトルリン産生能を有する微生物を、pHが5以上7以下の範囲にある培地で培養し、前記微生物の濃度を高めることを特徴とする、調製方法。
(14)アルカリの添加によって培地のpHを調整する、(13)に記載の培養液の調製方法。
(11) A method for preparing a culture solution comprising a microorganism having a citrulline-producing ability and having enhanced conversion efficiency from arginine to citrulline at a culture temperature of 40 ° C. or higher and 70 ° C. or lower, the microorganism having citrulline-producing ability Is cultured in a medium supplemented with arginine.
(12) Add arginine to the medium before culturing and / or
The method for preparing a culture solution according to (11), wherein arginine is intermittently added during the culture, or arginine is continuously added during the culture.
(13) A method for preparing a culture solution containing a microorganism having citrulline-producing ability and having an increased concentration of the microorganism, wherein the microorganism having citrulline-producing ability is a medium having a pH in the range of 5 to 7. A preparation method, characterized by culturing and increasing the concentration of the microorganism.
(14) The method for preparing a culture solution according to (13), wherein the pH of the medium is adjusted by adding an alkali.
(15)シトルリン産生能を有し、35℃以上70℃以下の培養温度におけるアルギニンからシトルリンへの変換効率が高められた微生物を含み、かつ当該微生物の濃度(菌体濃度)が高められた培養液の調製方法であって、シトルリン産生能を有する微生物を、アルギニンを添加し、かつpHが5以上7以下の範囲にある培地で培養して前記微生物の濃度を高めることを特徴とする、調製方法。
(16)培養の前にアルギニンを培地に添加する、および/または、
 培養の途中で断続的にアルギニンを添加する、もしくは、培養の途中で継続的にアルギニンを添加する、(15)に記載の培養液の調製方法。
(17)(11)~(16)のいずれかに記載の方法によって得られた培養液を遠心分離および/または膜分離して得られる、アルギニンからシトルリンへの変換効率を高めたシトルリン産生能を有する微生物の調製方法。
(18)(11)~(16)のいずれかに記載の培養液の調製方法によって得られた培養液または(17)に記載の微生物の調製方法によって得られた微生物を、培地に接種して培養する、(1)~(4)のいずれかに記載のシトルリンの調製方法、もしくは原料に添加して発酵させる、(5)~(10)のいずれかに記載のシトルリン含有組成物の製造方法。
(15) Culture having a citrulline producing ability, including a microorganism having an increased conversion efficiency from arginine to citrulline at a culture temperature of 35 ° C. or higher and 70 ° C. or lower, and having an increased concentration of the microorganism (cell concentration) A method for preparing a liquid, characterized in that a microorganism having citrulline-producing ability is added to arginine and cultured in a medium having a pH in the range of 5 to 7, to increase the concentration of the microorganism. Method.
(16) Add arginine to the medium before culturing, and / or
The method for preparing a culture solution according to (15), wherein arginine is intermittently added during the culture, or arginine is continuously added during the culture.
(17) The ability to produce citrulline with improved conversion efficiency from arginine to citrulline, obtained by centrifugation and / or membrane separation of the culture solution obtained by the method according to any one of (11) to (16). A method for preparing a microorganism.
(18) A culture solution obtained by the method for preparing a culture solution according to any one of (11) to (16) or a microorganism obtained by the method for preparing a microorganism according to (17) is inoculated into a medium. The method for producing citrulline according to any one of (1) to (4), or the method for producing a citrulline-containing composition according to any one of (5) to (10), wherein the method is cultivated or fermented by adding to a raw material .
 本発明のシトルリンの調製方法によれば、シトルリンを効率的に生産できる。また、本発明のシトルリン含有組成物の製造方法によれば、シトルリンを高濃度で含む乳製品などの栄養組成物を得られる。また、本発明の微生物の培養方法や発酵方法によれば、アルギニンからシトルリンへの変換効率を高められる。そして、本発明の微生物の培養方法によれば、微生物の濃度を高められる。さらに、本発明のシトルリンの調製方法やシトルリン含有組成物の製造方法によれば、アルギニンからシトルリンへの変換効率を高めた、および/または微生物の濃度を高めた、シトルリン産生能を有する微生物ならびに/もしくは当該培養液を用いて、シトルリンを効率的に生産できるし、シトルリンを高濃度で含む乳製品などの栄養組成物を得られる。 According to the method for preparing citrulline of the present invention, citrulline can be produced efficiently. Moreover, according to the method for producing a citrulline-containing composition of the present invention, a nutritional composition such as a dairy product containing citrulline at a high concentration can be obtained. Moreover, according to the microorganism culture method and fermentation method of the present invention, the conversion efficiency from arginine to citrulline can be increased. And according to the microorganism cultivation method of the present invention, the concentration of microorganisms can be increased. Furthermore, according to the method for preparing citrulline and the method for producing a citrulline-containing composition of the present invention, a microorganism having the ability to produce citrulline with improved conversion efficiency from arginine to citrulline and / or increased microorganism concentration and / or Alternatively, citrulline can be efficiently produced using the culture solution, and a nutritional composition such as a dairy product containing citrulline at a high concentration can be obtained.
水酸化ナトリウムを用いて、培地(培養液)のpHを5.5に制御して、L. lactis OLS3797株を培養したときのL. lactis OLS3797株の菌体濃度の経時変化を示すグラフである。It is a graph which shows the time-dependent change of the cell concentration of L. lactis OLS3797 strain | stump | stock when the pH of a culture medium (culture liquid) is controlled to 5.5 using sodium hydroxide, and L. lactis OLS3797 strain | stump | stock is cultured. . 培地(培養液)のpHを制御して、L. lactis OLS3797株を培養(pH制御培養)したときの培養開始から10、11、12時間後の培養液と、L. lactis OLS3797株を静置培養したときの培養液における、アルギニンからシトルリンへの変換効率の比較を示すグラフである。Controlling the pH of the medium (culture solution) and culturing the L. lactis OLS3797 strain (pH-controlled culture) 10, 11, and 12 hours after the start of culture, and the L. lactis OLS3797 strain It is a graph which shows the comparison of the conversion efficiency from arginine to citrulline in the culture solution when it culture | cultivates. 培養の前にアルギニンをMRS培地に添加して、L. lactis OLS3797株を培養したときのpHの経時変化、菌体濃度の経時変化、アルギニン濃度、シトルリン濃度、オルニチン濃度の経時変化を示すグラフである。Graph showing time-dependent change in pH, time-dependent change in cell concentration, time-dependent change in arginine concentration, citrulline concentration and ornithine concentration when arginine was added to MRS medium before culturing and L. lactis OLS3797 strain was cultured. is there. 培養開始から10時間後にアルギニンを断続的にMRS培地に添加して、L. lactis OLS3797株を培養したときのpHの経時変化、菌体濃度の経時変化、アルギニン濃度、シトルリン濃度、オルニチン濃度の経時変化を示すグラフである。10 hours after the start of culture, arginine was intermittently added to the MRS medium, and when L. lactis OLS3797 was cultured, the change in pH over time, the change in cell concentration over time, the arginine concentration, citrulline concentration, ornithine concentration over time It is a graph which shows a change. 培養開始から4時間後にアルギニンを継続的にMRS培地に添加して、L. lactis OLS3797株を培養したときのpHの経時変化、菌体濃度の経時変化、アルギニン濃度、シトルリン濃度、オルニチン濃度の経時変化を示すグラフである。4 hours after the start of the culture, arginine was continuously added to the MRS medium, and when the L. lactis OLS3797 strain was cultured, the pH change over time, the cell concentration change over time, the arginine concentration, citrulline concentration, ornithine concentration over time It is a graph which shows a change.
シトルリンの調製方法
 本発明のシトルリンの調製方法は、シトルリン産生能を有する微生物を培地に接種し、通常(微生物の培養の至適温度)よりも高い温度で培養することを特徴とする。培養温度は、具体的には40℃以上48℃以下、好ましくは42℃以上47℃以下、より好ましくは44℃以上46℃以下である。また本発明の別の態様によれば、前記培養温度は40℃以上70℃以下であり、好ましい上限は68℃、より好ましい上限は65℃であり、好ましい下限は42℃、より好ましい下限は43℃である。
Method for Preparing Citrulline The method for preparing citrulline of the present invention is characterized in that a microorganism having citrulline-producing ability is inoculated into a medium and cultured at a temperature higher than usual (the optimum temperature for culturing microorganisms). The culture temperature is specifically 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower. According to another aspect of the present invention, the culture temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
 前記したとおり、本発明における培養温度は、シトルリン産生能を有する微生物の通常の培養温度(例えば、至適温度)よりも高い温度である。このような温度域で、微生物を培養することによって、シトルリンを効率的に産生させることができる。この理由について、次のように考えられるが、以下の説明(理論)は、あくまでも仮定であって、本発明は、この理論によって、何ら限定されるものではない。すなわち、従来技術において記載したとおり、例えば、アルギニン代謝能を有するLlactisは、アルギニンをシトルリンに変換する酵素のアルギニンデイミナーゼ(ADI)と、シトルリンからオルニチンに変換する酵素のオルニチンカーボミルトランスフェラーゼ(OTC)の遺伝子を有しており、これら両者は同一のプロモーターにより発現が制御されていると考えられている。このとき、本発明のように、培養温度が高い温度の場合には、ADIにより、アルギニンからシトルリンへの変換が亢進されるか、OTCにより、シトルリンからオルニチンへの変換が抑制されるか、または、これら両方の作用や現象に伴って、シトルリンが培地(培養液)に蓄積されると考えられる。つまり、本発明のように、培養温度が高い場合には、アルギニンがシトルリンへ効率的に変換され、このため、シトルリンの効率的な調製方法を実現できると考えられる。 As described above, the culture temperature in the present invention is higher than the normal culture temperature (for example, optimum temperature) of microorganisms having citrulline production ability. Citrulline can be efficiently produced by culturing microorganisms in such a temperature range. The reason for this can be considered as follows. However, the following explanation (theory) is merely an assumption, and the present invention is not limited by this theory. That is, as described in the prior art, for example, L. lactis having the ability to metabolize arginine is arginine deiminase (ADI), an enzyme that converts arginine to citrulline, and ornithine carbamyltransferase (ADI), an enzyme that converts citrulline to ornithine. OTC) gene, both of which are thought to be controlled by the same promoter. At this time, as in the present invention, when the culture temperature is high, ADI enhances the conversion of arginine to citrulline, or OTC suppresses the conversion of citrulline to ornithine, or It is considered that citrulline accumulates in the medium (culture medium) with both of these actions and phenomena. That is, as in the present invention, when the culture temperature is high, arginine is efficiently converted to citrulline, and therefore, it is considered that an efficient method for preparing citrulline can be realized.
 本発明の培養時間は、シトルリン産生能を有する微生物を培養できる条件から適宜選択されればよく、特に限定されないが、好ましくは2~48時間、より好ましくは3~36時間、さらに好ましくは4~24時間である。 The culture time of the present invention is not particularly limited as long as it is appropriately selected from the conditions under which a microorganism capable of producing citrulline can be cultured, but is preferably 2 to 48 hours, more preferably 3 to 36 hours, and still more preferably 4 to 4 hours. 24 hours.
 本発明のシトルリン産生能を有する微生物は、シトルリンを産生するものであれば、特に限定されないが、好ましくは40℃以上48℃以下、より好ましくは42℃以上47℃以下、さらに好ましくは44℃以上46℃以下の温度で培養して、シトルリンを効率的に産生するものであることが好ましい。また本発明の別の態様によれば、前記温度は40℃以上70℃以下であり、好ましい上限は68℃、より好ましい上限は65℃であり、好ましい下限は42℃、より好ましい下限は43℃である。そして、本発明におけるシトルリン産生能を有する微生物は、好ましくは、シトルリン産生能を有する乳酸菌、ビフィズス菌またはプロピオン酸菌であり、より好ましくは、シトルリン産生能を有する乳酸菌またはビフィズス菌であり、さらに好ましくは、シトルリン産生能を有する乳酸菌である。 The microorganism having citrulline producing ability of the present invention is not particularly limited as long as it produces citrulline, but is preferably 40 ° C. or higher and 48 ° C. or lower, more preferably 42 ° C. or higher and 47 ° C. or lower, and further preferably 44 ° C. or higher. It is preferable to culture at a temperature of 46 ° C. or less to efficiently produce citrulline. According to another aspect of the present invention, the temperature is 40 ° C. or more and 70 ° C. or less, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43 ° C. It is. The microorganism having citrulline producing ability in the present invention is preferably a lactic acid bacterium, bifidobacteria or propionic acid bacterium having citrulline producing ability, more preferably a lactic acid bacterium or bifidobacteria having citrulline producing ability, and more preferably. Is a lactic acid bacterium having citrulline-producing ability.
 本発明のシトルリン産生能を有する乳酸菌は、好ましくは、ラクトコッカス・ラクティス、ラクトバチルス・ファーメンタム、ラクトバチルス・ブフネリ、エンテロコッカス・フェーカリス、オエノコッカス・オエニ、ペディオコッカス・ペントサセウス、ラクトバチルス・アミロボラス、ラクトバチルス・ブレビス、およびラクトバチルス・ロイテリからなる群から選択される1種または2種以上であり、より好ましくは、ラクトコッカス・ラクティス、ラクトバチルス・ファーメンタム、およびラクトバチルス・ブフネリからなる群から選択される1種または2種以上であり、さらに好ましくは、ラクトコッカス・ラクティスである。 The lactic acid bacteria having citrulline-producing ability of the present invention are preferably Lactococcus lactis, Lactobacillus fermentum, Lactobacillus buchnerii, Enterococcus faecalis, Oenococcus oeni, Pediococcus pentosaceus, Lactobacillus amylovorus, lacto One or more selected from the group consisting of Bacillus brevis and Lactobacillus reuteri, more preferably selected from the group consisting of Lactococcus lactis, Lactobacillus fermentum, and Lactobacillus buchneri Or more, more preferably Lactococcus lactis.
 本発明のシトルリン産生能を有するラクトコッカス・ラクティスは、好ましくは、ラクトコッカス・ラクティス亜種ラクティスおよびラクトコッカス・ラクティス亜種クレモリスからなる群から選択される1種または2種以上であり、より好ましくは、ラクトコッカス・ラクティス亜種ラクティスであり、さらに好ましくは、ラクトコッカス・ラクティス亜種ラクティス(Lactococcus lactis spp. lactis)OLS3789株、OLS3797株、およびOLS3818株からなる群から選択される1種または2種以上である。なお、これらの菌株は、後記したとおり、寄託機関に寄託されている。 The Lactococcus lactis having the ability to produce citrulline of the present invention is preferably one or more selected from the group consisting of Lactococcus lactis subspecies lactis and Lactococcus lactis subspecies cremolith, more preferably Is Lactococcus lactis subsp . Lactis, more preferably one or two selected from the group consisting of Lactococcus lactis spp. Lactis OLS3789, OLS3797, and OLS3818 More than a seed. These strains are deposited with the depository as described later.
 本発明のシトルリン産生能を有するラクトコッカス・ラクティス亜種ラクティスは、前記したとおり、Lactococcus lactis spp. lactis OLS3789であって、独立行政法人 製品評価技術機構 特許微生物寄託センターに受領番号:NITE BP-1387(識別の表示:Lactococcus lactis spp. lactis OLS3789、寄託日:2012年7月18日)で寄託されているもの、Lactococcus lactis spp. lactis OLS3797であって、独立行政法人 製品評価技術機構 特許微生物寄託センターに受領番号:NITE BP-1388(識別の表示:Lactococcus lactis spp. lactis OLS3797、寄託日:2012年7月18日)で寄託されているもの、Lactococcus lactis spp. lactis OLS3818であって、独立行政法人 製品評価技術機構 特許微生物寄託センターに受領番号:NITE BP-1389(識別の表示:Lactococcus lactis spp. lactis OLS3818、寄託日:2012年7月18日)で寄託されているものである。 Lactococcus lactis spp. Lactis OLS3789 having the ability to produce citrulline according to the present invention is Lactococcus lactis spp. Lactis OLS3789 as described above, and received from the National Institute of Microbiology, Japan Patent Evaluation Organization: NITE BP-1387 (Indication of identification: Lactococcus lactis spp. Lactis OLS3789, deposit date: July 18, 2012), Lactococcus lactis spp. Lactis OLS3797, independent administrative agency Product Evaluation Technology Organization, Patent Microorganism Depositary Center No. NITE BP-1388 (indication of identification: Lactococcus lactis spp. Lactis OLS3797, date of deposit: July 18, 2012), Lactococcus lactis spp. Lactis OLS3818, an independent administrative agency receiving the product evaluation technology mechanism, Patent microorganisms Depositary number: NITE BP-1389 (of identification:. Lactococcus lactis spp lactis OLS3818, date of deposit: July 18, 2012) that it has been deposited in A.
 ここで、Lactococcus lactis spp. lactis OLS3789は、次のような科学的な性質(形態的、培地上の特徴、生理学的な性質など)を有する。
(a)形態的な性質
 培地(Lactobacilli MRS Agar、DIFCO)上のコロニー性状:円形、白色、Smooth型、扁平状
(b)生理学的な性質
 菌形態:球菌、グラム染色:陽性、乳酸発酵形式:ホモ乳酸発酵、好気的発育:+
Here, Lactococcus lactis spp. Lactis OLS3789 has the following scientific properties (morphological, characteristics on the medium, physiological properties, etc.).
(A) Morphological properties Colony properties on medium (Lactobacilli MRS Agar, DIFCO): circular, white, smooth, flat (b) Physiological properties Bacterial morphology: cocci, Gram staining: positive, lactic acid fermentation format: Homolactic fermentation, aerobic growth: +
(c)その他、当該微生物を特徴付ける性質
 16srDNA配列は、以下のとおりである。(OLS3789)
GCTGGCGGGCGTGCCTAATACATGCAAGTTGAGCGCTGAAGGTTGGTACTTGTACCGACTGGATGAGCAGCGAACGGGTGAGTAACGCGTGGGGAATCTGCCTTTGAGCGGGGGACAACATTTGGAAACGAATGCTAATACCGCATAAAAACTTTAAACACAAGTTTTAAGTTTGAAAGATGCAATTGCATCACTCAAAGATGATCCCGCGTTGTATTAGCTAGTTGGTGAGGTAAAGGCTCACCAAGGCGATGATACATAGCCGACCTGAGAGGGTGATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCGGCAATGGACGAAAGTCTGACCGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGATCGTAAAACTCTGTTGGTAGAGAAGAACGTTGGTGAGAGTGGAAAGCTCATCAAGTGACGGTAACTACCCAGAAAGGGACGGCTAACTACGT(配列番号:1)
(C) Other properties that characterize the microorganism The 16s rDNA sequence is as follows. (OLS3789)
GCTGGCGGGCGTGCCTAATACATGCAAGTTGAGCGCTGAAGGTTGGTACTTGTACCGACTGGATGAGCAGCGAACGGGTGAGTAACGCGTGGGGAATCTGCCTTTGAGCGGGGGACAACATTTGGAAACGAATGCTAATACCGCATAAAAACTTTAAACACAAGTTTTAAGTTTGAAAGATGCAATTGCATCACTCAAAGATGATCCCGCGTTGTATTAGCTAGTTGGTGAGGTAAAGGCTCACCAAGGCGATGATACATAGCCGACCTGAGAGGGTGATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCGGCAATGGACGAAAGTCTGACCGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGATCGTAAAACTCTGTTGGTAGAGAAGAACGTTGGTGAGAGTGGAAAGCTCATCAAGTGACGGTAACTACCCAGAAAGGGACGGCTAACTACGT (SEQ ID NO: 1)
 また、Lactococcus lactis spp. lactis OLS3797は、次のような科学的な性質(形態的、培地上の特徴、生理学的な性質など)を有する。
(a)形態的な性質
 培地(Lactobacilli MRS Agar、DIFCO)上のコロニー性状:円形、白色、Smooth型、扁平状
(b)生理学的な性質
 菌形態:球菌、グラム染色:陽性、乳酸発酵形式:ホモ乳酸発酵、好気的発育:+
Lactococcus lactis spp. Lactis OLS3797 has the following scientific properties (morphological, characteristics on the medium, physiological properties, etc.).
(A) Morphological properties Colony properties on medium (Lactobacilli MRS Agar, DIFCO): circular, white, smooth, flat (b) Physiological properties Bacterial morphology: cocci, Gram staining: positive, lactic acid fermentation format: Homolactic fermentation, aerobic growth: +
(c)その他、当該微生物を特徴付ける性質
 16srDNA配列は、以下のとおりである。(OLS3797)
GAAGCTGGCGGCGTGCCTAATACATGCAAGTTGAGCGCTGAAGGTTGGTACTTGTACCGACTGGATGAGCAGCGAACGGGTGAGTAACGCGTGGGGAATCTGCCTTTGAGCGGGGGACAACATTTGGAAACGAATGCTAATACCGCATAAAAACTTTAAACACAAGTTTTAAGTTTGAAAGATGCAATTGCATCACTCAAAGATGATCCCGCGTTGTATTAGCTAGTTGGTGAGGTAAAGGCTCACCAAGGCGATGATACATAGCCGACCTGAGAGGGTGATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCGGCAATGGACGAAAGTCTGACCGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGATCGTAAAACTCTGTTGGTAGAGAAGAACGTTGGTGAGAGTGGAAAGCTCATCAAGTGACGGTAACTACCCAGAAAGGGACGGCTAACTACGT(配列番号:2)
(C) Other properties that characterize the microorganism The 16s rDNA sequence is as follows. (OLS3797)
GAAGCTGGCGGCGTGCCTAATACATGCAAGTTGAGCGCTGAAGGTTGGTACTTGTACCGACTGGATGAGCAGCGAACGGGTGAGTAACGCGTGGGGAATCTGCCTTTGAGCGGGGGACAACATTTGGAAACGAATGCTAATACCGCATAAAAACTTTAAACACAAGTTTTAAGTTTGAAAGATGCAATTGCATCACTCAAAGATGATCCCGCGTTGTATTAGCTAGTTGGTGAGGTAAAGGCTCACCAAGGCGATGATACATAGCCGACCTGAGAGGGTGATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCGGCAATGGACGAAAGTCTGACCGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGATCGTAAAACTCTGTTGGTAGAGAAGAACGTTGGTGAGAGTGGAAAGCTCATCAAGTGACGGTAACTACCCAGAAAGGGACGGCTAACTACGT (SEQ ID NO: 2)
 さらに、Lactococcus lactis spp. lactis OLS3818は、次のような科学的な性質(形態的、培地上の特徴、生理学的な性質など)を有する。
(a)形態的な性質
 培地(Lactobacilli MRS Agar、DIFCO)上のコロニー性状:円形、白色、Smooth型、扁平状
(b)生理学的な性質
 菌形態:球菌、グラム染色:陽性、乳酸発酵形式:ホモ乳酸発酵、好気的発育:+
Furthermore, Lactococcus lactis spp. Lactis OLS3818 has the following scientific properties (morphological, characteristics on the medium, physiological properties, etc.).
(A) Morphological properties Colony properties on medium (Lactobacilli MRS Agar, DIFCO): circular, white, smooth, flat (b) Physiological properties Bacterial morphology: cocci, Gram staining: positive, lactic acid fermentation format: Homolactic fermentation, aerobic growth: +
(c)その他、当該微生物を特徴付ける性質
 16srDNA配列は、以下のとおりである。(OLS3818)
GCGAAGCTGGCGGCGTGCCTAATACATGCAAGTTGAGCGCTGAAGGTTGGTACTTGTACCGACTGGATGAGCAGCGAACGGGTGAGTAACGCGTGGGGAATCTGCCTTTGAGCGGGGGACAACATTTGGAAACGAATGCTAATACCGCATAAAAACTTTAAACACAAGTTTTAAGTTTGAAAGATGCAATTGCATCACTCAAAGATGATCCCGCGTTGTATTAGCTAGTTGGTGAGGTAAAGGCTCACCAAGGCGATGATACATAGCCGACCTGAGAGGGTGATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCGGCAATGGACGAAAGTCTGACCGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGATCGTAAAACTCTGTTGGTAGAGAAGAACGTTGGTGAGAGTGGAAAGCTCATCAAGTGACGGTAACTACCCAGAAAGGGACGGCTAACTACGT(配列番号:3)
(C) Other properties that characterize the microorganism The 16s rDNA sequence is as follows. (OLS3818)
GCGAAGCTGGCGGCGTGCCTAATACATGCAAGTTGAGCGCTGAAGGTTGGTACTTGTACCGACTGGATGAGCAGCGAACGGGTGAGTAACGCGTGGGGAATCTGCCTTTGAGCGGGGGACAACATTTGGAAACGAATGCTAATACCGCATAAAAACTTTAAACACAAGTTTTAAGTTTGAAAGATGCAATTGCATCACTCAAAGATGATCCCGCGTTGTATTAGCTAGTTGGTGAGGTAAAGGCTCACCAAGGCGATGATACATAGCCGACCTGAGAGGGTGATCGGCCACATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCGGCAATGGACGAAAGTCTGACCGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGATCGTAAAACTCTGTTGGTAGAGAAGAACGTTGGTGAGAGTGGAAAGCTCATCAAGTGACGGTAACTACCCAGAAAGGGACGGCTAACTACGT (SEQ ID NO: 3)
 本発明の培地は、シトルリン産生能を有する微生物を培養できるものから適宜選択されればよく、特に限定されないが、例えば、脱脂乳、脱脂濃縮乳、還元脱脂乳、及びこれらのタンパク質分解物、ホエイ、ホエイ濃縮物、還元ホエイ、及びこれらのタンパク質分解物、生乳、全脂乳(殺菌乳)、全脂濃縮乳、還元全脂乳等を含むものであり、好ましくは、脱脂乳、還元脱脂乳、及びこれらのタンパク質分解物、ホエイ、還元ホエイ、及びこれらのタンパク質分解物を含むものである。 The medium of the present invention may be appropriately selected from those capable of culturing microorganisms capable of producing citrulline, and is not particularly limited. Examples thereof include skim milk, skim concentrated milk, reduced skim milk, and their protein degradation products, whey. , Whey concentrate, reduced whey, and their protein degradation products, raw milk, whole fat milk (sterilized milk), whole fat concentrated milk, reduced whole fat milk, etc., preferably skim milk, reduced skim milk , And these protein degradation products, whey, reduced whey, and these protein degradation products.
 本発明のシトルリンの調製方法において、シトルリンは培地中に産生される。このとき、シトルリンを含有する培地を、飲食品の原料や素材等として、好ましくは、乳製品の原料や素材等として、そのまま利用してもよいし、この培地からシトルリンを分離(単離等)や濃縮等の処理により加工してから、所望の純度のシトルリンを調製して利用してもよい。このとき、飲食品には、機能性食品、栄養食品等が挙げられ、乳製品には、例えば、乳飲料、発酵乳(より好ましくは、ヨーグルト)、乳酸菌飲料、チーズ、アイスクリーム等が挙げられる。 In the method for preparing citrulline of the present invention, citrulline is produced in the medium. At this time, the medium containing citrulline may be used as it is as a raw material or material for food or drink, preferably as a raw material or material for dairy products, or citrulline is separated (isolated or the like) from this medium. Alternatively, citrulline having a desired purity may be prepared and used after processing by treatment such as or concentration. At this time, functional foods, nutritional foods, etc. are mentioned as food and drink, and dairy products include, for example, milk drinks, fermented milk (more preferably yogurt), lactic acid bacteria drinks, cheese, ice cream and the like. .
シトルリン含有組成物の製造方法
 本発明のシトルリン含有組成物の製造方法は、シトルリン産生能を有する微生物を原料に添加(配合)し、通常(微生物の発酵の至適温度)よりも高い温度で発酵することを特徴とする。発酵温度は、具体的には、40℃以上48℃以下、好ましくは42℃以上47℃以下、より好ましくは44℃以上46℃以下である。また本発明の別の態様によれば、前記発酵温度は40℃以上70℃以下であり、好ましい上限は68℃、より好ましい上限は65℃であり、好ましい下限は42℃、より好ましい下限は43℃である。
Method for producing citrulline-containing composition In the method for producing a citrulline-containing composition of the present invention, a microorganism having citrulline-producing ability is added (mixed) to a raw material and fermented at a temperature higher than usual (the optimum temperature for fermentation of microorganisms). It is characterized by doing. The fermentation temperature is specifically 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower. Moreover, according to another aspect of the present invention, the fermentation temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
 前記したとおり、本発明における発酵温度は、シトルリン産生能を有する微生物の通常の発酵温度(例えば、至適温度)よりも高い温度である。このような温度域で、微生物を培養することによって、シトルリンを効率的に産生させることができる。この理由については、本発明のシトルリンの調製方法において既に説明した理由と同様に考えられる。 As described above, the fermentation temperature in the present invention is higher than the normal fermentation temperature (for example, optimum temperature) of microorganisms having citrulline production ability. Citrulline can be efficiently produced by culturing microorganisms in such a temperature range. About this reason, it is thought similarly to the reason already demonstrated in the preparation method of the citrulline of this invention.
 また、本発明のシトルリンの調製方法において、シトルリンを含有する培地からシトルリンを単離せずに、そのまま培地をシトルリン含有組成物として利用してもよいし、または、所望の操作(例えば、遠心分離、膜分離など)で処理した培地をシトルリン含有組成物として利用してもよい。 Further, in the method for preparing citrulline of the present invention, the citrulline may be used as it is as a citrulline-containing composition without isolating citrulline from the citrulline-containing medium, or a desired operation (for example, centrifugation, You may utilize the culture medium processed by membrane separation etc. as a citrulline containing composition.
 本発明の発酵時間は、シトルリン産生能を有する微生物が発酵できる条件から適宜選択されればよく、特に限定されないが、好ましくは2~24時間、より好ましくは3~16時間、さらに好ましくは4~12時間である。 The fermentation time of the present invention may be appropriately selected from the conditions under which a microorganism having citrulline producing ability can be fermented, and is not particularly limited, but is preferably 2 to 24 hours, more preferably 3 to 16 hours, still more preferably 4 to 4 hours. 12 hours.
 本発明の原料は、シトルリン産生能を有する微生物が発酵できるものから適宜選択されればよく、特に限定されないが、例えば、脱脂乳、脱脂濃縮乳、還元脱脂乳、及びこれらのタンパク質分解物、ホエイ、ホエイ濃縮物、還元ホエイ、及びこれらのタンパク質分解物、生乳、全脂乳(殺菌乳)、全脂濃縮乳、還元全脂乳等を含むものであり、好ましくは、脱脂乳、還元脱脂乳、及びこれらのタンパク質分解物、ホエイ、還元ホエイ、及びこれらのタンパク質分解物を含むものである。 The raw material of the present invention may be appropriately selected from those that can be fermented by microorganisms capable of producing citrulline, and is not particularly limited. For example, skim milk, skim concentrated milk, reduced skim milk, and their protein degradation products, whey , Whey concentrate, reduced whey, and their protein degradation products, raw milk, whole fat milk (sterilized milk), whole fat concentrated milk, reduced whole fat milk, etc., preferably skim milk, reduced skim milk , And these protein degradation products, whey, reduced whey, and these protein degradation products.
 本発明の好ましい一態様によれば、原料として、原料乳を用いれば、シトルリン含有組成物として、乳原料または乳製品等が得られる。この得られた乳原料または乳製品等(シトルリン含有組成物)には、シトルリンに由来する機能が付加されており、その栄養的な価値が高められている。さらに、本発明の乳原料または乳製品等では、シトルリンを外部から添加(配合)するのではなく、その製造工程において、シトルリン含有量を高めることができるため、その乳原料または乳製品等に基づく最終製品の製造費等を低く抑えることができる。 According to a preferred embodiment of the present invention, when raw milk is used as a raw material, a milk raw material or a dairy product can be obtained as a citrulline-containing composition. A function derived from citrulline is added to the obtained milk raw material or dairy product (citrulline-containing composition), and its nutritional value is enhanced. Furthermore, in the dairy material or dairy product of the present invention, citrulline is not added (mixed) from the outside, but the citrulline content can be increased in the production process. The manufacturing cost of the final product can be kept low.
 本発明の別の好ましい一態様によれば、原料として、発酵乳ミックス(より好ましくは、ヨーグルトミックス)を用いれば、シトルリン含有組成物として、発酵乳(より好ましくは、ヨーグルト)が得られる。この得られた発酵乳(より好ましくは、ヨーグルト)には、シトルリンに由来する機能が付加されており、その栄養的な価値が高められている。さらに、本発明の発酵乳(より好ましくは、ヨーグルト)では、シトルリンを外部から添加(配合)するのではなく、その製造工程において、シトルリン含有量を高めることができるため、その発酵乳(より好ましくは、ヨーグルト)に基づく最終製品の製造費等を低く抑えることができる。 According to another preferred embodiment of the present invention, fermented milk (more preferably yogurt) is obtained as a citrulline-containing composition by using fermented milk mix (more preferably yogurt mix) as a raw material. A function derived from citrulline is added to the obtained fermented milk (more preferably yogurt), and its nutritional value is enhanced. Furthermore, in the fermented milk (more preferably yogurt) of the present invention, citrulline content can be increased in the production process instead of adding (blending) citrulline from the outside. Can reduce the manufacturing cost of the final product based on yogurt).
 本発明のシトルリン含有組成物の製造方法において、シトルリンは原料中に産生される。このとき、シトルリンを含有する原料を、飲食品の原料や素材等として、好ましくは、乳製品の原料や素材等として、そのまま利用してもよいし、この原料からシトルリンを分離(単離等)や濃縮等の処理により加工してから、所望の純度のシトルリンを調製して利用してもよい。このとき、飲食品には、機能性食品、栄養食品等が挙げられ、乳製品には、例えば、乳飲料、発酵乳(より好ましくは、ヨーグルト)、乳酸菌飲料、チーズ、アイスクリーム等が挙げられる。 In the method for producing a citrulline-containing composition of the present invention, citrulline is produced in the raw material. At this time, the raw material containing citrulline may be used as it is as a raw material or raw material for food or drink, preferably as a raw material or raw material for dairy products, or citrulline is separated (isolated, etc.) from this raw material. Alternatively, citrulline having a desired purity may be prepared and used after processing by treatment such as or concentration. At this time, functional foods, nutritional foods, etc. are mentioned as food and drink, and dairy products include, for example, milk drinks, fermented milk (more preferably yogurt), lactic acid bacteria drinks, cheese, ice cream and the like. .
シトルリン含有飲食品
 前記したとおり、本発明のシトルリンの調製方法により得られるシトルリンを含む培地、または本発明によるシトルリン含有組成物の製造方法により得られるシトルリンを含む原料、あるいはこれらの加工品は、前記培地や原料として飲食品に適切な任意のものを選択して用いることにより、各々を飲食品そのものあるいは飲食品の原料または素材とすることができる。従って、本発明によれば、本発明のシトルリンを含む培地、またはシトルリンを含む原料、あるいはこれらの加工品を、飲食品そのものあるいは飲食品の原料または素材として利用した、シトルリン含有飲食品を提供することができる。
Citrulline-containing food and drink, as described above, a medium containing citrulline obtained by the method for preparing citrulline of the present invention, or a raw material containing citrulline obtained by the method for producing a citrulline-containing composition according to the present invention, or a processed product thereof, By selecting and using any suitable medium and raw material for food and drink, each can be used as the food and drink itself or the raw material or material of the food or drink. Therefore, according to the present invention, there is provided a citrulline-containing food or drink using the citrulline-containing medium of the present invention, or a raw material containing citrulline, or a processed product thereof as the food or drink itself or the raw material or material of the food or drink. be able to.
 また、前記した本発明のシトルリンの調製方法またはシトルリン含有組成物の製造方法により得られる、シトルリンまたはシトルリン含有組成物、あるいはこれらの加工品を、飲食品(好ましくは、乳製品、より好ましくは、発酵乳)に添加(配合)して、その飲食品にシトルリンに由来する機能を付加することができる。従って、本発明によれば、本発明のシトルリンまたはシトルリン含有組成物、あるいは、これらの加工品を、飲食品に添加して、シトルリン含有飲食品を提供することができる。 In addition, citrulline or a citrulline-containing composition obtained by the above-described method for preparing citrulline or a method for producing a citrulline-containing composition of the present invention, or a processed product thereof, a food or drink (preferably a dairy product, more preferably, Added to (fermented milk), the function derived from citrulline can be added to the food or drink. Therefore, according to this invention, the citrulline or citrulline containing composition of this invention, or these processed goods can be added to food-drinks, and a citrulline containing food-drinks can be provided.
 本発明のシトルリンの調製方法またはシトルリン含有組成物の製造方法によれば、シトルリンまたはシトルリン含有組成物、あるいはこれらの加工品について、その調製費(加工費)や製造費等を低く抑えて効率的に提供することができる。従って、本発明のシトルリンまたはシトルリン含有組成物を用いることで、シトルリンに由来する機能を付加する等して商品価値を高めながら、シトルリン含有飲食品について、その製造工程においてシトルリン含有量を高めることができる等の理由により、その製造費等を低く抑えて効率的に提供することができる。 According to the method for preparing citrulline or the method for producing a citrulline-containing composition of the present invention, the citrulline or citrulline-containing composition, or a processed product thereof can be efficiently kept at low preparation costs (processing costs), production costs, etc. Can be provided. Therefore, by using the citrulline or citrulline-containing composition of the present invention, it is possible to increase the citrulline content in the production process of citrulline-containing foods and drinks while increasing the commercial value by adding functions derived from citrulline. For the reason of being able to do so, the manufacturing cost etc. can be suppressed low and it can provide efficiently.
 本発明のシトルリン含有飲食品は、シトルリンの含有を許容するものであればよく、特に限定されないが、例えば、乳飲料、発酵乳(より好ましくは、ヨーグルト)、乳酸菌飲料、チーズ、アイスクリーム等の乳製品が挙げられる。 The citrulline-containing food or drink of the present invention is not particularly limited as long as it allows the inclusion of citrulline, and examples thereof include milk drinks, fermented milk (more preferably yogurt), lactic acid bacteria drinks, cheese, ice cream and the like. Dairy products.
アルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む培養液の調製方法
 本発明のアルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む培養液の調製方法は、前記微生物を通常(微生物の発酵の至適温度)よりも高い培養温度において、アルギニンを添加した培地で培養することを特徴とする。前記培養温度は、具体的には40℃以上48℃以下、好ましくは42℃以上47℃以下、より好ましくは44℃以上46℃以下である。また本発明の別の態様によれば、前記培養温度は40℃以上70℃以下であり、好ましい上限は68℃、より好ましい上限は65℃であり、好ましい下限は42℃、より好ましい下限は43℃である。
Preparation method of culture solution containing microorganisms capable of producing citrulline with increased conversion efficiency from arginine to citrulline Preparation of culture solution containing microorganisms capable of producing citrulline with improved conversion efficiency from arginine to citrulline of the present invention The method is characterized in that the microorganism is cultured in a medium to which arginine is added at a culture temperature higher than usual (the optimum temperature for fermentation of the microorganism). The culture temperature is specifically 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower. According to another aspect of the present invention, the culture temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
 本発明の好ましい一態様によれば、本発明のシトルリン産生能を有する微生物を、40℃以上48℃以下、好ましくは42℃以上47℃以下、より好ましくは44℃以上46℃以下の温度で培養する、前記微生物のシトルリン産生能の向上方法が提供される。また本発明の別の態様によれば、前記培養を40℃以上70℃以下で行い、好ましい培養の上限温度は68℃、より好ましい上限は65℃であり、好ましい下限温度は42℃、より好ましい下限は43℃である。このとき、本発明のシトルリン産生能を有する微生物には、本発明のシトルリンの調製方法またはシトルリン含有組成物の製造方法で得られた培養物または組成物を適切に処理することにより得られた、アルギニンからシトルリンへの変換効率を高めた微生物を用いることができる。 According to a preferred embodiment of the present invention, the microorganism having the ability to produce citrulline of the present invention is cultured at a temperature of 40 ° C. to 48 ° C., preferably 42 ° C. to 47 ° C., more preferably 44 ° C. to 46 ° C. A method for improving citrulline production ability of the microorganism is provided. According to another aspect of the present invention, the culturing is performed at 40 ° C. or higher and 70 ° C. or lower, a preferable upper limit temperature of the culture is 68 ° C., a more preferable upper limit is 65 ° C., and a preferable lower limit temperature is 42 ° C., more preferable. The lower limit is 43 ° C. At this time, the microorganism having the citrulline producing ability of the present invention was obtained by appropriately treating the culture or composition obtained by the method for preparing citrulline of the present invention or the method for producing a citrulline-containing composition, A microorganism having enhanced conversion efficiency from arginine to citrulline can be used.
 前記したとおり、本発明の好ましい一態様の培地は、アルギニンを添加した培地である。このような培地の組成(配合)で、微生物を培養することによって、シトルリンを効率的に産生させることができる。この理由について、次のように考えられるが、以下の説明(理論)は、あくまでも仮定であって、本発明は、この理論によって、何ら限定されるものではない。すなわち、従来技術において記載したとおり、例えば、上記の非特許文献1および2には、L. lactisのアルギニンの代謝活性について、アルギニンを培地に添加すると、ADIおよびOCTをコードする遺伝子の転写量が増大することが報告されている。この知見によれば、アルギニンを培地へ添加することにより、ADIをコードする遺伝子の転写量の増大が予想され、40℃以上70℃、ある場合には48℃以下という培養温度が高い温度の場合にも、この現象が維持されていることが考えられる。なお、アルギニンを培地に添加することにより、ADIをコードする遺伝子の転写量が増大することや、40℃以上70℃以下、ある場合には48℃以下という培養温度が高い温度の場合にも、この現象が維持され、あるいはOCTをコードする遺伝子の転写量が抑制されることは、直ちには予想しにくい。従って、本発明が非特許文献1および2から自明であると判断することは妥当でない。 As described above, the medium of a preferred embodiment of the present invention is a medium to which arginine is added. Citrulline can be efficiently produced by culturing microorganisms with such a medium composition (formulation). The reason for this can be considered as follows. However, the following explanation (theory) is merely an assumption, and the present invention is not limited by this theory. That is, as described in the prior art, for example, in Non-Patent Documents 1 and 2 above, regarding the metabolic activity of arginine in L. lactis, when arginine is added to the medium, the amount of transcription of genes encoding ADI and OCT is increased. It is reported to increase. According to this finding, the addition of arginine to the medium is expected to increase the transcription amount of the gene encoding ADI. When the culture temperature is 40 ° C. or higher and 70 ° C., and in some cases 48 ° C. or lower, the culture temperature is high. In addition, it is considered that this phenomenon is maintained. In addition, when arginine is added to the medium, the transcription amount of the gene encoding ADI increases, or even when the culture temperature is high, such as 40 ° C. or higher and 70 ° C. or lower, and in some cases 48 ° C. or lower, It is difficult to predict immediately that this phenomenon is maintained or that the transcription amount of the gene encoding OCT is suppressed. Therefore, it is not appropriate to judge that the present invention is obvious from Non-Patent Documents 1 and 2.
 本発明の好ましい一態様によれば、シトルリン産生能を有する微生物を培養する際に、培養の前にアルギニンを培地に添加する、および/または、培養の途中で断続的にアルギニンを培地に添加する、もしくは、培養の途中で継続的にアルギニンを培地に添加する。これにより、シトルリン産生能を有する微生物のシトルリン産生能を高めることができる。このとき、シトルリン産生能を有する微生物が、十分な濃度のアルギニンと接触する時間が長いことが好ましい。従って、シトルリン産生能を有する微生物を培養する際に、培養の前にアルギニンを培地に添加(配合)することが好ましく、培養の前にアルギニンを培地に添加すると共に、培養の途中で断続的又は継続的にアルギニンを培地に添加(追加)することがより好ましく、とりわけ、培養の途中で継続的にアルギニンを培地に添加することがさらに好ましい。 According to a preferred aspect of the present invention, when culturing a microorganism having citrulline-producing ability, arginine is added to the medium before culturing and / or arginine is intermittently added to the medium during the culture. Alternatively, arginine is continuously added to the medium during the culture. Thereby, the citrulline producing ability of the microorganisms having citrulline producing ability can be enhanced. In this case, it is preferable that the microorganism having citrulline-producing ability has a long time for contacting with a sufficient concentration of arginine. Therefore, when culturing a microorganism capable of producing citrulline, it is preferable to add (formulate) arginine to the medium before culturing, and add arginine to the medium before culturing, and intermittently or More preferably, arginine is continuously added (added) to the medium, and more preferably, arginine is continuously added to the medium during the culture.
 本発明のアルギニンの添加量は、シトルリンまたはシトルリン含有組成物、あるいは、これらの加工品を調製や製造できる条件から適宜選択されればよく、特に限定されないが、培地に対し、好ましくは0.5~5質量%、より好ましくは0.7~4質量%、さらに好ましくは1~3質量%である。 The addition amount of arginine of the present invention is not particularly limited as long as it is appropriately selected from citrulline or a composition containing citrulline, or conditions under which these processed products can be prepared and manufactured. To 5% by mass, more preferably 0.7 to 4% by mass, and still more preferably 1 to 3% by mass.
 本発明のアルギニンの添加方法は、培地に対し、アルギニンを無菌的に添加(配合)できればよく、特に限定されないが、培地に対し、アルギニンを添加した後に、当該培地を加熱殺菌や濾過滅菌してもよく、あるいは、アルギニン水溶液を別途調製し、当該アルギニン水溶液を加熱殺菌や濾過滅菌した後に、培地に対し、これを添加してもよい。 The method for adding arginine of the present invention is not particularly limited as long as arginine can be added (mixed) aseptically to the medium, and after adding arginine to the medium, the medium is subjected to heat sterilization or filter sterilization. Alternatively, an arginine aqueous solution may be separately prepared, and the arginine aqueous solution may be added to the medium after heat sterilization or filter sterilization.
 本発明の好ましい一態様によれば、シトルリン産生能を有する微生物を培養する際に、pHが5以上7以下の範囲にある培地を使用し、好ましくはpHが5以上6.5以下の範囲にある培地を使用し、より好ましくはpHが5以上6以下の範囲にある培地を使用し、さらに好ましくはpHが5.5以上6以下の範囲にある培地を使用する。これにより、シトルリン産生能を有する微生物の濃度(菌体濃度)を高めることができ、シトルリン産生能を高めることができる。このとき、アルカリの添加によって培地のpHを調整することが好ましく、アルカリとしてアルギニンまたはアルカリ金属水酸化物を用いることがより好ましい。 According to a preferred embodiment of the present invention, when culturing a microorganism having citrulline producing ability, a medium having a pH in the range of 5 or more and 7 or less is used, and preferably in a range of pH of 5 or more and 6.5 or less. A certain medium is used, more preferably a medium having a pH in the range of 5 or more and 6 or less, and further preferably a medium having a pH in the range of 5.5 or more and 6 or less. Thereby, the density | concentration (microbe density | concentration) of the microorganisms which have a citrulline production ability can be raised, and a citrulline production ability can be raised. At this time, it is preferable to adjust the pH of the medium by adding an alkali, and it is more preferable to use arginine or an alkali metal hydroxide as the alkali.
 本発明の一態様において、「pHが5以上7以下の範囲の培地で培養する」とは、好ましくは、培養の初期から終了まで、培地のpHが5以上7以下の範囲にあることを意味するが、必ずしも、培養の初期から終了まで常に、培地のpHが5以上7以下の範囲にあることを意味するものではない。すなわち、培地のpHが5以上7以下の範囲にある状態において、アルギニンからシトルリンへの変換効率が高まるために十分な時間で培養すればよく、具体的には1~60時間、好ましくは2~48時間、より好ましくは3~36時間、さらに好ましくは4~24時間で培養すればよい。 In one embodiment of the present invention, “cultured in a medium having a pH in the range of 5 to 7” preferably means that the pH of the medium is in the range of 5 to 7 from the beginning to the end of the culture. However, this does not necessarily mean that the pH of the medium is always in the range of 5 or more and 7 or less from the beginning to the end of the culture. That is, in the state where the pH of the medium is in the range of 5 or more and 7 or less, the culture may be performed for a sufficient time to increase the conversion efficiency from arginine to citrulline, specifically 1 to 60 hours, preferably 2 to The culture may be performed for 48 hours, more preferably 3 to 36 hours, and still more preferably 4 to 24 hours.
 本発明のアルカリの添加方法は、培地のpHを所定の範囲に制御又は管理できる条件から適宜選択されればよく、特に限定されない。例えば、pH計とコンピューター等を用いて、培地のpHを断続的又は継続的に観察しながら、培地のpHを所定の範囲で断続的又は継続的に制御又は管理することが好ましく、培地のpHを継続的に観察しながら、培地のpHを所定の範囲で継続的に制御や管理することがより好ましい。 The method for adding an alkali of the present invention is not particularly limited as long as it is appropriately selected from conditions under which the pH of the medium can be controlled or managed within a predetermined range. For example, it is preferable to control or manage the pH of the medium intermittently or continuously within a predetermined range while observing the pH of the medium intermittently or continuously using a pH meter and a computer. It is more preferable to continuously control and manage the pH of the medium within a predetermined range while observing continuously.
 本発明の好ましい一態様によれば、シトルリン産生能を有する微生物を培養する前に、その微生物を賦活培養してもよい。賦活培養の培養条件は、シトルリン産生能を有する微生物の種類に応じて適宜選択されればよく、特に限定されない。 According to a preferred embodiment of the present invention, before culturing a microorganism having citrulline-producing ability, the microorganism may be activated and cultured. The culture conditions for the activation culture may be appropriately selected according to the type of microorganism having citrulline production ability, and are not particularly limited.
 本発明の一つの態様によれば、アルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む培養液から、その微生物の菌体を遠心分離や膜分離などの処理に付してから、本発明のシトルリンの調製方法またはシトルリン含有組成物の製造方法に、その菌体を用いてもよい。 According to one aspect of the present invention, the microorganism cells are subjected to a treatment such as centrifugation or membrane separation from a culture solution containing microorganisms capable of producing citrulline with increased conversion efficiency from arginine to citrulline. Then, the cells may be used in the method for preparing citrulline or the method for producing a citrulline-containing composition of the present invention.
アルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む組成物の製造方法
 本発明のアルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む組成物の製造方法は、前記微生物を通常(微生物の発酵の至適温度)よりも高い培養温度において、アルギニンを添加した原料で発酵することを特徴とする。前記培養温度は、具体的には40℃以上48℃以下、好ましくは42℃以上47℃以下、より好ましくは44℃以上46℃以下である。また本発明の別の態様によれば、前記培養温度は40℃以上70℃以下であり、好ましい上限は68℃、より好ましい上限は65℃であり、好ましい下限は42℃、より好ましい下限は43℃である。
Method for producing a composition containing a microorganism capable of producing citrulline with enhanced conversion efficiency from arginine to citrulline Production of a composition comprising a microorganism capable of producing citrulline with enhanced efficiency of conversion of arginine into citrulline according to the present invention The method is characterized in that the microorganism is fermented with a raw material to which arginine is added at a culture temperature higher than usual (the optimum temperature for fermentation of the microorganism). The culture temperature is specifically 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower. According to another aspect of the present invention, the culture temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C.
 本発明の好ましい一態様によれば、本発明のシトルリン産生能を有する微生物を、40℃以上48℃以下、好ましくは42℃以上47℃以下、より好ましくは44℃以上46℃以下の温度で発酵する、前記微生物のシトルリン産生能の向上方法が提供される。また本発明の別の態様によれば、前記発酵温度は40℃以上70℃以下であり、好ましい上限は68℃、より好ましい上限は65℃であり、好ましい下限は42℃、より好ましい下限は43℃である。このとき、本発明のシトルリン産生能を有する微生物には、本発明のシトルリンの調製方法またはシトルリン含有組成物の製造方法で得られた培養物または組成物を適切に処理することにより得られる、アルギニンからシトルリンへの変換効率を高めた微生物を用いることができる。 According to a preferred embodiment of the present invention, the microorganism having citrulline producing ability of the present invention is fermented at a temperature of 40 ° C. or higher and 48 ° C. or lower, preferably 42 ° C. or higher and 47 ° C. or lower, more preferably 44 ° C. or higher and 46 ° C. or lower. A method for improving citrulline production ability of the microorganism is provided. Moreover, according to another aspect of the present invention, the fermentation temperature is 40 ° C. or higher and 70 ° C. or lower, a preferred upper limit is 68 ° C., a more preferred upper limit is 65 ° C., a preferred lower limit is 42 ° C., and a more preferred lower limit is 43. ° C. At this time, the microorganism having the citrulline production ability of the present invention is provided with arginine obtained by appropriately treating the culture or composition obtained by the method for preparing citrulline of the present invention or the method for producing a citrulline-containing composition. It is possible to use microorganisms that have improved the conversion efficiency from citrus to citrulline.
 前記したとおり、本発明の好ましい一態様の原料は、アルギニンを添加した原料である。このような原料の組成(配合)で、微生物を発酵することによって、シトルリンを効率的に産生させることができる。この理由について、本発明のアルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む培養液の調製方法において説明した理由と同様に考えられる。 As described above, the raw material according to a preferred embodiment of the present invention is a raw material to which arginine is added. Citrulline can be efficiently produced by fermenting microorganisms with the composition (formulation) of such raw materials. The reason for this is considered to be the same as the reason explained in the method for preparing a culture solution containing a microorganism having the ability to produce citrulline with improved conversion efficiency from arginine to citrulline of the present invention.
 本発明のアルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む培養液の調製方法において、シトルリンを含有する培地からシトルリンを単離せずに、そのまま培地をシトルリン含有組成物として利用してもよいし、または、所望の操作(例えば、遠心分離、膜分離など)で処理した培地をシトルリン含有組成物として利用してもよい。 In the method for preparing a culture solution containing a microorganism capable of producing citrulline with improved conversion efficiency from arginine to citrulline according to the present invention, the medium is directly used as a citrulline-containing composition without isolating citrulline from the citrulline-containing medium. The medium treated by a desired operation (for example, centrifugation, membrane separation, etc.) may be used as the citrulline-containing composition.
 本発明のアルギニンの添加量は、シトルリンまたはシトルリン含有組成物、あるいは、これらの加工品を調製や製造できる条件から適宜選択されればよく、特に限定されないが、原料に対し、好ましくは0.5~5質量%、より好ましくは0.7~4質量%、さらに好ましくは1~3質量%である。 The addition amount of arginine of the present invention is not particularly limited as long as it is appropriately selected from citrulline or a composition containing citrulline, or conditions under which these processed products can be prepared and manufactured, but is preferably 0.5 to the raw material. To 5% by mass, more preferably 0.7 to 4% by mass, and still more preferably 1 to 3% by mass.
 本発明のアルギニンの添加方法は、培地に対し、アルギニンを無菌的に添加(配合)できればよく、特に限定されないが、原料に対し、アルギニンを添加した後に、当該原料を加熱殺菌や濾過滅菌してもよく、あるいは、アルギニン水溶液を別途調製し、当該アルギニン水溶液を加熱殺菌や濾過滅菌した後に、原料に対し、これを添加してもよい。 The method for adding arginine of the present invention is not particularly limited as long as arginine can be aseptically added (blended) to the medium, and after adding arginine to the raw material, the raw material is subjected to heat sterilization or filter sterilization. Alternatively, an arginine aqueous solution may be separately prepared, and the arginine aqueous solution may be added to the raw material after heat sterilization or filter sterilization.
 本発明の好ましい一態様によれば、シトルリン産生能を有する微生物を培養する際に、培養の前にアルギニンを培地に添加する、および/または、培養の途中で断続的にアルギニンを培地に添加する、もしくは、培養の途中で継続的にアルギニンを培地に添加する。これにより、シトルリン産生能を有する微生物のシトルリン産生能を高めることができる。このとき、シトルリン産生能を有する微生物にとって、十分な濃度のアルギニンと接触する時間が長いことが好ましい。従って、培養の前にアルギニンを培地又は原料に添加(配合)することが好ましく、培養の前にアルギニンを培地に添加すると共に、培養の途中で断続的(例えば、所定量を一括して)又は継続的(例えば、少量ずつで徐々に)にアルギニンを培地に添加(追加)することがより好ましく、とりわけ、培養の途中で継続的にアルギニンを培地に添加することがさらに好ましい。これにより、シトルリン産生能を有する微生物を培養する際に、アルギニンからシトルリンへの変換効率を高めることができる。 According to a preferred aspect of the present invention, when culturing a microorganism having citrulline-producing ability, arginine is added to the medium before culturing and / or arginine is intermittently added to the medium during the culture. Alternatively, arginine is continuously added to the medium during the culture. Thereby, the citrulline producing ability of the microorganisms having citrulline producing ability can be enhanced. At this time, it is preferable for the microorganism having citrulline producing ability to have a long time for contacting with a sufficient concentration of arginine. Therefore, it is preferable to add (formulate) arginine to the medium or raw material before culturing, and add arginine to the medium before culturing and intermittently (for example, a predetermined amount in a lump) during the culturing or It is more preferable to add (add) arginine to the medium continuously (for example, gradually little by little), and it is more preferable to add arginine to the medium continuously during the culture. Thereby, when cultivating a microorganism having citrulline-producing ability, the conversion efficiency from arginine to citrulline can be increased.
 本発明の好ましい一態様によれば、シトルリン産生能を有する微生物を用いて発酵する前に、その微生物を賦活培養してもよい。賦活培養の培養条件は、シトルリン産生能を有する微生物の種類に応じて適宜選択されればよく、特に限定されない。 According to a preferred embodiment of the present invention, the microorganism may be activated and cultured before fermentation using a microorganism having citrulline-producing ability. The culture conditions for the activation culture may be appropriately selected according to the type of microorganism having citrulline production ability, and are not particularly limited.
 本発明の一つの態様によれば、アルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む組成物から、その微生物の菌体を遠心分離や膜分離などしてから、本発明のシトルリンの調製方法またはシトルリン含有組成物の製造方法に、その菌体を用いてもよい。 According to one aspect of the present invention, the composition of a microorganism containing citrulline-producing ability with enhanced conversion efficiency from arginine to citrulline is centrifuged, membrane-separated, etc. You may use the microbial cell for the preparation method of the citrulline of invention, or the manufacturing method of a citrulline containing composition.
微生物の濃度(菌体濃度)を高めた、シトルリン産生能を有する微生物を含む培養液の調製方法
 本発明の微生物の濃度(菌体濃度)を高めた、シトルリン産生能を有する微生物を含む培養液の調製方法は、前記微生物を通常(微生物の発酵の至適温度)の培養温度において、pHが5以上7以下の範囲にある培地で培養することを特徴としており、前記微生物を、35℃以上48℃以下、好ましくは38℃以上48℃以下、より好ましくは40℃以上48℃以下、さらに好ましくは42℃以上47℃以下、特に好ましくは44℃以上46℃以下の培養温度において、pHが5以上7以下の範囲、好ましくはpHが5以上6.5以下の範囲、より好ましくはpHが5以上6以下の範囲、さらに好ましくはpHが5.5以上6以下の範囲にある、アルギニンを添加した培地で培養することを特徴とする。つまり、ここでは、シトルリン産生能を有する微生物の培養に適した温度(例えば、至適温度)において、前記微生物を培養してもよい。本発明の別の態様によれば、前記微生物を、35℃以上70℃以下の培養温度(ここで、下限は好ましくは38℃、より好ましくは40℃、さらに好ましくは42℃、特に好ましくは44℃であり、上限は好ましくは68℃、さらに好ましくは65℃である)において、pHが5以上7以下の範囲、好ましくはpHが5以上6.5以下の範囲、より好ましくはpHが5以上6以下の範囲、さらに好ましくはpHが5.5以上6以下の範囲にある、アルギニンを添加した培地で培養することを特徴とする。
Method for preparing culture solution containing microorganisms having citrulline production ability with increased microorganism concentration (bacterial cell concentration) Culture solution containing microorganisms having citrulline production ability with increased microorganism concentration (bacterial cell concentration) of the present invention The preparation method is characterized in that the microorganism is cultured in a medium having a pH in the range of 5 or more and 7 or less at a normal culture temperature (optimum temperature for fermentation of the microorganism). At a culture temperature of 48 ° C. or lower, preferably 38 ° C. or higher and 48 ° C. or lower, more preferably 40 ° C. or higher and 48 ° C. or lower, more preferably 42 ° C. or higher and 47 ° C. or lower, particularly preferably 44 ° C. or higher and 46 ° C. or lower. In the range of 7 or less, preferably in the range of 5 to 6.5, more preferably in the range of 5 to 6 and even more preferably in the range of 5.5 to 6. Characterized by culturing in a medium supplemented with arginine. That is, here, the microorganism may be cultured at a temperature suitable for culturing a microorganism capable of producing citrulline (for example, an optimum temperature). According to another aspect of the present invention, the microorganism is cultured at a culture temperature of 35 ° C. or higher and 70 ° C. or lower (here, the lower limit is preferably 38 ° C., more preferably 40 ° C., still more preferably 42 ° C., particularly preferably 44 ° C.). And the upper limit is preferably 68 ° C., more preferably 65 ° C.), the pH is in the range of 5 to 7, preferably the pH is in the range of 5 to 6.5, more preferably the pH is 5 or more. It is characterized by culturing in a medium to which arginine is added, which is in the range of 6 or less, more preferably in the range of pH 5.5 or more and 6 or less.
 本発明の好ましい一態様によれば、本発明のシトルリン産生能を有する微生物を、35℃以上48℃以下、好ましくは38℃以上48℃以下、より好ましくは40℃以上48℃以下、さらに好ましくは42℃以上47℃以下、特に好ましくは44℃以上46℃以下の温度で培養する、前記微生物の濃度(菌体濃度)の向上方法が提供される。本発明の別の態様によれば、前記微生物を、35℃以上70℃以下の培養温度(ここで、下限は好ましくは38℃、より好ましくは40℃、さらに好ましくは42℃、特に好ましくは44℃であり、上限は好ましくは68℃、さらに好ましくは65℃である)で培養する、前記微生物の濃度(菌体濃度)の向上方法が提供される。このとき、本発明のシトルリン産生能を有する微生物には、本発明のシトルリンの調製方法またはシトルリン含有組成物の製造方法で得られた培養物または組成物を適切に処理することにより得られる、アルギニンからシトルリンへの変換効率を高めた微生物を用いることができる。 According to a preferred embodiment of the present invention, the microorganism having citrulline producing ability of the present invention is 35 ° C. or higher and 48 ° C. or lower, preferably 38 ° C. or higher and 48 ° C. or lower, more preferably 40 ° C. or higher and 48 ° C. or lower, and still more preferably. There is provided a method for improving the concentration of the microorganism (bacterial cell concentration), which is cultured at a temperature of 42 ° C. or higher and 47 ° C. or lower, particularly preferably 44 ° C. or higher and 46 ° C. or lower. According to another aspect of the present invention, the microorganism is cultured at a culture temperature of 35 ° C. or higher and 70 ° C. or lower (here, the lower limit is preferably 38 ° C., more preferably 40 ° C., still more preferably 42 ° C., particularly preferably 44 ° C.). And the upper limit is preferably 68 ° C., more preferably 65 ° C.), and a method for improving the concentration of the microorganism (cell concentration) is provided. At this time, the microorganism having the citrulline production ability of the present invention is provided with arginine obtained by appropriately treating the culture or composition obtained by the method for preparing citrulline of the present invention or the method for producing a citrulline-containing composition. It is possible to use microorganisms that have improved the conversion efficiency from citrus to citrulline.
 本発明の好ましい一態様によれば、シトルリン産生能を有する微生物を培養する際に、pHが5以上7以下の範囲にある培地を使用し、好ましくはpHが5以上6.5以下の範囲にある培地を使用し、より好ましくはpHが5以上6以下の範囲にある培地を使用し、さらに好ましくはpHが5.5以上6以下の範囲にある培地を使用する、前記微生物の濃度(菌体濃度)の向上方法が提供される。これにより、シトルリン産生能を有する微生物の濃度(菌体濃度)を高めることができ、シトルリン産生能を高めることができる。このとき、アルカリの添加によって培地のpHを調整することが好ましく、アルカリとしてアルギニンまたはアルカリ金属水酸化物を用いることがより好ましい。 According to a preferred embodiment of the present invention, when culturing a microorganism having citrulline producing ability, a medium having a pH in the range of 5 or more and 7 or less is used, and preferably in a range of pH of 5 or more and 6.5 or less. A concentration of the microorganism (bacteria) using a certain medium, more preferably using a medium having a pH in the range of 5 to 6, more preferably using a medium having a pH in the range of 5.5 to 6 A method for improving body concentration is provided. Thereby, the density | concentration (microbe density | concentration) of the microorganisms which have a citrulline production ability can be raised, and a citrulline production ability can be raised. At this time, it is preferable to adjust the pH of the medium by adding an alkali, and it is more preferable to use arginine or an alkali metal hydroxide as the alkali.
 本発明のアルギニンの添加量は、シトルリンまたはシトルリン含有組成物、あるいは、これらの加工品を調製や製造できる条件から適宜選択されればよく、特に限定されないが、培地に対し、好ましくは0.5~5質量%、より好ましくは0.7~4質量%、さらに好ましくは1~3質量%である。 The addition amount of arginine of the present invention is not particularly limited as long as it is appropriately selected from citrulline or a composition containing citrulline, or conditions under which these processed products can be prepared and manufactured. To 5% by mass, more preferably 0.7 to 4% by mass, and still more preferably 1 to 3% by mass.
 本発明の一態様において、「pHが5以上7以下の範囲の培地で培養する」とは、好ましくは、培養の初期から終了まで、培地のpHが5以上7以下の範囲にあることを意味するが、必ずしも、培養の初期から終了まで常に、培地のpHが5以上7以下の範囲にあることを意味するものではない。すなわち、培地のpHが5以上7以下の範囲にある状態において、菌体濃度が高まるために十分な時間で培養すればよく、具体的には1~60時間、好ましくは2~48時間、より好ましくは3~36時間、さらに好ましくは4~24時間で培養すればよい。 In one embodiment of the present invention, “cultured in a medium having a pH in the range of 5 to 7” preferably means that the pH of the medium is in the range of 5 to 7 from the beginning to the end of the culture. However, this does not necessarily mean that the pH of the medium is always in the range of 5 or more and 7 or less from the beginning to the end of the culture. That is, in the state where the pH of the medium is in the range of 5 or more and 7 or less, it may be cultured for a sufficient time to increase the bacterial cell concentration, specifically 1 to 60 hours, preferably 2 to 48 hours. The culture is preferably performed for 3 to 36 hours, more preferably 4 to 24 hours.
 アルカリの添加方法は、培地のpHを所定の範囲に制御又は管理できる条件から適宜選択されればよく、特に限定されない。例えば、pH計とコンピューター等を用いて、培地のpHを断続的又は継続的に観察しながら、培地のpHを所定の範囲に制御又は管理することが好ましく、培地のpHを継続的に観察しながら、培地のpHを所定の範囲に制御又は管理することがより好ましい。 The method for adding alkali is not particularly limited as long as it is appropriately selected from the conditions under which the pH of the medium can be controlled or managed within a predetermined range. For example, it is preferable to control or manage the pH of the medium within a predetermined range while observing the pH of the medium intermittently or continuously using a pH meter and a computer or the like. However, it is more preferable to control or manage the pH of the medium within a predetermined range.
 本発明の好ましい一態様によれば、シトルリン産生能を有する微生物を培養する前に、その微生物を賦活培養してもよい。賦活培養の培養条件は、シトルリン産生能を有する微生物の種類に応じて適宜選択されればよく、特に限定されない。 According to a preferred embodiment of the present invention, before culturing a microorganism having citrulline-producing ability, the microorganism may be activated and cultured. The culture conditions for the activation culture may be appropriately selected according to the type of microorganism having citrulline production ability, and are not particularly limited.
 本発明の一つの態様によれば、菌体濃度を高めた、シトルリン産生能を有する微生物を含む培養液から、その微生物の菌体を遠心分離や膜分離などの処理に付してから、本発明のシトルリンの調製方法またはシトルリン含有組成物の製造方法に、その菌体を用いてもよい。 According to one aspect of the present invention, the microorganism body is subjected to a treatment such as centrifugation or membrane separation from a culture solution containing a microorganism having a citrulline-producing ability and having an increased cell concentration, and then the present invention. You may use the microbial cell for the preparation method of the citrulline of invention, or the manufacturing method of a citrulline containing composition.
 本発明の一態様において、アルギニンをアルカリとして用いる際に、当該アルギニンは、本発明のシトルリンの調製方法、本発明のシトルリン産生能を有する微生物を含む培養液の調製方法などで培地に添加するアルギニンと共通する。従って、前記の調製方法などでアルギニンを培地に過剰に添加した場合には、当該培地のpHがアルカリ側に変化し、当該培地のpHが5以上7以下の範囲から大きく外れてしまうことがある。このようにアルギニンを培地に過剰に添加した場合には、シトルリン産生能を幾らか高められるため、シトルリン産生能を高めることのみを目的とすれば許容されるが、菌体濃度を十分には高められないこともある。そのため、このような場合には、シトルリン産生能を有する微生物(菌体)当たりのシトルリンの産生量(シトルリンの相対量)を高められるものの、当該微生物を含む培養液(培地)当たりのシトルリンの産生量(シトルリンの絶対量)を十分に高められない可能性があるため、留意が必要である。 In one embodiment of the present invention, when arginine is used as an alkali, the arginine is added to the medium by the method for preparing citrulline of the present invention, the method for preparing a culture solution containing a microorganism having the ability to produce citrulline of the present invention, or the like. And in common. Therefore, when arginine is excessively added to the medium by the above preparation method or the like, the pH of the medium may change to the alkali side, and the pH of the medium may greatly deviate from the range of 5 to 7. . When arginine is added excessively to the medium in this way, citrulline production ability can be increased somewhat, so it is acceptable only for the purpose of enhancing citrulline production ability, but the cell concentration is sufficiently increased. It may not be possible. Therefore, in such a case, although the citrulline production amount (relative amount of citrulline) per microorganism (cells) capable of producing citrulline can be increased, the production of citrulline per culture solution (medium) containing the microorganisms Note that the amount (absolute amount of citrulline) may not be sufficiently increased.
アルギニンからシトルリンへの変換効率を高め、かつ微生物の濃度(菌体濃度)を高めた、シトルリン産生能を有する微生物を含む培養液の調製方法
 本発明のアルギニンからシトルリンへの変換効率を高め、かつ微生物の濃度(菌体濃度)を高めた、シトルリン産生能を有する微生物を含む培養液の調製方法は、前記微生物を通常(微生物の発酵の至適温度)よりも高い培養温度において、pHが5以上7以下の範囲にある培地で培養することを特徴としており、前記微生物を、40℃以上48℃以下、好ましくは42℃以上47℃以下、より好ましくは44℃以上46℃以下の培養温度において、pHが5以上7以下の範囲、好ましくはpHが5以上6.5以下の範囲、より好ましくはpHが5以上6以下の範囲、さらに好ましくはpHが5.5以上6以下の範囲にある、アルギニンを添加した培地で培養することを特徴とする。また本発明の別の態様によれば、本発明による調製方法は、前記微生物を、40℃以上70℃以下の温度範囲(ここで、好ましい上限は68℃、より好ましい上限は65℃であり、好ましい下限は42℃、より好ましい下限は43℃である)において、pHが5以上7以下の範囲、好ましくはpHが5以上6.5以下の範囲、より好ましくはpHが5以上6以下の範囲、さらに好ましくはpHが5.5以上6以下の範囲にある、アルギニンを添加した培地で培養することを特徴とする。
Method for preparing a culture solution containing microorganisms having citrulline-producing ability with increased conversion efficiency from arginine to citrulline and increased microorganism concentration (bacterial cell concentration) Increased conversion efficiency from arginine to citrulline of the present invention, and A method for preparing a culture solution containing a microorganism having a citrulline-producing ability and having an increased microorganism concentration (cell concentration) has a pH of 5 at a culture temperature higher than normal (optimum temperature for fermentation of microorganisms). The microorganism is cultured in a medium in the range of 7 or less, and the microorganism is cultured at a culture temperature of 40 to 48 ° C., preferably 42 to 47 ° C., more preferably 44 to 46 ° C. The pH is in the range of 5 to 7, preferably the pH is in the range of 5 to 6.5, more preferably the pH is in the range of 5 to 6, more preferably the pH is In the range of .5 to 6, characterized by culturing in a medium supplemented with arginine. Moreover, according to another aspect of the present invention, the preparation method according to the present invention is a method in which the microorganism is in a temperature range of 40 ° C. or higher and 70 ° C. or lower (here, the preferable upper limit is 68 ° C., the more preferable upper limit is 65 ° C., The preferred lower limit is 42 ° C., and the more preferred lower limit is 43 ° C.), the pH is in the range of 5 to 7, preferably the pH is in the range of 5 to 6.5, more preferably the pH is in the range of 5 to 6. More preferably, the culture is performed in a medium supplemented with arginine having a pH in the range of 5.5 to 6.
 つまり、本発明のアルギニンからシトルリンへの変換効率を高めた、シトルリン産生能を有する微生物を含む培養液の調製条件、および本発明の微生物の濃度(菌体濃度)を高めた、シトルリン産生能を有する微生物を含む培養液の調製条件を併用することで、アルギニンからシトルリンへの変換効率を高め、かつ微生物の濃度(菌体濃度)を高めた、シトルリン産生能を有する微生物を含む培養液を調製できることとなる。 That is, the preparation conditions of the culture solution containing the microorganisms having citrulline-producing ability with improved conversion efficiency from arginine to citrulline of the present invention, and the citrulline-producing ability with increased microorganism concentration of the present invention (cell concentration) Preparation of a culture solution containing microorganisms capable of producing citrulline with increased conversion efficiency from arginine to citrulline and increased microorganism concentration (bacterial cell concentration) by combining the preparation conditions of the culture solution containing microorganisms It will be possible.
 本発明の一態様において、アルギニンの培地(培養液)への添加方法と、培地(培養液)のpHの調整(制御)方法には、アルギニンからシトルリンへの変換効率を高め、かつ微生物の濃度(菌体濃度)を高められる限りにおいて、前記の方法を適用することができる。 In one embodiment of the present invention, the method for adding arginine to a medium (culture solution) and the method for adjusting (controlling) the pH of the medium (culture solution) increase the conversion efficiency from arginine to citrulline and increase the concentration of microorganisms. As long as the (bacterial cell concentration) can be increased, the above method can be applied.
 本発明の好ましい一態様によれば、シトルリン産生能を有する微生物を培養する際に、培養の前にアルギニンを培地に添加する、および/または、培養の途中で断続的にアルギニンを培地に添加する、もしくは、培養の途中で継続的にアルギニンを培地に添加する。これにより、シトルリン産生能を有する微生物のシトルリン産生能を高めることができる。このとき、シトルリン産生能を有する微生物にとって、培養の開始時に培地のpHが中性程度であることが好ましい。従って、培養の前にアルギニンを培地に添加(配合)しないことが好ましく、培養の前にアルギニンを培地に添加せずに、培養の途中で断続的(例えば、所定量を一括して)又は継続的(例えば、少量ずつで徐々に)にアルギニンを培地に添加(追加)することがより好ましく、とりわけ、培養の途中で継続的にアルギニンを培地に添加することがさらに好ましい。これにより、シトルリン産生能を有する微生物を培養又は発酵する際に、アルギニンからシトルリンへの変換効率を高め、かつ微生物の濃度(菌体濃度)を高めることができる。 According to a preferred aspect of the present invention, when culturing a microorganism having citrulline-producing ability, arginine is added to the medium before culturing and / or arginine is intermittently added to the medium during the culture. Alternatively, arginine is continuously added to the medium during the culture. Thereby, the citrulline producing ability of the microorganisms having citrulline producing ability can be enhanced. At this time, it is preferable for the microorganism having citrulline producing ability that the pH of the medium is neutral at the start of the culture. Therefore, it is preferable not to add (formulate) arginine to the medium before culturing, and intermittently (for example, a predetermined amount in a lump) or during the culturing without adding arginine to the medium before culturing. It is more preferable to add (add) arginine to the medium (for example, gradually in small amounts), and it is more preferable to add arginine to the medium continuously during the culture. Thereby, when culturing or fermenting a microorganism having citrulline-producing ability, the conversion efficiency from arginine to citrulline can be increased, and the concentration of the microorganism (cell density) can be increased.
 本発明のアルギニンの添加量は、シトルリンまたはシトルリン含有組成物、あるいは、これらの加工品を調製や製造できる条件から適宜選択されればよく、特に限定されないが、培地に対し、好ましくは0.5~5質量%、より好ましくは0.7~4質量%、さらに好ましくは1~3質量%である。 The addition amount of arginine of the present invention is not particularly limited as long as it is appropriately selected from citrulline or a composition containing citrulline, or conditions under which these processed products can be prepared and manufactured. To 5% by mass, more preferably 0.7 to 4% by mass, and still more preferably 1 to 3% by mass.
 以下、本発明を実施例により、さらに詳しく説明する。ただし、本発明は、これら実施例に限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to these examples.
 本発明の実施例において、菌体濃度は「乳及び乳製品の成分規格等に関する省令(乳等省令)(日本国)」に記載の乳酸菌数の測定法により測定した。ただし、BCP培地の培養温度は30℃とした。また、アルギニン濃度、シトルリン濃度、オルニチン濃度はHPLC法により測定した。 In the examples of the present invention, the bacterial cell concentration was measured by the method for measuring the number of lactic acid bacteria described in "Ministerial Ordinance on Milk and Dairy Product Component Standards (Ministerial Ordinance on Milk) (Japan)". However, the culture temperature of the BCP medium was 30 ° C. Arginine concentration, citrulline concentration and ornithine concentration were measured by HPLC method.
実施例1: 乳酸菌とビフィズス菌のアルギニンの代謝能力
 下記の第1表に記載した、乳酸菌とビフィズス菌について、アルギニンの代謝能力を調べた。まず、MRS培地またはGAM培地を121℃、15分間で滅菌した。その後、アルギニン水溶液を濾過滅菌してから、これら培地に添加し、アルギニン濃度が27mMとなるように調整した。これら調整した培地に、下記の第1表に示される乳酸菌とビフィズス菌のMRS培地の賦活培養液を1重量%で接種した。ラクトコッカスでは、培養温度を30℃、培養時間を16時間として、静置状態において好気培養し、その他の菌体では、培養温度を37℃、培養時間を16時間として、静置状態において好気培養した。
Example 1 : Arginine metabolic capacity of lactic acid bacteria and bifidobacteria Arginine metabolic capacity was examined for lactic acid bacteria and bifidobacteria described in Table 1 below. First, the MRS medium or GAM medium was sterilized at 121 ° C. for 15 minutes. Thereafter, the aqueous arginine solution was sterilized by filtration and then added to these media to adjust the arginine concentration to 27 mM. These prepared media were inoculated with 1% by weight of an activating culture solution of lactic acid bacteria and bifidobacteria MRS medium shown in Table 1 below. In Lactococcus, the culture temperature is 30 ° C. and the culture time is 16 hours, and the aerobic culture is performed in a stationary state. In other cells, the culture temperature is 37 ° C. and the culture time is 16 hours, and the culture is preferably performed in a stationary state. Air-cultured.
 この結果は、下記の第1表に示されるとおりであった。Lactobacillus fermentum JCM1173T、Lactobacillus buchneri NCIMB8007T、Lactococcus lactis ssp.lactis JCM5805T、およびIFO12007において、アルギニンの代謝能力が確認された。 The results were as shown in Table 1 below. In Lactobacillus fermentum JCM1173T, Lactobacillus buchneri NCIMB8007T, Lactococcus lactis ssp. Lactis JCM5805T, and IFO12007, the ability to metabolize arginine was confirmed.
Figure JPOXMLDOC01-appb-I000001
Figure JPOXMLDOC01-appb-I000001
実施例2: Lactococcus lactis ssp.lactisLactococcus lactis ssp.diacetylactisのアルギニンの代謝能力
 実施例1の結果から、Lactococcus lactis ssp.lactisでは、2菌株のうち2菌株ともに、アルギニンの代謝能力が確認された。しかし、これら2菌株では、アルギニンの全部をシトルリンに変換した後に、そのシトルリンの大部分をオルニチンに変換していた。
Example 2: Lactococcus lactis ssp.lactis and Lactococcus lactis ssp.diacetylactis result of metabolic capacity Example 1 of arginine, in Lactococcus lactis ssp.lactis, both 2 strain of 2 strains, metabolic capacity of arginine was confirmed . However, in these two strains, after all of arginine was converted to citrulline, most of the citrulline was converted to ornithine.
 そこで、次に、下記の第2表に記載した、Lactococcus lactis ssp.lactisの29株と、 Lactococcus lactis ssp.lactisの近縁種であるLactococcus lactis ssp.diacetylactisの1株について、シトルリンをオルニチンに変換しない菌株を探索した。第2表中のNO.1~NO.29は、Lactococcus lactis ssp.lactisであり、NO.30は、Lactococcus lactis ssp.diacetylactisである。 Accordingly, next, described in Table 2 below, and 29 strains of Lactococcus lactis ssp.lactis, the Lactococcus lactis ssp. 1 strain of Lactococcus lactis ssp.diacetylactis a related species of the lactis, citrulline to ornithine conversion We searched for strains that did not. In Table 2, NO.1 to NO.29 are Lactococcus lactis ssp.lactis , and NO.30 is Lactococcus lactis ssp.diacetylactis .
 まず、MRS培地を121℃、15分間で滅菌した。その後、アルギニン水溶液を濾過滅菌してから、これら培地に添加し、アルギニン濃度が27mMとなるように調整した。これら調整した培地に、下記の第2表の菌株のMRS培地の賦活培養液を1重量%で接種した。これら菌株では、培養温度を30℃、培養時間を16時間として、静置状態において好気培養した。 First, the MRS medium was sterilized at 121 ° C. for 15 minutes. Thereafter, the aqueous arginine solution was sterilized by filtration and then added to these media to adjust the arginine concentration to 27 mM. These prepared media were inoculated with 1% by weight of an activated culture solution of MRS medium of the strains shown in Table 2 below. These strains were aerobically cultured in a stationary state at a culture temperature of 30 ° C. and a culture time of 16 hours.
 この結果は、下記の第2表に示されるとおりであった。Lactococcus lactis ssp.lactisの29菌株の全部において、アルギニンの代謝能力が確認された。ただし、アルギニンの大部分がオルニチンへと変換されており、オルニチンに対するシトルリンの生産比率(「Cit/Orn」)は0.02~0.13と低値であった。また、Lactococcus lactis ssp.diacetylactisの1菌株において、アルギニンの代謝能力は確認されなかった。 The results were as shown in Table 2 below. In all 29 strains of Lactococcus lactis ssp. Lactis, the ability to metabolize arginine was confirmed. However, most of the arginine was converted to ornithine, and the production ratio of citrulline to ornithine (“Cit / Orn”) was as low as 0.02 to 0.13. Moreover, in one strain of Lactococcus lactis ssp. Diacetylactis, the ability to metabolize arginine was not confirmed.
Figure JPOXMLDOC01-appb-I000002
Figure JPOXMLDOC01-appb-I000003
Figure JPOXMLDOC01-appb-I000002
Figure JPOXMLDOC01-appb-I000003
実施例3Lactococcus lactis ssp.lactisのアルギニンの代謝における培養温度(37℃、40℃)の影響
 培養温度を37℃または40℃とした以外は、実施例2と同様にして、菌体を培養し、アルギニンの代謝能力を調べた。この結果は、下記の第3表に示されるとおりであった。ここでは、Cit/Ornが比較的高い菌株を探索し、6菌株を選抜した。
Example 3 : Effect of culture temperature (37 ° C, 40 ° C) on the metabolism of arginine in Lactococcus lactis ssp. Lactis The cells were cultured in the same manner as in Example 2 except that the culture temperature was 37 ° C or 40 ° C. Then, the metabolic capacity of arginine was examined. The results were as shown in Table 3 below. Here, strains having relatively high Cit / Orn were searched and 6 strains were selected.
Figure JPOXMLDOC01-appb-I000004
Figure JPOXMLDOC01-appb-I000005
Figure JPOXMLDOC01-appb-I000004
Figure JPOXMLDOC01-appb-I000005
実施例4:還元脱脂乳中のLactococcus lactis ssp. lactisのアルギニンの代謝能力の検証(1)
 実施例3の結果から、Cit/Ornが比較的高い菌株を探索し、5菌株を選抜して使用した。すなわち、下記の第4表に記載した5菌株について、アルギニンの代謝能力を調べた。このとき、培地として、アルギニンを1重量%で添加した還元脱脂乳(脱脂粉乳の濃度:10重量%)(以降「1% Arg + 10% 還元脱脂乳」と記す)を使用した。
Example 4 : Verification of arginine metabolic capacity of Lactococcus lactis ssp. Lactis in reduced skim milk (1)
From the results of Example 3, strains having relatively high Cit / Orn were searched, and 5 strains were selected and used. That is, the metabolic ability of arginine was examined for 5 strains described in Table 4 below. At this time, reduced skim milk (concentration of skim milk powder: 10% by weight) to which arginine was added at 1% by weight (hereinafter referred to as “1% Arg + 10% reduced skim milk”) was used as a medium.
 下記の第4表に記載した5菌株のMRS培地の賦活培養液の20mLを遠心分離(8000rpm、10分間)し、これら5菌株の菌体を回収した。その後、「1% Arg + 10%還元脱脂乳」の40mLを95℃、3分間で殺菌したところに、前記のように回収した5菌株の菌体を接種した。なお、還元脱脂乳にアルギニンを添加する際には、まずアルギニンの水溶液を調製し、塩酸でpHを調整してから、還元脱脂乳と混合した。これら5菌株では、培養温度を40℃および43℃、培養時間を4時間および8時間として、静置状態において好気培養した。 20 mL of the activated culture solution of MRS medium of 5 strains described in Table 4 below was centrifuged (8000 rpm, 10 minutes), and the cells of these 5 strains were recovered. Thereafter, 40 mL of “1% Arg + 10% reduced skim milk” was sterilized at 95 ° C. for 3 minutes, and the cells of the 5 strains collected as described above were inoculated. In addition, when adding arginine to reduced skim milk, first, an aqueous solution of arginine was prepared, pH was adjusted with hydrochloric acid, and then mixed with reduced skim milk. In these 5 strains, the culture temperature was 40 ° C. and 43 ° C., and the culture time was 4 hours and 8 hours.
 この結果は、下記の第4表に示されるとおりであった。ここでは、Cit/Ornが比較的高い菌株を探索するとともに、Cit/Ornが比較的高い培養温度と培養時間を探索した。これら菌株では、全体として、培養温度が高いほど、そして、培養時間が長いほど、Cit/Ornが高くなる傾向が確認された。 This result was as shown in Table 4 below. Here, strains with relatively high Cit / Orn were searched, and culture temperatures and culture times with relatively high Cit / Orn were searched. In these strains as a whole, it was confirmed that the higher the culture temperature and the longer the culture time, the higher the Cit / Orn.
Figure JPOXMLDOC01-appb-I000006
Figure JPOXMLDOC01-appb-I000006
実施例5:還元脱脂乳中のLactococcus lactis ssp. lactisのアルギニンの代謝能力の検証(2)
 培養温度を44.5℃、46℃、さらに50℃から5度刻みで70℃までとした以外は、実施例4と同様にして、菌体を培養し、アルギニンの代謝能力を調べた。この結果は、下記の第5表に示されるとおりであった。なお、実施例4の結果から、Cit/Ornが比較的高い菌株を探索し、3菌株を選抜して使用した。
Example 5 : Verification of the ability of Lactococcus lactis ssp. Lactis to metabolize arginine in reduced skim milk (2)
Bacterial cells were cultured in the same manner as in Example 4 except that the culture temperature was 44.5 ° C., 46 ° C., and further from 50 ° C. to 70 ° C. in increments of 5 degrees, and the metabolic capacity of arginine was examined. The results were as shown in Table 5 below. In addition, from the result of Example 4, a strain having a relatively high Cit / Orn was searched, and three strains were selected and used.
Figure JPOXMLDOC01-appb-I000007
Figure JPOXMLDOC01-appb-I000008
Figure JPOXMLDOC01-appb-I000009
Figure JPOXMLDOC01-appb-I000007
Figure JPOXMLDOC01-appb-I000008
Figure JPOXMLDOC01-appb-I000009
実施例6Lactococcus lactis ssp.lactis OLS3797株またはOLS3818株を使用したシトルリンを含むヨーグルトの製造
 Lactococcus lactis ssp.lactis OLS3797株またはOLS3818株を使用し、シトルリンを含む発酵乳(ヨーグルト)を製造した。すなわち、下記の第6表に記載した原料乳(ヨーグルトベース)を調合し、95℃、3分間で殺菌した。そして、この原料乳に、ヨーグルトスターターとして、Lactobacillus bulgaricusおよびStreptococcus thermophilusの混合スターターを2重量%で添加するとともに、Lactococcus lactis ssp.lactis OLS3797株またはOLS3818株を添加し、45℃で発酵させて、ヨーグルトを製造した。なお、ここで、Lactococcus lactis ssp.lactis OLS3797株およびOLS3818株として、MRS培地の培養液を遠心分離(8000rpm、10分間)し、菌体のみを回収して使用した。このとき、MRS培地の使用量は、下記の第6表に記載した原料乳の使用量と同じ重量とした。
Example 6: Use the Lactococcus lactis ssp.lactis OLS3797 strain or manufacture of yogurt containing citrulline using OLS3818 strain Lactococcus lactis ssp.lactis OLS3797 strain or OLS3818 strain to produce a fermented milk containing citrulline (yogurt). That is, raw material milk (yogurt base) described in Table 6 below was prepared and sterilized at 95 ° C. for 3 minutes. Then, as a yogurt starter, 2% by weight of a mixed starter of Lactobacillus bulgaricus and Streptococcus thermophilus is added to this raw milk, and Lactococcus lactis ssp. Lactis OLS3797 strain or OLS3818 strain is added, fermented at 45 ° C, and yogurt Manufactured. Here, as the Lactococcus lactis ssp. Lactis OLS3797 strain and OLS3818 strain, the culture solution of the MRS medium was centrifuged (8000 rpm, 10 minutes), and only the cells were collected and used. At this time, the amount of MRS medium used was the same weight as the amount of raw milk described in Table 6 below.
Figure JPOXMLDOC01-appb-I000010
Figure JPOXMLDOC01-appb-I000010
 Lactococcus lactis ssp.lactis OLS3797株を使用した場合には、5時間30分で酸度が0.80%に達した。また、Lactococcus lactis ssp.lactis OLS3818株を使用した場合には、4時間30分で酸度が0.83%に達した。これら2菌株を使用した場合には、発酵が順調に進行したことが確認された。また、これら発酵乳(ヨーグルト)の風味と物性は、通常品や従来品と比較して大差はなかった。 When Lactococcus lactis ssp. Lactis OLS3797 strain was used, the acidity reached 0.80% in 5 hours and 30 minutes. In addition, when Lactococcus lactis ssp. Lactis OLS3818 was used, the acidity reached 0.83% in 4 hours and 30 minutes. When these two strains were used, it was confirmed that the fermentation proceeded smoothly. Moreover, the flavor and physical properties of these fermented milk (yogurt) were not significantly different from those of normal products and conventional products.
 これら発酵乳(ヨーグルト)のアルギニン、シトルリン、オルニチンの濃度を測定した。この結果は、下記の第7表に示されるとおりであった。アルギニンの大部分が代謝され、その大半がシトルリンへ変換されることが確認された。つまり、Lactococcus lactis ssp.lactis OLS3797株またはOLS3818株を使用し、シトルリンを高濃度で含む発酵乳(ヨーグルト)を製造できることが明らかとなった。 The concentrations of arginine, citrulline and ornithine in these fermented milk (yogurt) were measured. The results were as shown in Table 7 below. It was confirmed that most of arginine was metabolized and most of it was converted to citrulline. That is, it was revealed that fermented milk (yogurt) containing citrulline at a high concentration can be produced using Lactococcus lactis ssp. Lactis OLS3797 strain or OLS3818 strain.
Figure JPOXMLDOC01-appb-I000011
Figure JPOXMLDOC01-appb-I000011
実施例7:アルギニンからシトルリンへの変換効率の高い菌株(Lactococcus lactis ssp.lactis OLS3797株)の培養液の調製方法の検討(1)
 アルギニンからシトルリンへの変換効率(活性)の高い培養液の調製方法について検討した。上記の実施例では、L. lactisをMRS培地で静置培養して培養液を調製した。その結果として、L. lactisを静置培養すると、培養液のpHの低下に伴い、L. lactisの増殖が停止し、菌体濃度が高まらないことが観察された。そこで、アルカリを培養液に添加し、培養液のpHの低下を抑制して、そのpHを制御しながら、L. lactisをMRS培地で攪拌培養(pH制御培養)することで、菌体濃度への影響を検討した。つまり、L. lactisをMRS培地でpH制御培養することで、L. lactisの培養液における単位容量当たりのアルギニンからシトルリンへの変換効率が高まる可能性について検討した。なお、MRS培地を121℃、15分間で滅菌した。
Example 7 : Examination of preparation method of culture solution of strain having high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis OLS3797) (1)
A method for preparing a culture solution having high conversion efficiency (activity) from arginine to citrulline was examined. In the above examples, L. lactis was statically cultured in MRS medium to prepare a culture solution. As a result, it was observed that when L. lactis was statically cultured, the growth of L. lactis stopped and the bacterial cell concentration did not increase as the pH of the culture solution decreased. Therefore, by adding alkali to the culture solution, suppressing the decrease in the pH of the culture solution, and controlling the pH, L. lactis is stirred and cultured in the MRS medium (pH-controlled culture) to achieve the cell concentration. The effect of was examined. That is, the possibility of increasing the conversion efficiency from arginine to citrulline per unit volume in the culture solution of L. lactis by controlling the pH of L. lactis in MRS medium was examined. The MRS medium was sterilized at 121 ° C. for 15 minutes.
 水酸化ナトリウム水溶液(NaOH:10重量%)を培養液に添加し、培養液のpHを5.5に制御しながら、L. lactis OLS3797株を攪拌培養(pH制御培養)し、菌体濃度を経時的に測定した。具体的には、L. lactis OLS3797株のMRS培地の賦活培養液(培養温度:30℃、培養時間:16時間)を、MRS培地に1重量%で接種して攪拌培養(培養温度:30℃、撹拌速度:200rpm)した。この菌体濃度の経時的な変化は、図1に示されるとおりであった。 Aqueous sodium hydroxide (NaOH: 10% by weight) was added to the culture solution, and the L. lactis OLS3797 strain was stirred and cultured (pH controlled culture) while controlling the pH of the culture solution to 5.5. Measured over time. Specifically, the MRS medium activation culture solution (culture temperature: 30 ° C., culture time: 16 hours) of L. lactis OLS3797 strain was inoculated at 1% by weight into the MRS medium and stirred culture (culture temperature: 30 ° C.). , Stirring speed: 200 rpm). The change with time of the bacterial cell concentration was as shown in FIG.
 培養開始から10、11、12時間後におけるpH制御培養の培養液を採取し、これら培養液を氷水中で冷却保存した。そして、この培養液を「1% Arg + 10% 還元脱脂乳」に5重量%で接種して静置培養(培養温度:44.5℃、培養時間:8時間)し、アルギニンからシトルリンへの変換効率を調べた。このとき、比較対照として、前記の培養液をMRS培地に5重量%で接種して静置培養(培養温度:30℃、培養時間:16時間)し、アルギニンからシトルリンへの変換効率を調べた。この結果は、図2および下記の第8表に示されるとおりであった。 Culture media for pH-controlled culture at 10, 11, and 12 hours after the start of culture were collected, and these culture media were stored in ice water by cooling. Then, this culture broth is inoculated at 5% by weight into “1% Arg + 10% reduced skim milk” and statically cultured (culture temperature: 44.5 ° C., culture time: 8 hours), from arginine to citrulline. The conversion efficiency was examined. At this time, as a comparative control, the above culture broth was inoculated into MRS medium at 5% by weight and subjected to static culture (culture temperature: 30 ° C., culture time: 16 hours), and the conversion efficiency from arginine to citrulline was examined. . The results were as shown in FIG. 2 and Table 8 below.
Figure JPOXMLDOC01-appb-I000012
Figure JPOXMLDOC01-appb-I000012
 以上のとおり、MRS培地で静置培養した場合に比較して、MRS培地でpH制御培養した場合では、L. lactisの培養液における単位容量当たりのアルギニンからシトルリンへの変換効率が高まることが確認された。一方、MRS培地で静置培養した場合に比較して、MRS培地でpH制御培養した場合では、L. lactisの培養液における単位時間・単位菌体当たりのアルギニンからシトルリンへの変換効率に差はなかった。つまり、静置培養に比較して、pH制御培養では、菌体濃度は高まるが、単位菌体当たりのアルギニンからシトルリンへの変換効率は変化しないと判断できた。なお、単位時間・単位菌体当たりのアルギニンからシトルリンへの変換効率は、培養開始から4時間後と8時間後のシトルリンの濃度を、初発の生菌数と培養時間(4時間と8時間)で除した数値として算出した。 As described above, it is confirmed that the conversion efficiency from arginine to citrulline per unit volume in the culture solution of L. lactis is higher in the case of pH controlled culture in MRS medium than in the case of stationary culture in MRS medium. It was done. On the other hand, compared to the case of static culture in MRS medium, the difference in conversion efficiency from arginine to citrulline per unit time / unit cell in the culture solution of L. lactis in the case of pH controlled culture in MRS medium. There wasn't. That is, compared with static culture, it was determined that the pH control culture increased the cell concentration, but the conversion efficiency from arginine to citrulline per unit cell did not change. The conversion efficiency from arginine to citrulline per unit time / unit cell is the concentration of citrulline 4 hours and 8 hours after the start of culture, the number of viable bacteria and the culture time (4 hours and 8 hours). Calculated as the value divided by.
 さらに、pH制御培養の培養開始から12時間後の培養液を使用した場合について、「1% Arg + 10% 還元脱脂乳」における培養開始から4時間後と8時間後の菌数を調べた。その結果として、これら菌数は、それぞれ1×10 6 cfu/mLと1×10 4 cfu/mL (cfu : colony forming unit)であり、培養開始から時間の経過に伴い、菌数が低下していた。よって、アルギニンからシトルリンへの変換効率の測定中に、ADIが産生される可能性は低く、菌体自身が保有していたADIにより、アルギニンからシトルリンへ変換されていると推測できた。このとき、培養開始から時間の経過に伴い、ADIの活性が幾らか低下している可能性はあるが、培養開始から4時間と8時間後の変換効率に大差はなかった。 Furthermore, the number of bacteria at 4 hours and 8 hours after the start of the culture in “1% Arg + 10% reduced skim milk” was examined in the case of using the culture solution 12 hours after the start of the pH controlled culture. As a result, these numbers are 1 × 10 6 cfu / mL and 1 × 10 4 cfu / mL (cfu: colony forming unit), respectively. It was. Therefore, during the measurement of the conversion efficiency from arginine to citrulline, the possibility that ADI was produced was low, and it was estimated that ADI possessed by the cells themselves was converted from arginine to citrulline. At this time, there is a possibility that the activity of ADI is somewhat decreased with the passage of time from the start of the culture, but there was no great difference in the conversion efficiency after 4 hours and 8 hours from the start of the culture.
実施例8:アルギニンからシトルリンへの変換効率の高い菌株(Lactococcus lactis ssp.lactis 3797株)の培養液の調製方法の検討(2)
 実施例7において、L. lactisをpH制御培養すると、菌体濃度(菌数)は高まったが、単位時間・単位菌体当たりのアルギニンからシトルリンへの変換効率は変化しなかった。そこで、L. lactisの培養を開始する前に、アルギニンをMRS培地に添加して静置培養することで、L. lactisの培養液における単位容量当たりのアルギニンからシトルリンへの変換効率が高まる可能性について検討した。すなわち、L. lactis OLS3797株を通常のMRS培地と、アルギニンを0.5重量%で含むMRS培地で静置培養し、その培養液を使用して、「1% Arg + 10% 還元脱脂乳」におけるアルギニンからシトルリンへの変換効率を測定した。ここで、MRS培地を121℃、15分間で滅菌した。
Example 8 : Examination of preparation method of culture solution of strain having high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis 3797 strain) (2)
In Example 7, when L. lactis was cultured under pH control, the cell concentration (number of cells) increased, but the conversion efficiency from arginine to citrulline per unit time / unit cell did not change. Therefore, before starting the culture of L. lactis, by stationary culture was added to arginine to MRS medium, possibly the conversion efficiency is increased from arginine per unit volume in the culture of L. lactis to citrulline Was examined. That is, the L. lactis OLS3797 strain was statically cultured in a normal MRS medium and an MRS medium containing 0.5% by weight of arginine, and “1% Arg + 10% reduced skim milk” was used. The conversion efficiency from arginine to citrulline was measured. Here, the MRS medium was sterilized at 121 ° C. for 15 minutes.
 具体的には、L. lactis 3797株の賦活培養液(培養温度30℃、培養時間16時間)を、MRS培地に1重量%で接種して静置培養(培養温度:30℃、培養時間:16時間)した。そして、この培養液の20mLを遠心分離(8000rpm、10分間)し、菌体のみを回収してから、「1% Arg + 10% 還元脱脂乳」の40mLに接種して、攪拌培養(培養温度:44.5℃、培養時間:4時間)し、アルギニンからシトルリンへの変換効率を調べた。この結果は、下記の第9表に示されるとおりであった。 Specifically, an activated culture solution of L. lactis 3797 strain (culture temperature 30 ° C., culture time 16 hours) is inoculated into 1% by weight of MRS medium and left to stand (culture temperature: 30 ° C., culture time: 16 hours). Then, 20 mL of this culture solution is centrifuged (8000 rpm, 10 minutes), and only the cells are collected, then inoculated into 40 mL of “1% Arg + 10% reduced skim milk” and stirred culture (culture temperature) : 44.5 ° C., culture time: 4 hours), and the conversion efficiency from arginine to citrulline was examined. The results were as shown in Table 9 below.
 一方、前記の賦活培養液を、アルギニンを0.5重量%で含むMRS培地に1重量%で接種して静置培養(培養温度:30℃、培養時間:16時間)した。そして、この培養液の20mLを遠心分離(8000rpm、10分間)し、菌体のみを回収してから、「1% Arg + 10% 還元脱脂乳」の40mLに接種して、攪拌培養(培養温度:44.5℃、培養時間:4時間)し、アルギニンからシトルリンへの変換効率を調べた。この結果は、下記の第9表に示されるとおりであった。 On the other hand, the activated culture solution was inoculated at 1% by weight into MRS medium containing 0.5% by weight of arginine and allowed to stand (culture temperature: 30 ° C., culture time: 16 hours). Then, 20 mL of this culture solution is centrifuged (8000 rpm, 10 minutes), and only the cells are collected, then inoculated into 40 mL of “1% Arg + 10% reduced skim milk” and stirred culture (culture temperature) : 44.5 ° C., culture time: 4 hours), and the conversion efficiency from arginine to citrulline was examined. The results were as shown in Table 9 below.
Figure JPOXMLDOC01-appb-I000013
Figure JPOXMLDOC01-appb-I000013
 以上のとおり、通常の(従来の)MRS培地で静置培養した場合に比較して、アルギニンを含むMRS培地で静置培養した場合では、L. lactisの培養液における単位時間、単位菌体当たりのアルギニンからシトルリンへの変換効率が2倍以上に高まることが確認された。 As described above, in the case of static culture in an MRS medium containing arginine, compared to the case of static culture in a normal (conventional) MRS medium, the unit time per unit cell in the culture solution of L. lactis It was confirmed that the conversion efficiency from arginine to citrulline increased more than twice.
実施例9:アルギニンからシトルリンへの変換効率の高い菌株(Lactococcus lactis ssp.lactis OLS3797株)の培養液の調製方法の検討(3)
 実施例8において、アルギニンを培地に添加すると、L. lactisのアルギニンからシトルリンへの変換効率が高まった。そこで、L. lactisの培養を開始する前に、アルギニンをMRS培地に添加してからpH制御培養することで、L. lactisの培養液における単位容量当たりのアルギニンからシトルリンへの変換効率が高まる可能性について検討した。すなわち、L. lactis OLS3797株を、アルギニンを0.5重量%で含むMRS培地でpH制御培養し、その培養液を使用して、「1% Arg + 10% 還元脱脂乳」におけるアルギニンからシトルリンへの変換効率を測定した。ここで、MRS培地を121℃、15分間で滅菌した。その後、アルギニン水溶液を濾過滅菌してから、この培地に添加し、アルギニン濃度が0.5重量%となるように調整した。
Example 9 : Examination of preparation method of culture solution of strain having high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis OLS3797) (3)
In Example 8, when arginine was added to the medium, the conversion efficiency of L. lactis from arginine to citrulline increased. Therefore, by adding arginine to the MRS medium before starting the cultivation of L. lactis and then carrying out pH-controlled cultivation, the conversion efficiency of arginine to citrulline per unit volume in the culture solution of L. lactis can be increased. The sex was examined. That is, L. lactis OLS3797 strain was subjected to pH control culture in MRS medium containing 0.5% by weight of arginine, and the culture solution was used to convert arginine to citrulline in “1% Arg + 10% reduced skim milk”. The conversion efficiency of was measured. Here, the MRS medium was sterilized at 121 ° C. for 15 minutes. Thereafter, the aqueous arginine solution was sterilized by filtration and then added to this medium to adjust the arginine concentration to 0.5% by weight.
 水酸化ナトリウム水溶液(NaOH:10重量%)を培養液に添加し、培養液のpHを5.5に制御しながら、L. lactis OLS3797株を攪拌培養(pH制御培養)し、菌体濃度などを経時的に測定した。具体的には、L. lactis OLS3797株のMRS培地の賦活培養液(培養温度:30℃、培養時間:16時間)を、アルギニンを0.5重量%で含むMRS培地に1重量%で接種してから、NaOHを添加し、培養液のpHを5.5に制御しながら攪拌培養(培養温度:30℃、撹拌速度:200rpm)した。この菌体濃度、pH、アルギニン濃度、シトルリン濃度、オルニチン濃度の経時的な変化は、図3に示されるとおりであった。 Sodium hydroxide aqueous solution (NaOH: 10% by weight) was added to the culture solution, and the L. lactis OLS3797 strain was stirred and cultured (pH controlled culture) while controlling the pH of the culture solution to 5.5. Was measured over time. Specifically, the MRS medium activation culture solution (culture temperature: 30 ° C., culture time: 16 hours) of L. lactis OLS3797 strain was inoculated at 1% by weight into MRS medium containing 0.5% by weight of arginine. After that, NaOH was added, and stirring culture (culture temperature: 30 ° C., stirring speed: 200 rpm) was performed while controlling the pH of the culture solution to 5.5. The changes over time in the bacterial cell concentration, pH, arginine concentration, citrulline concentration, and ornithine concentration were as shown in FIG.
 以上のとおり、L. lactisの培養を開始する前に、アルギニンを培地へ添加したところ、培養開始時の培地のpHが8.3に上昇した。そして、この培養開始時(培養の初期)の培地のpHの上昇により、菌株の増殖が遅延したと思われる。ただし、培養の後期(後半)では、乳酸菌(菌体)が順調に増殖し、培養開始から10時間以降にアルギニンの消費が開始され、13時間後にアルギニン濃度は0となった。なお、この培養では、最高到達の菌体濃度が2.7×10 9 cfu/mLとなり、実施例7と比較して、菌体濃度が半分(2分の1)以下に低下した。 As described above, when arginine was added to the medium before starting the cultivation of L. lactis, the pH of the medium at the start of the cultivation increased to 8.3. And, it seems that the growth of the strain was delayed by the increase in pH of the medium at the start of the culture (initial stage of the culture). However, in the later stage (second half) of culture, lactic acid bacteria (bacteria) grew smoothly, and consumption of arginine started 10 hours after the start of culture, and the arginine concentration became 0 after 13 hours. In this culture, the highest cell concentration reached 2.7 × 10 9 cfu / mL, and compared to Example 7, the cell concentration was reduced to half (1/2) or less.
 培養開始から8、9、10、11、12、13時間後における培養液を採取し、これら培養液を氷水中で冷却保存した。そして、この培養液を「1% Arg + 10% 還元脱脂乳」に5重量%で接種して静置培養(培養温度:44.5℃、培養時間:8時間)し、アルギニンからシトルリンへの変換効率を調べた。この結果は、下記の第10表に示されるとおりであった。 The culture broths after 8, 9, 10, 11, 12, and 13 hours from the start of the culture were collected, and these culture broths were cooled and stored in ice water. Then, this culture broth is inoculated at 5% by weight into “1% Arg + 10% reduced skim milk” and statically cultured (culture temperature: 44.5 ° C., culture time: 8 hours), from arginine to citrulline. The conversion efficiency was examined. The results were as shown in Table 10 below.
Figure JPOXMLDOC01-appb-I000014
 以上のとおり、培養開始から11時間以降にアルギニンの消費が急激に増加した。これらのアルギニンの消費が速い培養液を使用すると、アルギニンからシトルリンへの変換効率が高まることが確認された。
Figure JPOXMLDOC01-appb-I000014
As described above, consumption of arginine increased rapidly after 11 hours from the start of culture. It was confirmed that the conversion efficiency from arginine to citrulline is increased by using a culture medium that consumes these arginines quickly.
実施例10:アルギニンからシトルリンへの変換効率の高い菌株(Lactococcus lactis ssp.lactis OLS3797株)の培養液の調製方法の検討(4)
 実施例9において、乳酸菌(菌体)の培養を開始する前に、アルギニンを培地へ添加すると、アルギニンからシトルリンへの変換効率が大幅に高まるが、アルギニンを添加しない場合に比較して、最高到達の菌体濃度が低下した。ここで、培養開始時の培地のpHが高いと、最高到達の菌体濃度が低下しやすいと考えられた。そこで、L. lactisを培養している途中で、アルギニンを培地(培養液)へ一括して(断続的に)添加して、pH制御培養することで、L. lactisの培養液における単位容量当たりのアルギニンからシトルリンへの変換効率が高まる可能性について検討した。ここで、MRS培地を121℃、15分間で滅菌した。
Example 10 : Examination of a method for preparing a culture solution of a strain having a high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis OLS3797 strain) (4)
In Example 9, when arginine was added to the medium before starting the culture of lactic acid bacteria (bacteria), the conversion efficiency from arginine to citrulline was greatly increased, but reached the highest level compared to the case where arginine was not added. The bacterial cell concentration decreased. Here, it was considered that when the pH of the culture medium at the start of the culture was high, the highest cell concentration was likely to decrease. Therefore, in the middle of culturing the L. lactis, collectively arginine to the culture medium (culture solution) (intermittently) was added, by pH control culture, per unit volume in the culture fluid of L. lactis The possibility of increasing the conversion efficiency of arginine to citrulline was investigated. Here, the MRS medium was sterilized at 121 ° C. for 15 minutes.
 水酸化ナトリウム水溶液(NaOH:10重量%)を培養液に添加し、培養液のpHを5.5に制御しながら、L. lactis OLS3797株を攪拌培養(pH制御培養)して、菌体濃度などを経時的に測定した。このとき、培養開始から10時間後に、アルギニン水溶液(アルギニン:10重量%)を濾過滅菌してから、この培地(培養液)に添加し、アルギニン濃度が0.5重量%となるように調整した。具体的には、L. lactis OLS3797株のMRS培地の賦活培養液(培養温度:30℃、培養時間:16時間)を、MRS培地に1重量%で接種してから、NaOHを添加し、培養液のpHを5.5に制御しながら攪拌培養(培養温度:30℃、撹拌速度:200rpm)するとともに、培養開始から10時間後に、アルギニン水溶液を濾過滅菌してから、この培地に添加し、アルギニン濃度が0.5重量%となるように調整した。この菌体濃度、pH、アルギニン濃度、シトルリン濃度、オルニチン濃度の経時的な変化は、図4に示されるとおりであった。 An aqueous sodium hydroxide solution (NaOH: 10% by weight) was added to the culture solution, and the L. lactis OLS3797 strain was stirred and cultured (pH controlled culture) while controlling the pH of the culture solution to 5.5. Etc. were measured over time. At this time, 10 hours after the start of the culture, an arginine aqueous solution (arginine: 10% by weight) was sterilized by filtration and then added to this medium (culture solution) to adjust the arginine concentration to 0.5% by weight. . Specifically, the MRS medium activation culture solution of L. lactis OLS3797 strain (culture temperature: 30 ° C., culture time: 16 hours) was inoculated into the MRS medium at 1% by weight, NaOH was added, and the culture was performed. Stirring culture (culture temperature: 30 ° C., stirring speed: 200 rpm) while controlling the pH of the solution to 5.5, and 10 hours after the start of the culture, the aqueous arginine solution is sterilized by filtration, and then added to this medium. The arginine concentration was adjusted to 0.5% by weight. Changes in the bacterial cell concentration, pH, arginine concentration, citrulline concentration and ornithine concentration over time were as shown in FIG.
 培養開始から8、10、12、13時間後における培養液を採取し、この培養液を氷水中で冷却保存した。そして、この培養液を「1% Arg + 10% 還元脱脂乳」に5重量%で接種して静置培養(培養温度:44.5℃、培養時間:4.5時間)し、アルギニンからシトルリンへの変換効率を調べた。この結果は、下記の第11表に示されるとおりであった。 The culture solution after 8, 10, 12, 13 hours from the start of the culture was collected, and this culture solution was stored in ice water by cooling. Then, this culture broth is inoculated at 5% by weight into “1% Arg + 10% reduced skim milk” and statically cultured (culture temperature: 44.5 ° C., culture time: 4.5 hours), from arginine to citrulline. The conversion efficiency to was investigated. The results were as shown in Table 11 below.
Figure JPOXMLDOC01-appb-I000015
 以上のとおり、最高到達の菌体濃度が7.1×10 9 cfu/mLとなり、実施例7と比較して、菌体濃度が同程度となった。一方、実施例9と比較して、アルギニンからシトルリンへの変換効率は低下した。
Figure JPOXMLDOC01-appb-I000015
As described above, the highest cell concentration reached 7.1 × 10 9 cfu / mL, and compared with Example 7, the cell concentration was comparable. On the other hand, compared with Example 9, the conversion efficiency from arginine to citrulline decreased.
実施例11:アルギニンからシトルリンへの変換効率の高い菌株(Lactococcus lactis ssp.lactis OLS3797株)の培養液の調製方法の検討(5)
 実施例10において、乳酸菌(菌体)を培養している途中で、アルギニンを培地(培養液)へ一括して(断続的に)添加して、pH制御培養すると、通常(従来)のpH制御培養する場合と比較して、最高到達の菌体濃度は同程度となるが、乳酸菌(菌体)の培養を開始する前に、アルギニンを培地へ添加する場合と比較して、アルギニンからシトルリンへの変換効率が低下した。そこで、L. lactisを培養している途中で、アルギニンを培地(培養液)へ少量ずつで(継続的に)添加しながら、pH制御培養することで、L. lactisの培養液における単位容量当たりのアルギニンからシトルリンへの変換効率が高まる可能性について検討した。ここで、MRS培地を121℃、15分間で滅菌した。
Example 11 : Examination of a method for preparing a culture solution of a strain having a high conversion efficiency from arginine to citrulline ( Lactococcus lactis ssp. Lactis OLS3797 strain) (5)
In Example 10, during the cultivation of lactic acid bacteria (cells), arginine was added to the medium (culture solution) all at once (intermittently), and when pH-controlled culture was performed, normal (conventional) pH control was performed. Compared to the case of culturing, the highest cell concentration reached the same level, but before starting the cultivation of lactic acid bacteria (bacteria), arginine is added to citrulline compared to the case where arginine is added to the medium. The conversion efficiency decreased. Therefore, while culturing L. lactis , arginine was added to the medium (culture medium) in small amounts (continuously), and pH-controlled culture was performed, so that per unit volume in the culture medium of L. lactis. The possibility of increasing the conversion efficiency of arginine to citrulline was investigated. Here, the MRS medium was sterilized at 121 ° C. for 15 minutes.
 アルギニン水溶液(アルギニン:10重量%)を培養液に添加し、培養液のpHを5.5に制御しながら、L. lactis OLS3797株を攪拌培養(pH制御培養)して、菌体濃度などを経時的に測定した。このとき、培養開始から4時間後に、アルギニン水溶液(アルギニン:10重量%)を濾過滅菌してから、この培地(培養液)に添加し、培地のpHが5.5となるように調整した。具体的には、L. lactis OLS3797株のMRS培地の賦活培養液(培養温度:30℃、培養時間:16時間)を、MRS培地に1重量%で接種してから、アルギニンを添加し、培養液のpHを5.5に制御しながら攪拌培養(培養温度:30℃、撹拌速度:200rpm)するとともに、培養開始から4時間後に、アルギニン水溶液を濾過滅菌してから、この培地に添加し、培地のpHが5.5となるように調整した。この菌体濃度、pH、アルギニン濃度、シトルリン濃度、オルニチン濃度の経時的な変化は、図5に示されるとおりであった。 An aqueous arginine solution (arginine: 10% by weight) was added to the culture solution, and the L. lactis OLS3797 strain was stirred and cultured (pH controlled culture) while controlling the pH of the culture solution to 5.5. Measured over time. At this time, 4 hours after the start of the culture, an aqueous arginine solution (arginine: 10% by weight) was sterilized by filtration and then added to this medium (culture solution) to adjust the pH of the medium to 5.5. Specifically, the MRS medium activation culture solution of L. lactis OLS3797 strain (culture temperature: 30 ° C., culture time: 16 hours) was inoculated into the MRS medium at 1% by weight, arginine was added, and the culture was performed. Stirring culture (culture temperature: 30 ° C., stirring speed: 200 rpm) while controlling the pH of the solution to 5.5, and 4 hours after the start of the culture, the arginine aqueous solution was sterilized by filtration and then added to this medium. The pH of the medium was adjusted to 5.5. Changes in the bacterial cell concentration, pH, arginine concentration, citrulline concentration and ornithine concentration over time were as shown in FIG.
 培養開始から8、10、12、13時間後の培養液を採取し、この培養液を氷水中で冷却保存した。そして、この培養液を「1% Arg + 10% 還元脱脂乳」に5重量%で接種して静置培養(培養温度:44.5℃、培養時間:4.5時間)し、アルギニンからシトルリンへの変換効率を調べた。この結果は、下記の第12表に示されるとおりであった。ここで、表中、「Culture」は、培養液をそのままで「1% Arg + 10% 還元脱脂乳」に5重量%で接種したものである。また、「Supernatant」は、培養液を遠心分離して得た上清を「1% Arg + 10% 還元脱脂乳」に5重量%で接種したものである。さらに、「Cell」は、培養液を遠心分離して上清を除いて回収した菌体を-80℃で凍結保存し、その後に解凍したものを「1% Arg + 10% 還元脱脂乳」に5重量%で接種したものである。 The culture solution after 8, 10, 12, 13 hours from the start of the culture was collected, and this culture solution was stored in ice water by cooling. Then, this culture solution is inoculated into “1% に Arg + 10% reduced skim milk” at 5% by weight, and statically cultured (culture temperature: 44.5 ° C., culture time: 4.5 hours), from arginine to citrulline. The conversion efficiency to was investigated. The results were as shown in Table 12 below. Here, in the table, “Culture” is an inoculation of “1% Arg + 10% reduced skim milk” with 5% by weight of the culture solution. “Supernatant” is obtained by inoculating a supernatant obtained by centrifuging a culture solution into “1% に Arg + 10% reduced skim milk” at 5% by weight. In addition, “Cell” was prepared by centrifuging the culture broth, removing the supernatant, freezing the collected cells at −80 ° C., and then thawing them into “1% Arg + 10% reduced skim milk” Inoculated at 5% by weight.
Figure JPOXMLDOC01-appb-I000016
Figure JPOXMLDOC01-appb-I000016
 ここでは、培養開始から4時間後に、アルギニン(中和剤、基質)の培地(培養液)への添加を開始し、培養終了まで継続した。このとき、アルギニンの培地への添加を開始してから暫くの間、アルギニンは直ちにオルニチンへ変換されていたが、培養の後半では、アルギニンの幾らかはオルニチンへ変換されず、そのまま蓄積されていた。 Here, 4 hours after the start of the culture, the addition of arginine (neutralizing agent, substrate) to the medium (culture solution) was started and continued until the end of the culture. At this time, arginine was immediately converted to ornithine for a while after starting the addition of arginine to the medium, but in the latter half of the culture, some of the arginine was not converted to ornithine and was accumulated as it was. .
 以上のとおり、最高到達の菌体濃度が6.5×10 9 cfu/mLとなり、実施例7および実施例10と比較して、菌体濃度が同程度となった。そして、実施例9と比較して、アルギニンからシトルリンへの変換効率が同程度となった。つまり、ここでは、菌体濃度が高まると共に、アルギニンからシトルリンへの変換効率が高まった。 As described above, the highest cell concentration reached 6.5 × 10 9 cfu / mL, and compared with Example 7 and Example 10, the cell concentration was comparable. And compared with Example 9, the conversion efficiency from arginine to citrulline became comparable. That is, here, the bacterial cell concentration increased and the conversion efficiency from arginine to citrulline increased.
 また、菌体の培養液をそのままで使用した場合と比較して、菌体のみを回収して凍結保存した場合にも、アルギニンからシトルリンへの変換効率は同程度となった。そして、培養開始から4~8時間後には、アルギニンの全部が代謝され、アルギニンの大部分がシトルリンへ変換されていた。 In addition, compared to the case where the culture solution of the bacterial cells was used as it was, the conversion efficiency from arginine to citrulline was also comparable when only the bacterial cells were collected and stored frozen. Then, 4 to 8 hours after the start of the culture, all of the arginine was metabolized and most of the arginine was converted to citrulline.
 そして、菌体の培養液をそのままで使用する場合に比較して、菌体のみを回収して使用する場合には、培地(培養液)への添加濃度(接種量)は20分の1~50分の1程度へ減少する。ここでは、培地への添加濃度が5重量%であることから、菌体のみを回収して使用する場合には、培地への添加濃度は0.25~0.1重量%と試算できる。すなわち、アルギニンを(中和剤として)培養の途中で継続的に(例えば、培養終了まで)添加しながら、pH制御培養して培養液を調製した場合には、菌体のみを回収して使用すると、シトルリンを高濃度で含む乳製品を効率的に製造できることとなる。 Then, compared to the case where the culture solution of the bacterial cells is used as it is, when only the bacterial cells are collected and used, the concentration (inoculation amount) added to the medium (culture solution) is from 1/20 Decrease to about 1/50. Here, since the concentration added to the medium is 5% by weight, when only the cells are collected and used, the concentration added to the medium can be estimated to be 0.25 to 0.1% by weight. That is, when arginine is added (as a neutralizing agent) continuously during culture (for example, until the end of the culture) and a culture solution is prepared by pH-controlled culture, only the cells are collected and used. Then, a dairy product containing citrulline at a high concentration can be efficiently produced.

Claims (18)

  1.  シトルリン産生能を有する微生物を培地に接種し、40℃以上70℃以下の温度で培養することを特徴とする、シトルリンの調製方法。 A method for preparing citrulline, which comprises inoculating a medium with a citrulline-producing microorganism and culturing at a temperature of 40 ° C. or higher and 70 ° C. or lower.
  2.  シトルリン産生能を有する微生物が乳酸菌、ビフィズス菌またはプロピオン酸菌である、請求項1に記載のシトルリンの調製方法。 The method for preparing citrulline according to claim 1, wherein the microorganism having citrulline-producing ability is a lactic acid bacterium, a bifidobacteria or a propionic acid bacterium.
  3.  乳酸菌がラクトコッカス・ラクティス、ラクトバチルス・ファーメンタム、およびラクトバチルス・ブフネリからなる群から選択される1種または2種以上である、請求項2に記載のシトルリンの調製方法。 The method for preparing citrulline according to claim 2, wherein the lactic acid bacteria is one or more selected from the group consisting of Lactococcus lactis, Lactobacillus fermentum, and Lactobacillus buchneri.
  4.  乳酸菌がラクトコッカス・ラクティス亜種ラクティス(Lactococcus lactis spp. lactis) OLS3789株、OLS3797株、およびOLS3818株からなる群から選択される1種または2種以上である、請求項2に記載のシトルリンの調製方法。 The preparation of citrulline according to claim 2, wherein the lactic acid bacterium is one or more selected from the group consisting of Lactococcus 亜 lactis spp. Lactis OLS3789, OLS3797, and OLS3818. Method.
  5.  シトルリン産生能を有する微生物を原料に添加し、40℃以上70℃以下の温度で発酵することを特徴とする、シトルリン含有組成物の製造方法。 A method for producing a citrulline-containing composition, wherein a microorganism having citrulline-producing ability is added to a raw material and fermented at a temperature of 40 ° C to 70 ° C.
  6.  シトルリン産生能を有する微生物が乳酸菌、ビフィズス菌またはプロピオン酸菌である、請求項5に記載のシトルリン含有組成物の製造方法。 The method for producing a citrulline-containing composition according to claim 5, wherein the microorganism having citrulline-producing ability is a lactic acid bacterium, a bifidobacteria or a propionic acid bacterium.
  7.  乳酸菌がラクトコッカス・ラクティス、ラクトバチルス・ファーメンタム、およびラクトバチルス・ブフネリからなる群から選択される1種または2種以上である、請求項6に記載のシトルリン含有組成物の製造方法。 The method for producing a citrulline-containing composition according to claim 6, wherein the lactic acid bacteria are one or more selected from the group consisting of Lactococcus lactis, Lactobacillus fermentum, and Lactobacillus buchneri.
  8.  乳酸菌がラクトコッカス・ラクティス亜種ラクティス(Lactococcus lactis spp. lactis) OLS3789株、OLS3797株、およびOLS3818株からなる群から選択される1種または2種以上である、請求項6に記載のシトルリン含有組成物の製造方法。 The citrulline-containing composition according to claim 6, wherein the lactic acid bacterium is one or more selected from the group consisting of Lactococcus 亜 lactis spp. Lactis 37 OLS3789, OLS3797, and OLS3818. Manufacturing method.
  9.  原料が原料乳である、請求項5~8のいずれか一項に記載のシトルリン含有組成物の製造方法。 The method for producing a citrulline-containing composition according to any one of claims 5 to 8, wherein the raw material is raw material milk.
  10.  シトルリン含有組成物が飲食品である、請求項5~9のいずれか一項に記載のシトルリン含有組成物の製造方法。 The method for producing a citrulline-containing composition according to any one of claims 5 to 9, wherein the citrulline-containing composition is a food or drink.
  11.  シトルリン産生能を有し、かつ40℃以上70℃以下の培養温度におけるアルギニンからシトルリンへの変換効率が高められた微生物を含む培養液の調製方法であって、シトルリン産生能を有する微生物を、アルギニンを添加した培地で培養することを特徴とする、調製方法。 A method for preparing a culture solution containing a microorganism having a citrulline producing ability and having an enhanced conversion efficiency from arginine to citrulline at a culture temperature of 40 ° C. or higher and 70 ° C. or lower, wherein the microorganism having citrulline producing ability is obtained by A method of preparation, comprising culturing in a medium to which is added.
  12.  培養の前にアルギニンを培地に添加する、および/または、
     培養の途中で断続的にアルギニンを添加する、もしくは、培養の途中で継続的にアルギニンを添加する、請求項11に記載の培養液の調製方法。
    Add arginine to the medium before culturing and / or
    The method for preparing a culture solution according to claim 11, wherein arginine is intermittently added during the culture, or arginine is continuously added during the culture.
  13.  シトルリン産生能を有する微生物を含み、かつ当該微生物の濃度が高められた培養液の調製方法であって、シトルリン産生能を有する微生物を、pHが5以上7以下の範囲にある培地で培養し、前記微生物の濃度を高めることを特徴とする、調製方法。 A method for preparing a culture solution containing a microorganism having citrulline producing ability and having an increased concentration of the microorganism, wherein the microorganism having citrulline producing ability is cultured in a medium having a pH in the range of 5 to 7. A preparation method characterized by increasing the concentration of the microorganism.
  14. アルカリの添加によって培地のpHを調整する、請求項13に記載の培養液の調製方法。 The method for preparing a culture solution according to claim 13, wherein the pH of the medium is adjusted by adding an alkali.
  15.  シトルリン産生能を有し、35℃以上70℃以下の培養温度におけるアルギニンからシトルリンへの変換効率が高められた微生物を含み、かつ当該微生物の濃度が高められた培養液の調製方法であって、シトルリン産生能を有する微生物を、アルギニンを添加し、かつpHが5以上7以下の範囲にある培地で培養して前記微生物の濃度を高めることを特徴とする、調製方法。 A method for preparing a culture solution having a citrulline-producing ability, comprising a microorganism having an enhanced conversion efficiency from arginine to citrulline at a culture temperature of 35 ° C. or higher and 70 ° C. or lower, and having an increased concentration of the microorganism, A method for preparing a microorganism comprising citrulline-producing ability, wherein arginine is added and the microorganism is cultured in a medium having a pH in the range of 5 to 7, thereby increasing the concentration of the microorganism.
  16.  培養の前にアルギニンを培地に添加する、および/または、
     培養の途中で断続的にアルギニンを添加する、もしくは、培養の途中で継続的にアルギニンを添加する、請求項15に記載の培養液の調製方法。
    Add arginine to the medium before culturing and / or
    The method for preparing a culture solution according to claim 15, wherein arginine is intermittently added during the culture, or arginine is continuously added during the culture.
  17.  請求項11~16のいずれか一項に記載の方法によって得られた培養液を、遠心分離および/または膜分離して得られる、アルギニンからシトルリンへの変換効率を高めたシトルリン産生能を有する微生物の調製方法。 A microorganism having the ability to produce citrulline with improved conversion efficiency from arginine to citrulline, obtained by centrifuging and / or membrane-separating the culture solution obtained by the method according to any one of claims 11 to 16 Preparation method.
  18.  請求項11~16のいずれか一項に記載の培養液の調製方法によって得られた培養液または請求項17に記載の微生物の調製方法によって得られた微生物を、培地に接種して培養する、請求項1~4のいずれか一項に記載のシトルリンの調製方法、もしくは原料に添加して発酵する、請求項5~10のいずれか一項に記載のシトルリン含有組成物の製造方法。 A culture solution obtained by the method for preparing a culture solution according to any one of claims 11 to 16 or a microorganism obtained by the method for preparing a microorganism according to claim 17 is inoculated into a medium and cultured. The method for producing citrulline according to any one of claims 1 to 4, or the method for producing a citrulline-containing composition according to any one of claims 5 to 10, wherein the citrulline preparation method according to any one of claims 1 to 4 is added to the raw material for fermentation.
PCT/JP2015/051462 2014-01-22 2015-01-21 Method for preparing citrulline WO2015111597A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2015559080A JP6535285B2 (en) 2014-01-22 2015-01-21 Method of preparing citrulline
SG11201605881YA SG11201605881YA (en) 2014-01-22 2015-01-21 Method for preparing citrulline
CN201580015339.1A CN107172883A (en) 2014-01-22 2015-01-21 The preparation method of citrulling
HK18102979.1A HK1243461A1 (en) 2014-01-22 2018-03-01 Method for preparing citrulline

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014009583 2014-01-22
JP2014-009583 2014-01-22

Publications (1)

Publication Number Publication Date
WO2015111597A1 true WO2015111597A1 (en) 2015-07-30

Family

ID=53681399

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/051462 WO2015111597A1 (en) 2014-01-22 2015-01-21 Method for preparing citrulline

Country Status (5)

Country Link
JP (1) JP6535285B2 (en)
CN (1) CN107172883A (en)
HK (1) HK1243461A1 (en)
SG (1) SG11201605881YA (en)
WO (1) WO2015111597A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106479923A (en) * 2016-10-19 2017-03-08 江南大学 The Lactobacillus fermenti of one plant of simultaneously degrade arginine and carbamide
JP2018023301A (en) * 2016-08-09 2018-02-15 株式会社明治 Citrulline-containing fermented milk and method for producing the same
JP2018076714A (en) * 2016-11-10 2018-05-17 大阪瓦斯株式会社 Petroleum recovery increasing nutrition
JP2018075036A (en) * 2018-02-02 2018-05-17 株式会社明治 Citrulline-containing fermented milk and method for producing the same
WO2018220917A1 (en) * 2017-05-31 2018-12-06 キリン株式会社 Composition for fatigue recovery and/or prevention of fatigue accumulation
WO2022030493A1 (en) * 2020-08-03 2022-02-10 国立大学法人北海道大学 Zinc protoporphyrin ix-forming agent containing lactic acid bacteria, and color tone-improving method and manufacturing method for processed food using same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107916282B (en) * 2017-12-13 2021-06-04 湖北新生源生物工程有限公司 Method for preparing L-citrulline and L-ornithine by biological method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04287636A (en) * 1991-03-18 1992-10-13 Snow Brand Milk Prod Co Ltd Fermented milk and its production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298918B1 (en) * 1998-02-20 2000-02-07 Mendes Srl USE OF ARGININE DEIMINASE BACTERIA TO INDUCE APOPTOSIS AND / OR REDUCE AN INFLAMMATORY REACTION AND PHARMACEUTICAL COMPOSITIONS
KR100634482B1 (en) * 2004-06-03 2006-10-16 재단법인서울대학교산학협력재단 Method for separating ADI from Lactococcus lactis
JP5247120B2 (en) * 2007-11-02 2013-07-24 雪印メグミルク株式会社 Method for producing L-ornithine-containing material
CN102695422A (en) * 2010-01-06 2012-09-26 株式会社明治 Method for producing fermented milk, and dairy product
CN102433290B (en) * 2012-01-16 2013-06-12 江南大学 Strain for producing citrulline and method for biologically synthesizing citrulline with same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04287636A (en) * 1991-03-18 1992-10-13 Snow Brand Milk Prod Co Ltd Fermented milk and its production

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HU Y ET AL.: "Study on the Production of L- citrulline by Engineering Bacteria and Applied to the Tobacco", SHIPIN GONGYE, vol. 33, 2012, pages 55 - 58 *
KUNIO YAMAUCHI ET AL., MILK SOGO JITEN, 1998, pages 233 - 251 *
POOLMAN B ET AL.: "Regulation of arginine- ornithine exchange and the arginine deiminase pathway in Streptococcus lactis", JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5597 - 5604, XP055214696 *
VRANCKEN G ET AL.: "The arginine deiminase pathway of Lactobacillus fermentum IMDO 130101 responds to growth under stress conditions of both temperature and salt", FOOD MICROBIOLOGY, vol. 26, 2009, pages 720 - 727, XP026583272 *
WANG Y ET AL.: "Study on optimization on fermentation conditions of producing citrulline by Enterococcus faecalis SK 23.001", SCIENCE AND TECHNOLOGY OF FOOD INDUSTRY, vol. 33, 2012, pages 233 - 241 *
ZHAO Y ET AL.: "Enzymatic and continuous production of L-citrulline by immobilized Streptococcus faecalis cells", JOURNAL OF BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY ( NATURAL SCIENCE, vol. 37, 2010, pages 98 - 102 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018023301A (en) * 2016-08-09 2018-02-15 株式会社明治 Citrulline-containing fermented milk and method for producing the same
WO2018030388A1 (en) * 2016-08-09 2018-02-15 株式会社明治 Citrulline-containing fermented milk and method for producing same
CN109661178A (en) * 2016-08-09 2019-04-19 株式会社明治 Acidified milk and its manufacturing method containing citrulling
CN106479923A (en) * 2016-10-19 2017-03-08 江南大学 The Lactobacillus fermenti of one plant of simultaneously degrade arginine and carbamide
CN106479923B (en) * 2016-10-19 2019-05-17 江南大学 The lactobacillus fermenti of one plant of degrade simultaneously arginine and urea
JP2018076714A (en) * 2016-11-10 2018-05-17 大阪瓦斯株式会社 Petroleum recovery increasing nutrition
WO2018220917A1 (en) * 2017-05-31 2018-12-06 キリン株式会社 Composition for fatigue recovery and/or prevention of fatigue accumulation
US11103543B2 (en) 2017-05-31 2021-08-31 Kirin Holdings Kabushiki Kaisha Composition for recovering from fatigue and/or preventing fatigue accumulation
JP2018075036A (en) * 2018-02-02 2018-05-17 株式会社明治 Citrulline-containing fermented milk and method for producing the same
WO2022030493A1 (en) * 2020-08-03 2022-02-10 国立大学法人北海道大学 Zinc protoporphyrin ix-forming agent containing lactic acid bacteria, and color tone-improving method and manufacturing method for processed food using same
JP2022028150A (en) * 2020-08-03 2022-02-16 国立大学法人北海道大学 Lactic acid bacterium-containing agent for forming zinc protoporphyrin ix, and color tone improvement method using the same and production method
JP7190750B2 (en) 2020-08-03 2022-12-16 国立大学法人北海道大学 Zinc protoporphyrin IX forming agent containing lactic acid bacteria, method for improving color tone of processed food using the same, and method for producing processed food

Also Published As

Publication number Publication date
CN107172883A (en) 2017-09-15
JPWO2015111597A1 (en) 2017-03-23
SG11201605881YA (en) 2016-09-29
JP6535285B2 (en) 2019-06-26
HK1243461A1 (en) 2018-07-13

Similar Documents

Publication Publication Date Title
JP6535285B2 (en) Method of preparing citrulline
Hemme et al. Leuconostoc, characteristics, use in dairy technology and prospects in functional foods
JP4862053B2 (en) New lactic acid bacteria
Hernandez-Mendoza et al. Preparation of a whey-based probiotic product with Lactobacillus reuteri and Bifidobacterium bifidum
EP2568815B1 (en) Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
Cho et al. Isolation and characterization of lactic acid bacteria from kimchi, Korean traditional fermented food to apply into fermented dairy products
Harun-ur-Rashid et al. Probiotic characteristics of lactic acid bacteria isolated from traditional fermented milk “Dahi” in Bangladesh
JP5774517B2 (en) Method for producing fermented food containing Bifidobacterium
Guzel-Seydim et al. Kefir and koumiss: microbiology and technology
WO2012029835A1 (en) Method for producing fermented food containing bifidobacterium bacteria
JP2006238743A (en) Method for culturing lactic acid bacteria, lactic acid bacteria cultured product, food and drink, feed and feed additive, and pharmaceutical
JP4794592B2 (en) New lactic acid bacteria
RU2579907C2 (en) Application of nisin-resistant mutants for reduction of post-oxidation of food products
WO2015111598A1 (en) Method for culturing lactic acid bacteria at high concentration
JP6117474B2 (en) Food / beverage product containing lactic acid bacteria having high survival rate and method for producing the food / beverage product
CN109593668B (en) Lactococcus lactis subspecies lactis capable of highly producing isovaleraldehyde and application thereof
JP4794593B2 (en) Method for producing fermented milk using novel lactic acid bacteria
Srinivasan et al. Invitro Anti-bacterial activity of Lactobacillus plantarum isolated from soy milk
Abiona et al. Molecular characteristics of probiotics lactic acid bacteria isolated from soursop, cowmilk, goatmilk yoghurts and cheese
JP5351113B2 (en) Method for producing fermented food containing Bifidobacterium
Isa et al. The behavior of lactobacillus casei as a potential probiotic in food carrier and simulated gastric juice
Simova et al. In vitro and in situ bacteriocin activity of lactic acid bacteria from Bulgarian dairy products and methods for making of Lactobacillus protective fermented milks with bacteriocin inhibitory substances
FARHADI et al. RESEARCH Production of propionic acid in a fermented dairy beverage
Gray The Influence of Yeasts At Prolonging the Shelf-Life of Probiotics in Yogurt.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15740900

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2015559080

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15740900

Country of ref document: EP

Kind code of ref document: A1